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Research suggests that the concurrent use of alcohol and medications can lead to a 
number of health problems.  This is of importance for older adults, who take more medication 
than any other age group.  Despite older adults’ increased risk of alcohol-medication interaction 
there has been limited research focused on the patterns and correlates of simultaneous alcohol 
and medication use in older adults.  The purpose of this study was to examine the prevalence and 
patterns of concurrent use among community-dwelling older adults by gender, race and age.  The 
impact of group membership on health status was also examined. 
Data from the Cardiovascular Health Study (CHS), a population-based longitudinal study 
of older adults, were analyzed for this study.  The CHS cohort consists of 5,888 individuals ages 
65 and older. Participants completed a series of face-to-face and telephone interviews along with 
clinical examinations. This analysis utilizes CHS data from waves 1 through 6.    Univariate 
analyses were conducted at baseline to determine the prevalence rates and correlates of 
concomitant use among older adults.  Group-based logit modeling was used to chart longitudinal 
patterns of use over the course of the study.  Finally, multinomial logistic regression analyses 
were employed to assess the relationship between various patterns of concurrent use and health 
outcomes. 
 v 
Results demonstrated that concurrent use is fairly common among community-dwelling 
older adults.  Men, Whites, younger individuals and problem drinkers were significantly more 
likely to concurrently use than women, African Americans, older respondents and low to 
moderate alcohol users.  Furthermore, group-based logic analysis revealed four distinct patterns 
of concurrent use: a no to low use group, a decreasing use group, an increasing use group, and a 
high use group.  Males and Whites had the highest probability of being in the high use group.  
Group membership was found to be related to physical and mental health.  Furthermore, 
concurrent use was found to increase the risk of mortality among study participants. 
These findings indicate a significant need for social work and health care professionals to 
educate older adults about the dangers of concurrent alcohol-medication use.  Additionally, it 
appears that there is a need for health campaigns that focus on the promotion of safer use of 
alcohol and medications by older adults. 
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1.0  INTRODUCTION 
Medication may well be the single most important health care technology to prevent illness, 
disability, and death in older adults (American Society of Consultant Pharmacists (ASCP), 2004; 
American Society on Aging (ASA), 2001).  Older persons with chronic conditions and diseases 
benefit the most from taking medications yet risk the most from failing to take them properly 
and/or combining them with alcohol (Sullivan et al., 2007; Vik et al., 2006).  The misuse of 
alcohol and medications among older adults is one of the most rapidly developing public health 
issues in the United States (Sullivan et al., 2007; Christensen et al., 2006; Patterson & Jeste, 
1999).  Over half of individuals aged 65 and older consume alcohol, with approximately 34% of 
older adults reporting regular weekly consumption of alcoholic beverages (Onder et al., 2002). In 
addition, seniors take an average of 5.3 prescription drugs and 5.7 over-the-counter medications 
a day (Substance Abuse and Mental Health Service Administration (SAMHSA), 2004; ASA, 
2001).  Although the interaction of alcohol and prescription drugs is an important health concern 
for individuals of all ages, it is a particularly salient issue for older adults who take more 
medication than any other age cohort and are more susceptible to the effects of alcohol and/or 
medications. 
Older adults are at an increased risk for medication misuse for a number of reasons 
including but not limited to polypharmacy, socioeconomic changes, and physiological as well as 
psychological changes associated with aging (Sullivan et al., 2007; Swift et al., 2007; SAMHSA, 
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2004).   Social workers, who come in frequent contact with older Americans, are employed in a 
variety of settings and have a wide range of duties, making them uniquely situated to deal with 
issues associated with concurrent alcohol and medication use among older adults.  Social 
workers can play an instrumental role in identifying and reducing rates of concomitant use as 
well as the subsequent negative social and economic costs associated with the behavior by 
assisting in the development of screening and diagnostic measures of concurrent use; 
implementing education programs for older adults, caregivers and health care professionals; 
helping to form linkages among professionals in the aging care network; and assisting in the 
implementation of harm reduction models.  
Despite an emerging body of empirical evidence that suggests that concurrent use is 
rather common among older adults, little research has focused on examining patterns of 
concomitant alcohol and medication use among older adults.  The primary goal of this study was 
to examine the prevalence, correlates, and consequences associated with the concurrent use of 
alcohol and medication in a sample of community-dwelling older adults.  Although past 
empirical research has examined concurrent use among community-dwelling older adults, this 
study is unique in that it explores the issue of concurrent use outside of the primary and acute 
care settings using longitudinal data from a large sample of individuals aged 65 and older.  This 
allowed for the exploration of the prevalence and patterns of concurrent use in a general 
population of older adults without a precipitating adverse drug event. 
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1.1 STUDY PURPOSE 
The overall aim of this research study was to examine patterns of concurrent alcohol and 
prescription and/or over-the-counter medications use among community-dwelling older adults.  
This study explored how usage patterns evolve over time and the factors, including age, gender, 
and race, affecting various trajectories of concurrent use.  Group-based modeling was used to 
identify distinct clusters of individuals with homogenous longitudinal patterns of concurrent use 
within the sample.  Moreover, individual-level differences in concomitant usage patterns at the 
group level were also explored.  Being able to identify distinctive trajectories of concurrent use is 
particularly helpful for both research and practice.  In addition, understanding individual 
developmental trajectories and what factors impact patterns of concurrent use can be 
instrumental in the formulation of both policy and intervention strategies that target subgroups of 
older adults at increased risk for concurrent use. 
In addition to examining longitudinal patterns of concurrent use, this study sought to 
explore the impact of individual trajectories of concomitant use on health status.  Despite the fact 
that older adults are at an increased risk of alcohol-medication interaction, limited research has 
focused on the effects of concomitant alcohol and medication use on their health status.  In an 
effort to expand upon the existing knowledge base regarding concurrent use and health, this 
study also sought to examine how specific trajectories of concomitant use affected the health 
status of older adults.  While existing research indicates that moderate levels of alcohol use may 
be beneficial to the overall health of older adults (Hendriks & van Tol, 2005), there is reason to 
believe that the concomitant use of alcohol and medication can lead to a number of significant 
health problems for older adults (Blow & Barry, 2002; Kennedy et al., 1999; Weathermon & 
Crabb, 1999).  Physiological changes associated with aging, coupled with the high rates of 
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medication use, make older adults extremely vulnerable to the adverse effects of concurrent 
alcohol and medication use.  Past research indicates that a broad range of measures are necessary 
to accurately assess physical and mental health functioning (Newsom & Schulz, 1996).  
Therefore, a combination of measures was used to obtain a comprehensive measure of health 
status including, self-reported health status and physical functioning (IADLs and ADLs) to 
measure physical health status and depression to assess mental health.  
Concurrent use has been defined in a variety of ways; however, a common definition and 
the one employed in the present study refers to the use of one or more substances in the same 
time period but not necessarily at the same time (Schensul, Convey & Burkholder, 2005; 
McCabe, Cranford, Morales & Young 2006).1
The current study used longitudinal data from the Cardiovascular Health Study (CHS), a 
population-based longitudinal study of nearly 6,000 adults 65 years or older, to explore patterns 
of concurrent use and examine the effects of concurrent alcohol and medication on the health of 
older adults. This study had three specific goals: 
  The focus of this study is the concurrent use of 
alcohol and alcohol-interactive drugs.  Medications are considered alcohol-interactive if the use 
of alcohol with the medication influences the metabolism of the drug, impacts the enzymes 
involved in drug pharmacokinetics, or magnifies the effects of the medication (Jalbert et al., 
2007; Alberta Alcohol and Drug Abuse Commission (AADAC), 2003).   
(1) To describe the prevalence rates of concurrent alcohol and medication use among 
community-dwelling older adults.  In addition, analyses were conducted to examine 
whether rates of concomitant alcohol and medication use vary by demographic 
factors including age, gender, and race. 
                                                 
1 Note:  An in-depth explanation of key study terms, including definitions of concurrent use and alcohol-interactive  
            medications, is presented in the literature review and methodology sections. 
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(2) To examine how the concomitant use of alcohol and medications in older adults 
evolves over time.  Analyses explored various trajectories of concurrent use and 
whether individual patterns of use differ by age, gender, and race. 
(3) To assess how various trajectories of concomitant alcohol and medication use affect 
the physical and mental health status of older adults.  
1.2 RESEARCH QUESTIONS AND HYPOTHESES 
This study focused on three primary areas of interest: 1) prevalence of concurrent alcohol and 
medication use among community-dwelling older adults; 2) differences in longitudinal patterns 
of concurrent use among older adults and; 3) the relationship between patterns of concurrent use 
and physical as well as mental health status among community-dwelling older adults.  Given 
these three areas of focus the current investigation addresses the following questions and 
hypotheses. 
  Given the fact that approximately half of individuals aged 65 and older consume alcohol, 
and seniors take an average of 5.3 prescription drugs and 5.7 over-the-counter medications a day 
it was predicted that concurrent use would be fairly common among older adults (Substance 
Abuse and Mental Health Service Administration (SAMHSA), 2004; ASA, 2001).   The 
literature also shows that Women and African Americans report higher rates of abstinence than 
Men and Whites.  Therefore, it was hypothesized that rates of concurrent use would be greatest 
among males and Whites (Breslow et al., 2003) 
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1.  Prevalence of concurrent use among community-dwelling older adults 
 
 
 
 
 
 
 
 
  
 
 
 
Approximately half of all seniors consume alcohol on a regular basis and epidemiological 
research on alcohol use among older adults estimates that anywhere from 2% to 15% of older 
adults are at-risk or problem drinkers (Grant et al., 2004; NIAAA, 2004; Olsin & Holden, 2002; 
ASA, 2001).  Furthermore, 2% to 5% of these seniors meet the criteria for alcohol abuse or 
dependence (NIAAA, 2004; ASA, 2001).   Prevalence and amount of consumption also varies by 
gender and race; men and Whites tend to consume higher rates of alcohol and drink more 
frequently than women and African Americans (Satre & Arean, 2005; Breslow et al., 2003).  
Based on these facts it was hypothesized that there would be several unique trajectories of 
Q-1:  What is the prevalence rate of concurrent alcohol and medication use among  
          community-dwelling older adults? 
 
H.1:  Concurrent use is common among community-dwelling older adults. 
 
Q-2:  Do rates of concurrent alcohol and medication use differ by gender, race, and age? 
 
H.2.a:  Males are more likely than female community-dwelling older adults to concurrently  
           use alcohol and medications. 
 
H.2.b:  White community-dwelling older adults have higher rates of concurrent use than 
          their African American counterparts. 
H.2.c:  Younger community-dwelling older adults are more likely to concurrently use when  
           compared to older individuals. 
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concurrent use.  In addition, it was postulated that men and Whites would be more likely to be 
members of group trajectories with higher rates of concurrent use.  
 
2. Longitudinal patterns of concurrent use among community-dwelling older adults 
 
 
 
 
 
 
 
 
 
 
  
Q-1:  Are there varying longitudinal patterns of concurrent use among community- 
          dwelling older adults? 
H.1:  There are a minimum of two distinct trajectories of concurrent use among 
          community- dwelling older adults. 
 
Q-2:   Do patterns of concurrent alcohol and medication use differ by gender and race? 
H.2.a:  Males are less likely than female community-dwelling older adults to have  
             patterns of concurrent alcohol and medications characterized by a trajectory of  
             no use over time. 
H.2.b:  White older adults are more likely than their African American counterparts to 
             have longitudinal patterns of concurrent alcohol and medication use  
             characterized by a trajectory of sustained concomitant use over time. 
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There are a number of serious consequences associated with concurrent alcohol and 
medication use among older adults.  For example, concomitant use of medications like 
benzodiazepines, muscle relaxants, and opioids can cause ADEs such as increased sedation and 
decreased motor skills; these problems can lead to falls or other accidents (Tanaka, 2003; 
Weathermon & Crabb, 1999).  Concurrent alcohol and medication use can also adversely affects 
the illness for which the medications are prescribed.  Many of the chronic conditions common 
among older adults such as hypertension, diabetes, gastrointestinal conditions, insomnia and 
depression are exacerbated by alcohol use (Moore et al., 2007).  Thus, it was hypothesized that 
individuals with higher levels of concurrent use would report lower overall physical and mental 
health. 
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3.   The association between patterns of concurrent use and physical and mental health 
status 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Q-1:  Do patterns of concurrent alcohol and medication use affect the physical health status  
         of community-dwelling older adults? 
 
H.1.a:  Older adults who have sustained longitudinal patterns of concurrent use are more 
           likely to report poor physical health when compared to individuals with no  
                       concurrent use. 
H.1.b:  Older adults who have sustained longitudinal patterns of concurrent use are more  
             likely to report difficulties with physical functioning when compared to older  
             adults who report no longitudinal pattern of concurrent use. 
 
Q-2:  Do patterns of concurrent alcohol and medication use affect the mental health status of  
         community-dwelling older adults? 
 
H.2.a:  Rates of depression are more common among community-dwelling older adults 
             who have longitudinal patterns of concurrent alcohol and medication use when  
             compared to older adults  who report no longitudinal pattern of concurrent use. 
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1.3 STUDY SIGNIFICANCE 
In recent years, significant advances have been made in the understanding of both the aging 
process with its attendant health problems and in the understanding and consequences of alcohol 
misuse.  However, our understanding of concomitant alcohol and medication use in older adults 
remains limited.  The majority of research regarding concurrent alcohol and medication use has 
been conducted with young or middle-aged populations and has focused primarily on chronic 
heavy drinkers; few studies have examined the alcohol-medication interactions among low to 
moderate users in the general population of older adults (Onder et al., 2002).  Some studies have 
investigated the prevalence of concomitant use in retirement communities (Adams, 1995), 
emergency room departments (Adams, 1992), primary care settings (Blow et al., 2000; Adams et 
al., 1996) and hospitals (Bristow & Clare, 1992).  Yet, community level studies are scarce, and 
those focusing on the effects of moderate alcohol use and medication use among older adults are 
even more uncommon.   
This study makes a number of significant contributions to social work, gerontology, and 
public health policy—all of which can help improve the lives of older adults and their families.  
Furthermore, the results of this study can aid in developing programs and policies that reduce the 
economic and health burdens associated with medication misuse among older adults.  First, the 
current study expands upon the existing knowledge base by examining concurrent use among the 
full spectrum of drinkers.  Examining concurrent use in community-dwelling older adults will 
aid in developing a more thorough understanding of concomitant usage rates and patterns among 
seniors.  Studies indicate that suboptimal drug use and medication errors such as concomitant use 
have an important impact on health and the national economy; adverse drug events have been 
found to be associated with increased costs of care in both the inpatient and outpatient settings 
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(Burton et al., 2007).  In a recent study Ernst and Grizzle (2001) found that since 1995, the costs 
associated with adverse drug events has more than doubled.  In 2000, the costs of drug-related 
morbidity and mortality exceeded $177.4 billion with hospital admissions accounting for nearly 
70% of total costs (Ernst & Grizzle, 2001).   Older adults are disproportionately affected by 
adverse drug events and reactions, yet, research has found that identifying problem alcohol 
and/or medication misuse is particularly difficult in elderly individuals (Sullivan, 2007).  
Identifying at risk individuals is the key to aiding social workers, health care professionals, and 
other members of the Aging care network with designing effective education, prevention, and 
intervention strategies that can assist in mitigating the high economic as well as medical burdens 
associated with adverse drug events and improve the quality of life for older adults; this study 
will assist in identifying specific subpopulations that may be at an increased risk for concomitant 
use.   
Traditionally, studies examining the concurrent use of alcohol and medication have 
focused on heavy or chronic drinkers; thus, we know very little about the prevalence rates, 
patterns of usage and the adverse effects of concurrent use among low or moderate drinkers.  
Research paradigms that focus on persons who are abusing or who are dependent on alcohol are 
not as useful when applied to older drinkers whose alcohol use, despite a  lower alcohol 
consumption level, can be problematic due to age-related physiological changes, medication use, 
and functional mobility (Moore et al., 1999).  Given these factors, it is critical that we explore 
concurrent use in all older adults who consume alcohol, not just those who are considered 
problem drinkers.  The current study explored longitudinal patterns of concomitant use in older 
adults with a range of alcohol consumption patterns.  The identification of various patterns of 
concurrent use, as well as the sociodemographic factors associated with unique trajectories of 
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concomitant use, is crucial knowledge that can assist social workers, health professionals, and 
other members of the aging care network with designing prevention as well as intervention 
strategies that target at-risk population such as older adults who consume the majority of 
medications taken in the United States.  
In addition to issues associated with the conceptualization of concurrent use, the small 
body of research that has examined the concomitant use of alcohol and medication in older 
adults has largely drawn from acute or primary care settings and tends to focus on prevalence 
rates rather than examining health outcomes (Aira, 2005).  This study is unique in that it 
examines concurrent use in a sample of community-dwelling older adults.  The growing 
population of older adults coupled with increased life expectancies will likely lead to more 
seniors living within the community, making the understanding of the correlates and usage 
patterns of concurrent use among older adults increasingly important for social workers, health 
care professionals, and other individuals in the aging care network who work with older adults 
on a daily basis.  Data from this study can be used to educate geriatric social workers, case 
managers and other health care professionals about the dangers of concomitant alcohol and 
medication use.  It can also help to inform relevant professionals of specific subpopulations that 
are at an increased risk for concurrent use.  Further, this study advances our knowledge of 
concurrent use among older adults and can be used to assist geriatric social workers, as well as 
other health care practitioners, in the development of policies and programs that educate older 
adults about the dangers of concurrent alcohol-medication use.  Additionally, it appears that 
there is a need for health campaigns to focus on the promotion of safer use of alcohol and 
medications by older adults.  Public awareness campaigns and educational efforts are two key 
 13 
tactics that can play a large role in reducing the burden associated with medication misuse 
(Sullivan et al., 2007). 
Finally, despite the fact that research has shown that the use of alcohol with alcohol-
interactive medications can lead to a number of physical and mental health issues, most of the 
empirical research on concurrent use among community-dwelling older adults has explored the 
prevalence of adverse drug events associated with concomitant use (Aira, 2005; Blow, 2002).  In 
the majority of these studies, adverse drug reactions have been the primary outcome measure; 
therefore, we have very limited knowledge about the broader adverse health consequences 
associated with concurrent alcohol and medication use.  This study is unique in that it explores a 
variety of health outcomes.  Concomitant use is a dangerous practice that can be harmful to older 
adults, reducing their quality of life, impacting upon their health, and possibly leading to lethal 
consequences (Moore et al., 2007).  For example, concomitant use of medications like 
benzodiazepines, muscle relaxants, and opioids can cause adverse drug events such as increased 
sedation and decreased motor skills, which can lead to falls or other accidents in older adults 
(Tanaka, 2003; Weathermon & Crabb, 1999).  In order to develop effective policies and 
programs aimed at reducing medication misuse among older adults we must have an 
understanding of the patterns and correlates of medication use among this population.  
Understanding what subpopulations of older adults are at an increased risk for concurrent use 
and identifying concomitant use patterns is crucial to developing effective prevention and 
intervention strategies.  
Over the coming decades, the increasing number of aging baby boomers will have a 
considerable impact on the need and demand for health care among older adults (Blow et al., 
2002).  With the demographic projections and alcohol use trends indicating that newer cohorts of 
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older adults are more likely to drink and to have heavier drinking habits than previous 
generations, alcohol use among older adults presents one of the most salient health problems 
facing this country.  Moreover, as the number of older individuals using prescription medications 
increases, so too does the absolute number of older adults using alcohol-interactive medications.  
Despite these trends, little is known about the prevalence of concurrent alcohol and medication 
use in community-dwelling older adults.   
The increased service needs of aging alcohol users will also place additional financial 
strain on existing resources.  In a recent study Ernst and Grizzle (2001) found that the costs 
associated with adverse drug events have more than doubled since 1995.  In 2000, the costs of 
drug-related morbidity and mortality exceeded $177.4 billion, with hospital admissions 
accounting for nearly 70% of total costs, followed by long-term-care admissions, which 
accounted for 18% (Ernst & Grizzle, 2001).  Prevention and intervention strategies are needed in 
order help mitigate the high economic as well as medical burdens associated with adverse drug 
events.   
In spite of these facts, little is known about patterns of concurrent alcohol and medication 
use among older Americans, a common form of medication misuse among older adults which 
can lead to adverse drug events.  The growing population of older adults has led to service 
providers making primary disease prevention and the promotion of healthy lifestyles top 
priorities in the provision of services to older adults.  Gaining a better understanding of the 
prevalence, correlates, and consequences of concomitant alcohol and medication use is critical to 
developing prevention and intervention strategies that effectively meet the needs of older adults. 
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2.0  REVIEW OF LITERATURE 
2.1 OVERVIEW OF LITERATURE REVIEW 
The literature review is divided into three major sections: alcohol use, medication use, and 
concurrent alcohol and medication use among older adults.  In the first section there is an 
overview of the basic mechanisms for processing alcohol by older adults.  The description of 
alcohol pharmacokinetics is followed by a discussion of definitions, guidelines and screening, 
and diagnostic issues associated with alcohol use among older adults.  The next section includes 
a summary of past research on the prevalence rates of alcohol use among older adults.  The final 
alcohol section is a review of the literature on the relationship between alcohol use and health 
status among older adults.   
The review of the literature on medication use among older adults follows a similar 
format to that of the section on alcohol use, beginning with a summary of the pharmacokinetics 
of prescription medications.  This is followed by a discussion of the literature regarding the 
prevalence of medication use and the risks associated with using prescription medications drugs.  
The portion of the review on concurrent use ties together the research reviewed regarding alcohol 
and medication use among older adults.  This section includes a discussion of the prevalence and 
potential consequences of concurrent use.  
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2.2 ALCOHOL USE AMONG OLDER ADULTS 
2.2.1 Alcohol pharmacokinetics 
Alcohol pharmacokinetics in humans is a complex process and is dependent upon a number of 
factors, including the amount and type of alcohol ingested, the presence of food in the stomach, 
body water, age, and gender (Norberg et al., 2003).  There are three basic processes associated 
with the delivery and removal of alcohol (ethanol) from the body: absorption, distribution and 
metabolism.   
After entering the body, most alcohol (80%) is absorbed by the duodenum, a portion of 
the small intestine; the remaining alcohol is absorbed through the stomach (Swift, 2003).  There 
are a number of factors that determine the rate at which alcohol is distributed throughout the 
body.  The most important is the presence of food in the stomach (Paton, 2005; Swift, 2003).  
Food slows the rate of alcohol delivery to the intestine by delaying gastric emptying.  Reducing 
the speed at which alcohol is transported to the intestine serves to lower the resulting blood 
alcohol level (Swift, 2003).  In addition, food in the stomach lowers the concentration of alcohol 
by dilution (Swift, 2003).  Other factors that impact the absorption process are time of day, the 
concentration of the alcohol ingested, and the pattern of drinking (Norberg et al., 2003). 
After the stomach and intestine have absorbed the alcohol, it is distributed in the body via 
the bloodstream (Swift, 2003).  Most tissues—such as the heart, brain, and muscle—are exposed 
to alcohol because it is dispersed throughout the water in the body (Paton, 2005).  The majority 
of alcohol ingested (95–98%) is metabolized in the liver, while the remainder is excreted through 
the breath, urine, and sweat (Norberg et al., 2003).   
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The metabolism of alcohol is a two-step process.  First, the enzyme gastric alcohol 
dehydrogenase (ADH) converts the alcohol to acetaldehyde (Swift, 2003).  The acetaldehyde, a 
highly reactive and toxic substance, is then converted to harmless acetic acid by the enzyme 
aldehyde dehydrogenase (ALDH), metabolizing ethanol in the body (Paton, 2005).  In healthy 
individuals this oxidation process happens rapidly (Paton, 2005).  As stated earlier, there are a 
number of physiological and behavioral factors that influence the body’s ability to process 
alcohol; of particular importance to this study are age, gender, and medication use. 
2.2.1.1 Factors Influencing the Metabolism of Alcohol 
Age 
Older adults are especially susceptible to the adverse consequences of alcohol use because of 
physiological changes associated with aging (Sullivan et al., 2007; Lands, 1998; Atkinson et al., 
1992; Vestal, 1977).  Between the ages of 25 and 65, the proportion of total body weight 
represented by fat dramatically increases: it doubles in men and grows by almost 50% in women 
(Dufour, 1992).  The result is a vast decrease in lean body mass and a reduction in total body 
water (Friedlander & Norman, 2006).  Alcohol is a water-soluble substance; therefore, when 
alcohol is distributed in a lower volume of body water it leads to a high blood alcohol 
concentration (Friedlander & Norman, 2006).  As a result older adults, because of their low 
levels of body water, develop higher blood alcohol levels than younger individuals who consume 
the same amount of alcohol.   
In addition to changes in the body’s composition, other physical conditions associated 
with aging also affect the distribution and metabolism of alcohol in older adults.  Aging leads to 
an impaired ability to metabolize and clear alcohol from one’s system due to compromised 
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hepatic and renal functioning, a decreased effectiveness of the blood brain barrier, and an 
increased use of medications (Sanjuan & Langenbucher, 1999).  Older adults also have lower 
levels of the enzyme ADH, which inhibits their ability to metabolize alcohol as rapidly as 
younger people.  The result is an increased blood alcohol concentration (Beechem, 2002).  A 
slower metabolic rate also increases the amount of time that alcohol is in the stomach, 
intensifying its toxic effects (Beechem, 2002). 
Gender 
Due to physiological differences between the sexes, women of all ages prove more susceptible to 
the effects of alcohol than men.  Women reach higher blood alcohol concentrations than their 
male counterparts in the same weight-adjusted levels of alcohol consumption (Epstein et al., 
2007).  This is due to several factors: women have less body water than men of a similar weight; 
less lean muscle mass; and lower levels of the enzyme ADH, which is responsible for breaking 
down alcohol in the stomach (Epstein et al., 2007).  The unique physiology of women leads to 
what has been termed the “telescoping effect”: females develop issues earlier in their drinking 
careers; they suffer more severe adverse health consequences from their alcohol consumption; 
and the health effects of their alcohol use emerge more rapidly than the rates seen in men 
(Redgrave et al., 2003).  
An example of the telescoping effect is the development of cirrhosis of the liver: 
compared to men, women develop cirrhosis with less alcohol consumption and after a shorter 
duration of alcohol use (Nolen-Hoeksema, 2004).  Age-related changes in physiology, coupled 
with the decrease of lean tissue experienced by older women, serve to intensify the telescoping 
effect in females.  Thus, even low to moderate levels of alcohol consumption can be particularly 
hazardous for older women (Epstein et al., 2007).  
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2.2.2 Alcohol Guidelines for Older Adults 
The physiological changes associated with aging, high levels of physical and mental health 
problems, and increased levels of medication use have led to the creation of alcohol guidelines 
for older adults that are lower than those recommended for other age cohorts.  The National 
Institute of Alcohol Abuse and Alcoholism (NIAAA) recommends that individuals ages 65 and 
older consume no more than one standard drink a day or seven standard drinks a week (NIAAA, 
1995).  A standard drink contains approximatly14 grams or 0.6 fluid ounces (NIAAA, 1995).  
Although different brands and types of beverages vary in their actual alcohol content, a standard 
drink is roughly the equivalent of one 12-ounce beer, a 5-ounce glass of wine, or 1.5-ounces of 
80 proof distilled liquor (Blow et al., 2002).  NIAAA guidelines also recommend that older 
adults should not consume more than two drinks on any one occasion; more than this is 
considered binge drinking (Blow et al., 2002).  The NIAAA-recommended guidelines for levels 
of alcohol use among older adults are consistent with research regarding alcohol-related 
problems, as well as current data on the beneficial health effects of moderate alcohol 
consumption (Blow et al., 2002). 
2.2.3 Definitions of Alcohol Use among Older Adults 
Older adults who consume alcohol can be placed into one of five categories: abstinence, low-
risk, at-risk, problem, and alcohol abuse or dependence (Barry et al., 2001; Blow, 1998).  These 
categories of alcohol use are designed to form a framework for understanding the spectrum of 
alcohol consumption among older adults (Barry et al., 2001; Blow, 1998).   
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Older adults who presently consume no alcohol are classified as abstainers (Barry et al., 
2001; Blow, 1998).  Individuals are categorized as low-risk drinkers if their alcohol consumption 
is below or within the recommended guidelines for older adults—one or less drinks a day or no 
more than seven drinks a week (Barry et al., 2001; Blow, 1998).  Older adults who drink above 
the recommended guideline but who do not meet specific criteria for alcohol abuse or 
dependence are classified as at-risk drinkers (Oslin & Holden, 2002; Barry et al., 2001; Blow, 
1998).   
At-risk drinkers are individuals who may develop alcohol-related problems because they 
consume more than one drink a day or seven drinks a week.  This is a particularly relevant 
classification category for older adults who may be consuming what they believe are safe 
amounts of alcohol, but who are putting themselves at risk for alcohol-related problems due to 
the physiology of aging and increased levels of medication use.   
Problem use is defined as the consumption of alcohol at a level that has already led to a 
least one adverse medical, psychological or social consequence (Olsin & Holden, 2002; Barry et 
al., 2001; Blow, 1998).  For example, an individual’s alcohol use may  negatively impact his/her 
depression or diabetes.  It is not assumed that alcohol is the cause of the problem; however, there 
is an inference that the usage has led to or has exasperated the issue (Olsin & Holden, 2002). 
The final classification category is alcohol abuse or dependence.  According to the most 
recent version of the Diagnostic and Statistical Manual Fourth Edition (DSM-IV), alcohol abuse 
is characterized by an inability to fulfill responsibilities and continued drinking despite 
experiencing negative consequences (American Psychiatric Association (APA), 2000).  Alcohol 
dependence or alcoholism is distinguished by the following: a loss of control, a preoccupation 
with alcohol, and physiological symptoms such as tolerance and withdrawal (APA, 2000).  It is 
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worth noting that the DSM-IV criteria for diagnosing alcohol abuse and dependence have 
undergone minimal validation with older adults; criteria are based on knowledge gathered from 
young to middle-aged adults (Olsin & Holden, 2002).  Therefore, the DSM-IV criteria may not 
be the best way to assess hazardous drinking in older adults (Olsin & Holden, 2002).  Recently, 
the accuracy of current problem rates among older adults has been called into question (Barrick 
& Connors, 2002; Klein & Jess, 2002; Johnson, 2000).  It is suggested that the prevalence of 
alcohol use among older adults significantly underestimates the problem (Barrick & Connors, 
2002).   
2.2.4 Screening and Diagnostic Issues 
Diagnostic criteria and screening instruments for addictive disorders have tended to ignore age, 
lending to a dearth of information on specific diagnostic criteria for older adults (O’Connell et 
al., 2004).  Thus, traditional screening instruments are not as useful when applied to older 
drinkers where substance use, regardless of consumption level, can be problematic because of 
age-related physiological changes, medication use, and functional mobility (Moore et al., 1999).  
A lack of adequate detection and diagnostic techniques for older adults means that substance 
abuse often goes undetected in this population, and those needing treatment do not receive 
services.  One of the primary issues associated with determining accurate prevalence rates of 
alcohol use among older adults is the lack of adequate geriatric screening and diagnostic tools.  
This problem is confounded by age-related social and physiological issues.  The number and 
interrelationship of physical and mental health disorders in older adults can complicate the 
diagnosis and treatment of substance abuse disorders.  Typically, substance-related problems in 
this population are only identified when these individuals are hospitalized for physical illnesses.   
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Although screening instruments and diagnostic criteria for alcohol use disorders are 
clearly defined for younger populations, there is a lack of information on age-specific criteria for 
older adults (O’Connell et al., 2004).  In a study of patients entering a general hospital in the 
United States, 60% of people under the age of 60 who screened positive for alcoholism were 
identified, as compared to only 37% of those persons 60 and older (Lynskey et al., 2003). Many 
of the social and legal problems that have served as traditional markers of alcohol-related 
problems may not be applicable to older individuals (Lynskey et al., 2003).   
Additionally, existing measures of alcohol use, even those developed specifically for 
geriatric populations, are based on paradigms of alcohol use that have conceptualized alcohol-
related problems in terms of abuse and dependence.  These paradigms are not as useful when 
applied to older drinkers whose alcohol use, regardless of consumption level, can be problematic 
because of age-related physiological changes, medication use, and issues related to functional 
mobility (Moore et al., 1999).  Adequately determining alcohol usage among older adults is 
further complicated by the natural processes of aging.  Self-reports of alcohol consumption by 
older adults may be difficult to assess due to poor recall, especially if there are medical or 
psychiatric conditions that impair cognitive functioning (Crum et al., 2002).  Moreover, service 
providers may have problems distinguishing symptoms of excessive alcohol consumption from 
health problems that are natural consequences of aging, such as forgetfulness, depression and 
unsteady gait (Klein & Jess, 2002). 
Thus, screening tools that detect hazardous drinking (consumption above the 
recommended guidelines for older adults) as well as alcohol abuse among older adults need to be 
designed.  Furthermore, diagnostic criteria should be able to classify drinking behaviors among 
older adults along a spectrum of use that takes into account the unique risks associated with 
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drinking in late life.  Finally, screening and diagnostic tools need to be designed in a manner that 
takes into account the unique challenges associated with aging such as cognitive decline and 
comorbid health conditions. 
2.2.5 Prevalence Rates of Alcohol Use among Older Adults 
In recent years, there has been an increase in research on the use, misuse and abuse of alcohol by 
older adults (Klein & Jess, 2002; Johnson, 2002).  Scholars have identified five primary reasons 
for the expanded interest in problem drinking among older adults: (1) the growing population of 
individuals aged 65 and older; (2) the lower prevalence of abstinence and more problem drinking 
among younger age cohorts; (3) the continued under-identification, diagnosis and treatment of 
older adults with alcohol use disorders; (4) the likelihood of the increased utilization of mental 
health services among older adults;  and (5) the high costs associated with treating alcohol and its 
related health conditions (Gurnack, 2002; Klein & Jess, 2002; Gurnack & Hoffman, 1992).   
Even though there has been an expansion of the literature about alcohol use disorders in 
older adults, the findings have often been inconsistent, and there are still large gaps in the 
knowledge base, especially in regards to alcohol use among older women and minority 
populations.  Despite inconsistent findings, it is almost universally accepted that substance 
misuse and abuse, particularly of alcohol, among older adults is becoming one of the fastest 
growing health problems in the United States (ASA, 2001; Rigler, 2000).   
Research indicates that 50% of older adults consume some alcohol, with approximately 
34% of respondents reporting regular alcohol consumption (Onder et al., 2002; SAMHSA, 2002; 
ASA, 2001).  A recent study of Medicare beneficiaries found that one-quarter of respondents 
drank within the NIAAA guidelines for older adults (Merrick et al., 2008).  These findings are 
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similar to those found in a large sample of primary care patients: 21.5% drank within the 
guidelines of seven or less drinks a week (Kirchner et al., 2007).  Although half of all older 
adults abstain from alcohol use and an additional quarter are low-risk drinkers, many older adults 
drink above the recommended guidelines, placing themselves at risk for the negative 
consequences associated with alcohol use (NIAAA, 2004). 
It is estimated that anywhere from 1% to 15% of older adults are at-risk or problem 
drinkers; rates vary based on how rates of alcohol use were conceptualized (NIAAA, 2004).  In 
their cross-sectional study of nearly 50,000 older adults, Kirchner and colleagues (2007) found 
that 4.1% of respondents were at-risk drinkers, consuming between 8 to 14 drinks a week, which 
is in excess of the recommended alcohol guidelines for older adults.  Another recent study of 
alcohol usage among seniors found that 9% of the study participants utilized alcohol at levels 
that exceeded the guidelines of no more than 30 drinks a month or the single day limit of three 
drinks (Merrick et al., 2008).  Analysis of the 2005 National Survey on Drug Use and Health 
revealed that 8.3% of older adults reported binge use, defined as 5 or more drinks on one 
occasion which is the standard for adults but greater than the recommended definition of binge 
drinking for older adults which is 2 or more drinks on one occasion (Merrick et al., 2008; Blow 
et al., 2002).  Other recent research also points to harmful alcohol use among older adults.  In a 
large study of older primary care patients, 4.5% were heavy drinkers, consuming 14 or more 
drinks a week (Kirchner et al., 2007).  These findings are consistent with epidemiological 
research on alcohol use among older adults which estimate that anywhere from 2% to 15% of 
older adults are at-risk or problem drinkers and between 2% to 5% of these seniors meet the 
criteria for alcohol abuse or dependence (Grant et al., 2004; NIAAA, 2004; Olsin & Holden, 
2002; ASA, 2001).   
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It should be noted that recent work has called into question the accuracy of current 
statistics regarding the prevalence of alcohol use disorders in elderly populations.  Rates vary 
based on methodological differences between studies including:  the study's location, the 
population studied, how alcohol-related problems are defined, and the age limits used.  One of 
the primary reasons for variations in prevalence rates results from the various definitions of 
problem alcohol use employed by the researchers and how studies define levels of drinking 
behavior (Blow & Barry, 2002).  Some studies use NIAAA guidelines to classify individuals into 
categories based on the quantity of alcoholic beverages they consume while others look at the 
quantity and frequency of consumption but use general drinking guidelines instead of those 
specifically designed for older adults.  Moreover, researchers and clinicians have suggested that 
problem drinking is underestimated due to a variety of factors, including low rates of alcohol 
screening, insufficient diagnostic criteria, and misinterpretation of abuse symptoms.   
2.2.5.1 Gender Differences in Prevalence Rates of Alcohol Use by Older Adults 
Although limited research has focused on alcohol consumption and older women, the research 
that does exist suggests that there are gender differences in prevalence rates and utilization 
patterns between men and women.  Studies have shown that older women are more likely to 
abstain from alcohol use than men, and that women that do drink have lower rates of heavy 
drinking than their male counterparts (Breslow & Smothers, 2004; Breslow & Smothers, 2003).   
Between 2000 and 2001, approximately 11 million older adults consumed alcohol 
however, the prevalence and level of alcohol use differs between men and women (Breslow et 
al., 2003).  In a recent study, a higher percentage of older women (62.8%) than older men 
(48.9%) reported abstaining from alcohol use in the past year; women also had higher levels of 
lifetime abstinence compared to men (42% versus 19.3%) (Breslow et al., 2003).  Data from the 
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National Health Interview Survey also indicate lower levels of alcohol use by older women, with 
41% of women compared to 56% of men between the ages of 65 to 74 consuming alcohol in the 
past year (Schoenborn & Adams, 2002).  Of individuals ages 75 and older, 30% of women 
versus 45% of men reported drinking in the last year (Schoenborn & Adams, 2002).   
In addition, to variations in the prevalence of alcohol use between the genders, evidence 
also points to differences in usage patterns between men and women.  Research on the 
prevalence of alcohol use in individuals over the age of 65 has found that 37.6% of men and 
32.3% of women consumed moderate amounts of alcohol; both men and women consume less 
quantities of alcohol at one time as they age (Breslow & Smothers, 2004; Breslow et al., 2003).  
Finally, studies indicate that older men have a higher prevalence of hazardous drinking than 
women—10% to 16% versus 1% to 8%, respectively (Merrick et al., 2008; Breslow & Smothers, 
2004; Breslow et al., 2003; Fleming, 2004).   
Despite the fact that men consume more alcohol than women, alcohol use by females is a 
growing problem.  Decreased disparity in drinking between younger men and women, coupled 
with other emerging cohort-related factors impacting women’s consumption patterns, creates an 
expectation that the prevalence of older female drinkers will increase in the upcoming decades 
(Epstein et al., 2007).  For example, in their study of cohort effects on gender differences in 
alcohol use, Holdcraft and Iacono (2002) found higher rates of alcohol dependence in individuals 
born in later cohorts compared to participants from earlier birth groups.  This difference was 
particularly high among women: the prevalence of alcohol dependence in later cohorts was 
117% greater for women versus only 21% for men (Holdcraft and Iacono, 2002).   
In addition to gender differences in consumption rates, a growing body of literature has 
provided evidence to support assertions that there are variations in alcohol usage patterns 
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between men and women.  Research indicates that roughly one-third of older alcoholics are late-
onset drinkers who typically experience their first alcohol-related problems after age 40 
(Menninger, 2002).  Late-onset drinking appears to be more prevalent in females than males and 
is often associated with difficulties coping with a wide variety of age-related changes and 
stressors (Barrick & Connors, 2002).  Variations in drinking patterns between the sexes have also 
been found in longitudinal studies of alcohol use among older adults.  One examination of 
alcohol consumption by the elderly found that moderate drinking in women decreased with age; 
however, heavy drinking remained stable (Breslow et al., 2003).   
2.2.5.2 Racial Differences in Prevalence Rates of Alcohol Use among Older Adults 
Little research has specifically focused on alcohol use among older adult racial and ethnic 
minority populations.  The majority of the research on alcohol-related issues in the United States 
has been conducted with samples of Whites, largely ignoring the potential influence of cultural 
factors such as race or ethnicity (Caetano, 1998).  Over the past decade, while considerable 
advances have been made in alcohol studies among ethnic minorities these groups remain 
underrepresented in alcohol research, particularly in studies regarding older adults.  The limited 
research that does exist on alcohol use in racial and ethnic minority populations has primarily 
focused on comparing drinking patterns and problems between African Americans and Whites 
(Jones-Webb, 1998).  Therefore, this discussion will focus on the prevalence of alcohol 
consumption in African Americans and Whites. 
Studies have consistently found that older African Americans tend to drink less than 
Whites (Satre & Arean, 2005; Breslow et al., 2003).  For example, a report using data from 
National Survey on Drug Use and Health (NSDUH) found that in 2000, rates of alcohol 
consumption among individuals aged 55 and older during a one-month period were twice as high 
 28 
among Whites (40%) as compared to African Americans (20%) (SAMHSA, 2001).  NSDUH 
data from 2002 and 2003 also showed higher rates of alcohol consumption among Whites aged 
50 and older (SAMHSA, 2005).  Alcohol use in the past month for adults aged 50 and above was 
48.3% among Whites versus only 30.2% among African Americans (SAMHSA, 2005). 
Older Whites drink higher quantities of alcohol than older African Americans.  In their 
analysis of data from three nationally representative surveys, Breslow and colleagues (2003) 
found that in older White men and women had the highest prevalence of moderate and heavy 
alcohol use compared to other racial and ethnic groups.  These findings are supported by a recent 
study of nearly 50,000 Medicare beneficiaries ages 65 and older, in which African (81%) had 
higher rates of abstinence than Whites (63%) (Merrick et al., 2008).  In the same study, nearly 
10% of Whites versus only 5.6% of African Americans, reported drinking above the 
recommended guidelines of one drink a day or seven drinks a week (Merrick et al., 2008).   
2.2.6 Alcohol Use and Health Status among Older Adults 
Research has shown that many of the acute and chronic medical and psychiatric conditions 
experienced by the elderly are influenced by the consumption of alcohol (Blow & Barry, 2002).  
Although rates of heavy drinking among older individuals are fairly low, many older Americans 
engage in alcohol consumption that exceeds the recommended guidelines for older adults.  It is 
estimated that nearly 10% of older adults drink alcohol above the NIAAA recommended limits 
(Blow & Barry, 2002).  Age-related changes in physiology cause levels of alcohol tolerance to 
decline while sensitivity increases, potentially putting older persons who consume alcohol, 
especially those that exceed recommended guidelines, at risk for adverse health consequences 
(Kennedy et al., 1999).  Alcohol use among older adults can lead to the development of new 
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physical and mental health conditions, can interfere with the management and treatment of 
existing conditions, and can decrease overall quality of life in old age (Zanjani et al., 2008; 
Onder et al., 2002; Weintraub et al., 2002). 
Alcohol-related health problems account for a significant proportion of hospital 
admissions among older adults, with considerable economic and social costs as well as high 
morbidity and mortality rates (Onder et al., 2002).  Furthermore, serious medical conditions are 
more common among older adults who misuse alcohol than among the overall population of a 
similar age (O’Connell, 2003).  Individuals who have had a history of heavy drinking have also 
been shown to be affected by more major illnesses, self perceived health status, more visits to the 
doctor, and more depressive symptoms than non-heavy drinkers and alcohol abstainers 
(O’Connell, 2003).  For example, in a recent study of male veterans aged 65 and above, 
individuals classified as problem drinkers were significantly more likely than non-problematic 
alcohol users to report having a chronic disease, a diagnosis of depression or a functional 
impairment (Zanjani et al., 2008).   
In addition to impacting the overall health burden experienced by older adults, alcohol 
use is a primary correlate of disease.  Alcohol has been linked to over 60 diseases: including, 
cancer, gastrointestinal disturbances, depression and cognitive impairment (Taylor et al., 2005; 
Corrao et al., 2004; Moore et al., 2003).  The relationship between alcohol and disease etiology 
is based on a variety of factors including the average amount of alcohol consumed as well as the 
pattern of consumption (Taylor et al., 2005).   
Epidemiological evidence has made a strong link between the use of alcohol and an 
increased risk for certain cancers.  For example, in a recent meta-analysis of studies on alcohol 
consumption and disease, the use of alcohol was strongly associated with an increased risk for 
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cancers of the oral cavity, esophagus, and larynx (Corrao et al., 2004).  There is also an 
association between alcohol consumption and cancers of the liver, bowel and breast (Zhang et 
al., 2007; Corrao et al., 2004).  Furthermore, heavy use of alcohol has been linked to a number of 
gastrointestinal disorders, including gastritis, stomach ulcers, cirrhosis and pancreatitis (Falck-
Ytter et al., 2000).  For example, prolonged alcohol use over the lifespan can lead to cirrhosis 
and pancreatitis in approximately 20% of people (Perreira & Sloan, 2002).  In their meta-
analysis, Taylor and Rehm (2005) found that even a moderate intake of alcohol was related to a 
number of gastrointestinal conditions.  Finally, chronic alcohol use is associated with a decrease 
in the effectiveness of the immune system, which results in a heightened susceptibility to 
infections such as pneumonia and tuberculosis (Chang et al., 2002).   
Alcohol not only impacts the physical health of older adults, it can also contribute to the 
development of mental health disorders such as depression and anxiety.  Serotonin and other 
neurotransmitters in the brain that play an integral role in preventing depression are affected by 
alcohol use (Devanand, 2002; Thomas et al., 2002; Swift, 1999).  Comorbid alcohol use 
disorders and depression are common among older adults; it is estimated that anywhere from 
15% to 30% of individuals with late-life depression also have alcohol-related problems 
(Devanand, 2002).  Problem alcohol use has also been associated with cognitive decline 
(Thomas et al., 2001).  Neurotoxic effects associated with problem alcohol use can lead to the 
development of alcohol-related dementia or other illnesses, such as Alzheimer’s or Wernicke-
Korsakoff syndrome (Thomas et al., 2002; SAMHSA, 1998).  These illnesses are associated with 
memory loss, cognitive problems and motor impairment (Friedlander & Norman, 2006). 
Despite the solid body of research correlating alcohol use with health and disease, the 
relationship between health and drinking in late-life has become complicated in light of a 
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growing body of literature touting the benefits associated with moderate levels of drinking 
(Hendriks & van Tol, 2005).  This emerging research increasingly points to the benefits of low-
risk alcohol use among older adults.  In general, findings suggest that the consumption of 
moderate amounts of alcohol are not necessarily harmful and may have some beneficial impacts 
upon health (Hendriks & van Tol, 2005).  For instance, the relationship between cardiovascular 
health and alcohol use among older adults has been widely explored, and has often been used as 
an example of the protective effects of alcohol use among older adults (Turvey et al., 2006; Thun 
et al., 1997; Scherr et al., 1992).  One illustration of this protective relationship between alcohol 
and disease can be seen in a study of individuals ages 70 and older: persons who consume 
approximately one drink per day had a lower relative risk of coronary disease compared to 
abstainers or heavy drinkers (Turvey et al., 2006).  It should be noted that moderate alcohol 
consumption has only been shown to reduce the risk of specific conditions, including some 
forms of dementia, cardiovascular disease, and certain cancers (Blow, 2002).   
The benefits of moderate drinking need to be weighed in light of the risks they pose to 
other key geriatric syndromes, such as cognitive impairment, depression and falls.  Furthermore, 
good health among older adults who use moderate amounts of alcohol may be a function of 
positive health behaviors, such as proper diet and exercise, rather than a direct benefit from 
alcohol use (Tivis & Tivis, 2008).  Finally, variations in the conceptualization and measurement 
of moderate drinking between studies inhibit the ability draw any concrete conclusions about the 
benefits of alcohol use among older adults (Tivis & Tivis, 2008).  Further research is needed to 
fully explore the effects of various levels of alcohol consumption on a broad range of health 
outcomes with diverse populations, including women and people of color.  
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2.2.6.1 Gender Effects of Alcohol Consumption on Health among Older Adults 
The effect of alcohol consumption on health continues to be debated.  Increasingly, studies have 
focused on investigating both the harmful, as well as beneficial, effects of alcohol use among 
older adults.  Recently, a number of studies examining the health consequences of moderate 
drinking in individuals aged 65 and older have found sex-dependent effects (Beulens et al., 2007; 
Flannery et al., 2007; Mann et al., 2005; Burger et al., 2004).  These studies have primarily 
focused on cardiovascular disease, cancer, neuro-cognitive functioning, bone disease and liver 
problems (Epstein et al., 2007).   
For example, a recent review of the literature regarding how gender affects the onset of 
liver disease reported that studies have consistently found that it takes less time and lower doses 
of alcohol exposure to cause liver damage in females than in males (Kovacs & Messingham, 
2002).  The consumption of moderate amounts of alcohol by women is associated with an 
increase risk of breast cancer (Zhang et al., 2007).  Studies on cognitive functioning have been 
mixed: some research indicates that female alcoholics perform as poorly as men, even with fewer 
years of drinking and smaller quantities of alcohol consumed at each drinking occasion 
(Flannery et al., 2007; Mann et al., 2005).  Sohrobji (2002) found increased risk of dementia and 
memory deficiencies among women.  In contrast, while there may be a positive relationship 
between moderate alcohol consumption and cognition in both men and women, the association is 
strongest in women (McGuire et al., 2007; Britton et al., 2004). 
Although some studies have documented significant gender differences in health 
outcomes related to alcohol consumption, many have found comparable effects for both men and 
women.  Moderate drinking has been found to have similar effects on cardiovascular 
functioning, cognition, diabetes risk, and bone density in both men and women (Djousse et al., 
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2007; Lang et al., 2007; Mukamal et al., 2007; Sierksma et al., 2007).  Contradictory findings 
regarding gender differences in the effects of alcohol on health status point to a continued need 
for research that investigates the relationship between alcohol use and health in older adults.  
Understanding the relationship between health and alcohol use is especially salient for older 
women who, even in the absence of alcohol use, face a number of unique health challenges 
associated with aging (Blow et al., 2000).  Additionally, although findings indicate some benefits 
associated with alcohol consumption by older women, studies have continued to document that 
on average, despite drinking for the same length of time and consuming about the same amount 
of alcohol, women exhibited more severe health consequences from their alcohol use than their 
male counterparts (Redgrave et al., 2003; Hill, 1995).   
In summary, women are particularly vulnerable to the adverse consequences associated 
with alcohol consumption, including physical injury, cognitive impairment, cirrhosis, heart 
disease and negative drug interaction (Blow, 2000).  Despite this fact, alcohol use in older 
women often goes undetected and treated (Sedlak et al., 2000).  Further investigation of the 
epidemiology of alcohol use in subpopulations of older adults, especially with women, is key to 
identifying at-risk populations and developing effective intervention strategies.   
2.2.6.2 The Impacts of Minority Status on the Effects of Alcohol Use on Health Status of 
Older Adults 
Since African Americans are often underrepresented in longitudinal studies of alcohol use, the 
literature regarding the role that race plays in the relationship between alcohol and health among 
older adults is scarce.  However, research on the general population indicates that the negative 
consequences of alcohol use have disproportionally impacted racial and ethnic minorities 
(McDonald et al., 2004; Boyd et al., 2003; Jones-Webb, 1998).  For example, alcohol mortality 
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rates are highest for African-American men in all age cohorts, even though alcohol use tends to 
be more moderate for African Americans than for Whites or Hispanics (Caetano, 1998).  African 
Americans are also more likely than Whites to die from cirrhosis of the liver or from an alcohol 
related injury (Jones-Webb, 1998).  It has been postulated that older African Americans are more 
severely impacted by alcohol consumption because their health is typically worse than the health 
status of older Whites (Satre and Arean, 2005).  Further research is needed to examine the 
relationship between race, alcohol use and health status. 
2.3 MEDICATION USE AMONG OLDER ADULTS 
2.3.1 Medication Pharmacokinetics 
The pharmacokinetics of medications or how drugs are handled by the body is related to 
absorption, distribution and elimination, which consists of metabolism and excretion (Wright & 
Warpula, 2007).  In order to produce their pharmacological effects, medications must be 
absorbed into the body and distributed to the site of action (Sharif, 2003).  Absorption is the 
process by which a drug passes from the site of administration into circulation via the 
bloodstream.  The rate, ease and degree of absorption are related to the route of administration 
(Sharif, 2003).  Once the medication has been administered and absorbed into the bloodstream, it 
is then distributed to various organs in the body (Sharif, 2003).  The distribution of medications 
is influenced by a number of factors, including: how well each organ is supplied with blood, 
organ size, binding of the drug to various components of blood and tissue, and the permeability 
of tissue membranes (Lococo & Staplin, 2006).   
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The majority of medications are metabolized in the liver. The cytochrome P-450 
(CYP450) enzyme system is the most important known system for drug metabolism (Wright & 
Warpula, 2004; Sharif, 2003).  As they pass through the liver, drugs undergo either phase I 
(oxidation, reduction, and hydrolysis) or phase II (glucuronidation, sulfation, and acetylation) 
metabolism (Wright & Warpula, 2004).  Phase I reactions use the CYP450 system; the reaction 
can produce biologically active metabolites.  More than half of all drugs are metabolized via the 
CP450 enzyme pathway (Wright & Warpula, 2004; Williams, 2002).  Phase II metabolism 
produces inactive metabolites, which are more readily excreted by the kidneys (through urine) 
and the liver (through bile) than those formed in phase I non-synthetic reactions (Wright & 
Warpula, 2004).  Some drugs undergo only phase I or phase II reactions; thus, phase numbers 
reflect functional rather than sequential classification (Williams, 2002).  After drugs are 
metabolized they are removed from the body, with the kidney primarily responsible for drug 
elimination (Wright & Warpula, 2004). 
2.3.1.1 The Influence of Age and Alcohol on the Metabolism of Medications 
Two of the key factors that impact upon the body’s ability to metabolize medications are age and 
alcohol consumption.  Advancing age is accompanied by pharmacokinetic and pharmodynamic 
changes that, in conjunction with comorbid health conditions and the use of multiple 
medications, influence the metabolism of drugs in older adults (Herrlinger & Kolz, 2001).  Some 
of the primary physiological changes that influence medication pharmacokinetics include:   
 
1. As individuals age, there is a decrease in lean body mass and an increase in fat. 
Therefore, fat soluble drugs, such as valium, will remain in the body longer (Wright & 
Warpula, 2007; Williams, 2002). 
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2. The liver enzymes responsible for metabolizing and detoxifying medications decrease in 
efficiency in older individuals (Wright & Warpula, 2007; Williams, 2002). 
3. Kidney extraction may not function as well, so drugs may remain in the body longer than 
anticipated (Wright & Warpula, 2007; Williams, 2002). 
4. Absorption of drugs in the gastrointestinal tract is slowed (Wright & Warpula, 2007; 
Williams, 2002). 
 
In addition to age, alcohol consumption also has a marked effect on the body’s ability to process 
medications.  There are four primary alcohol-drug interactions.  First, alcohol may inhibit the 
metabolism of a drug by competing with the medication for the same set of metabolizing 
enzymes in the liver (Blow, 2002).  This type of interaction prolongs and enhances the 
medication’s availability, which can result in an increased risk for experiencing harmful side 
effects from the drugs (AADAC, 2003).  Second, long term alcohol use may activate drug-
metabolizing enzymes, thus decreasing the drug’s availability and diminish its effects (Blow, 
2002).  In a third type of reaction, enzymes activated by chronic alcohol consumption transform 
some medications into toxic chemicals that can damage the liver and other organs (Palmer, 
2004).  Finally, alcohol can interact with sedative and narcotic medications, magnifying the 
inhibitory effects of these drugs (Lococo & Staplin, 2006).  To add to the complexity of alcohol-
drug interactions, some drugs affect the metabolism of alcohol, which alters its potential for 
intoxication and the adverse affects associated with alcohol consumption (AADAC, 2003). 
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2.3.2 Definitions Related to Medication Use 
There are a variety of terms used to describe patterns of medication use and their associated 
consequences among older adults.  Of particular importance to this study are the terms 
potentially inappropriate medications, alcohol-interactive medications, and concurrent use.  All 
refer to various patterns of medication use.   
 A potentially inappropriate medication (PIM) is defined as any drug that poses more risks 
than benefits when used by older adults; many PIM interact with alcohol (Fick et al., 2003).  In 
other words, if the potential risks outweigh the possible clinical benefits, the therapeutic use of 
the medication is considered to be inappropriate (Egger at al., 2006).  The Beers criterion is the 
most widely used approach to assess the appropriateness of the use of specific medications with 
the elderly (Fu et al., 2007).  The Beers criterion, first compiled in 1991 by an expert consensus 
panel, consists of a list of medications that may be unsuitable for use among older adults 
(Budnitz et al., 2007).  Table 1 provides some examples of medications or therapeutic classes 
considered potentially inappropriate for use among older adults.  Many of the medications 
identified as inappropriate under the Beers criteria could potentially interact with other drugs 
and/or alcohol. 
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Table 1 Inappropriate Medications and Therapeutic Classes to Avoid in Older Adults 
 
Classification Medication 
 
Never appropriate 
 
Barbiturates 
Dicyclomine, propantheline, phenobarbital 
Flurazepam 
Meperidine 
Meprobamate 
Pentazocine 
Trimethobenzamide 
 
Rarely appropriate Chlordiazepoxide, diazepam 
Muscle relaxants (chlorzoxazone, metaxalone, methocarbamol) 
Propoxyphene 
 
Sometimes appropriate Amitriptyline 
Diphenhydramine, cyproheptadine, hydroxyzine, promethazine 
Indomethacin 
Alprazolam 
Lorazepam 
Zolpidem 
Source:  Wright & Warpula, 2004; Frick et al., 2003; Zhan et al., 2001 
 
 
A prescription medication or over-the-counter drug is considered to be alcohol-interactive if the 
concurrent use of alcohol and the medication influences the metabolism of the drug, impacts the 
enzymes involved in drug pharmacokinetics or magnifies the effects of the medication (Jalbert et 
al., 2007; AADAC, 2003).  Some examples of classes of alcohol-interactive medications 
commonly used by older adults and the effects of these interactions are: 
 
1. Nonsteroidal anti-inflammatories/Aspirin:  interactions between alcohol and anti-
inflammatory drugs can lead to gastritis and gastrointestinal hemorrhage; 
 39 
2. Antidepressants/Antipsychotics:  interaction between alcohol and these psychotropic        
medications and cause leads to decreased drug  metabolism, causing toxicity and central 
nervous system depression; and 
3. Narcotic analgesics:  narcotic analgesics such as Codeine or Vicodin interact with             
alcohol and can cause CNS depression (Lynskey et al., 2003;  SAMHSA, 1999).2
 
 
 Often medications are used in concert with a variety of other substances, such as alcohol, 
illicit drugs, over-the-counter medications and/or prescription drugs.  Studies typically refer to 
this behavior as simultaneous or concurrent polydrug use (McCabe et al., 2006).  Simultaneous 
drug use is defined as the co-ingestion of different drugs at the same time; for instance, the 
simultaneous use of alcohol and marijuana (Schensul et al., 2005).  Concurrent polydrug use also 
refers to the use of more than one substance within the same time period (e.g., 1 day, 30 days, or 
12 months), but not necessarily at the same time (Schensul et al., 2005).  For example, an 
individual may take an antidepressant each morning to treat anxiety; however, it is also this 
individual’s pattern to have a glass of wine with dinner.  Although the two substances are not 
ingested together, they are taken within the same time period—in this case the same day.  
Therefore, this usage pattern would be considered concurrent use.  The specific focus of this 
discussion is the concurrent use of medications with alcohol.3
                                                 
2 A more extensive list of specific alcohol-interactive medications and the associated reactions is    
 
   presented later in this review (see Table 2.) 
3 The terms concurrent and concomitant will be used interchangeably throughout this document. 
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2.3.3 Prevalence Rates of Medication Use among Older Adults 
2.3.3.1 Rates of Medication Use Among Older Adults 
 
Older adults consume more prescription and over-the-counter medications than any other age 
group (Perhats et al., 2008).  Though older adults comprise only 14% of the total U.S. 
population, they use more than 30% of all prescription drugs and approximately 40% of all over-
the-counter medications [Department of Health and Human Services (DHHS), 2004].  Seniors 
use prescription drugs approximately three times as frequently as the general population, and 
their use of over-the-counter medications is even more extensive (Patterson & Jeste, 1999).   
On average, seniors take 5.3 prescription drugs and 5.7 over-the-counter drugs per day 
(ASA, 2001).  A survey of the noninstitutionalized U.S. population found that more than 90% of 
individuals aged 65 and older used at least one medication per week (Gurwitz et al., 2004; 
Kaufman et al., 2002).  Moreover, 40% reported using 5 or more different medications a week, 
and 12% utilized 10 or more different drugs (Gurwitz et al., 2004).  These findings are consistent 
with other research on patterns of medication use among community-dwelling older adults.  For 
example, in a recent national study of Medicare beneficiaries, only 11% of seniors reported not 
taking any prescription medications; however, 22.8% of participants reported taking 1–2 
medications, just over 25% were taking 3–4 medications, and 41% reported using 5 or more 
prescription medications (Wilson et al., 2007).   
Not only do older adults consume high numbers of medications, they also use 
medications from different therapeutic categories, this substantially increases their risk of 
experiencing an adverse drug event or reaction.  For instance, a recent study of nearly 28,000 
Medicare+Choice enrollees found that 49% of participants were prescribed drugs from four or 
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more classes (Gurwitz et al., 2003).  Similarly, in a study of homebound elders, Sharkey and 
colleagues (2005) found that, typically seniors used drugs from 3 to 4 different medication 
classes.  Research indicates that the most common medications taken by seniors are 
cardiovascular drugs, antibiotics/anti-infectives, diuretics, opiods, antihyperlipidemics, NSAIDs, 
and medications for the gastrointestinal tract (Gurwitz et al., 2003).  Older adults are also 
substantial users of psychotropic medications.  A retrospective analysis of the 1996 Medical 
Expenditures Survey (MEPS) found that nearly 1 in 5 community dwelling older adults (19%) 
used a psychotropic medication (Aparasu et al., 2003).  The most commonly used psychotropic 
medications were antidepressants and antianxiety drugs.  Gurwitz and colleagues (2003) found 
similar rates of use among community-dwelling older adults: just over 13% of participants 
reported using an antidepressant and 12.9% were taking a sedative or hypnotic drug (Gurwitz et 
al., 2003).   
2.3.3.2 The Relationship of Demographic Characteristics to Medication Use Patterns 
 
Although the majority of seniors report taking one or more medications, demographic 
characteristics also predict rates of medication use.  Variations in both rates of use as well as the 
types of drugs taken have been found by age group, gender and race.  Studies have continually 
reported that among older persons, women and Whites are more likely to use medications. 
Gender 
Most studies indicate that gender predicts medication use; older women have higher rates of 
medication use and consume a larger number of medications than older men (Ballantyne et al., 
2005; Xu et al., 2003; Linjakumpu et al, 2002).  For instance, a study of adults in the ambulatory 
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care setting aged 18 and above, found that women aged 65 and older had higher rates of 
prescription medication use than all other adults (Kaufman et al., 2002).  In the same study, 81% 
of the women surveyed reported taking at least one medication and 23% used five or more 
different drugs per week (Kaufman et al., 2002).  Not only do females use medications at higher 
rates than men, but women take larger quantities of medications that are potentially 
inappropriate.  In an analysis of rates of potentially inappropriate medication use among older 
adults enrolled in managed care plans, women, when compared to men, had greater rates of use 
of medications that were classified as “should always be avoided,” 6.1% versus 3.8% (Simon et 
al., 2004).  The same study found that women also used medications classified as “rarely 
appropriate” at higher rates than their male counterparts, 15.7% versus 10.5% (Simon et al., 
2004).  Older women also use more psychotropic medications than older men; females are more 
likely to use higher rates of antidepressants and antianxiety agent (Aparasu et al, 2003).  Many 
psychotropic medications are alcohol-interactive or considered inappropriate for use among older 
adults.  This places women at an increased risk for adverse drug events (ADE) and adverse drug 
reactions (ADR).  
Race 
Continued disparities in health outcomes among African Americans and Whites have fueled 
recent research efforts to document disparities in health service utilization and to identify their 
causes (Wang et al., 2007).  Unfortunately, studies have not addressed the use of prescription 
drugs in a comprehensive manner, especially among older adults.  The existing body of literature 
suggests that, in general, African Americans have lower rates of mediation use and take fewer 
medications than Whites (Sirey et al., 1999; Brown et al., 1995; Fillenbaum et al., 1993; Hanlon 
et al., 1992).  In a more recent study of new prescription drug utilization by individuals age 18 
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and older, racial disparities were found: Whites were more likely than African Americans to 
obtain and use a new prescription (Wang et al., 2007).   
Racial differences in medication use have also been found in several studies specifically 
focused on use among older adults.  For instance, in a study of Medicare beneficiaries, Gaskin 
and colleagues (2006) reported that Whites used 2.3 more prescriptions on average than African 
Americans.  The same study also found that much of the disparity in prescription drug spending 
was attributed to race: total spending for Whites was nearly 9% more than for African Americans 
(Gaskin et al., 2006).  In addition, racial differences in medication use among older adults are 
greatest for psychotropic medications.  For example, Blazer and colleagues (2000) found that 
among community-dwelling older adults, only 5% of African Americans were taking an 
antidepressant compared to 14% of Whites.  In another study of the use of psychotropic 
medications by the elderly, African Americans were less likely than Whites to report sedative 
and hypnotic usage (Aparasu et al., 2003). 
Summary 
The large volume of medications taken by older adults coupled with the higher likelihood that 
they will be prescribed an alcohol-interactive medication puts them at increased risk for adverse 
drug interactions.  Also, drug-drug or alcohol-medication interactions in older adults can be 
especially problematic because of slowed metabolic and clearance mechanisms, which can result 
in the delayed resolution of adverse reactions (SAMHSA, 2004).  Finally, differences in rates 
and types of medications used by gender as well as race place certain groups—women and 
Whites—at an increased risk for experiencing an ADE or ADR.  
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2.3.3.3 Prevalence of Adverse Drug Events and Adverse Drug Reactions Among Older 
Adults 
The unintentional or intended misuse of prescription drugs can have a number of negative 
consequences; two widely investigated outcomes are ADEs and ADRs.  Both ADEs and ADRs 
are caused by one of three primary types of interactions: drug-drug, drug-disease, or drug-
nutritional interactions.  Drug-drug interactions are defined as the effects that one drug has on 
another; these interactions are pharmacokinetic or pharmacodynamic in nature (Lococo & 
Staplin, 2006).  If a medication exacerbates an underlying disease or medical condition, it is 
referred to as a drug-disease interaction (Mallet et al., 2007).  Of particular relevance to this 
study are drug-nutritional interactions; this includes interactions between medications and 
alcohol, food or herbal products (Mallet et al., 2007).  All of these interactions have the potential 
to cause medication-related problems, ADEs, or ADRs in older adults. 
Typically, an ADE is defined as any injury resulting from the use of a prescription or 
over-the-counter medication (Gurwitz et al., 2003).  ADEs included both expected drug side 
effects as well as events due to error (Lococo & Staplin, 2006).  Problems that occur when 
treatment goes beyond the desired effect or when the medication causes additional problems are 
termed side effects.  Some fairly common medication side effects include symptoms such as 
dizziness, fatigue, nausea and vomiting (Agency for Healthcare Research and Quality, US 
Department of Health & Human Services (AHRQ), 2001).   
Although some ADEs are the unintended consequence of side effects resulting from the 
use of a particular drug, other ADEs the product of errors made by the patient or by medical 
professionals, which by definition are considered preventable (Lococo & Staplin, 2006).  
Examples of common errors that can lead to ADEs include: poor medication adherence, 
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inappropriate prescribing, and incorrect drug dosing (Perhats et al., 2008; Lococo & Staplin, 
2006).  It should be noted that identifying something as an adverse event does not imply 
negligence or poor quality of care; it simply denotes an undesirable clinical outcome which is not 
the result of an underlying disease process, has resulted from some aspect of the chosen 
pharmacological therapy (AHRQ, 2001.). 
In contrast to ADEs, ADRs are harmful unintended reactions resulting from the use of a 
certain medication.  These reactions are produced by the use of a drug in the recommended 
manner (Lococo & Staplin, 2006; AHRQ, 2001).  The World Health Organization (1975) defines 
ADRs as any response to a drug which is noxious and unintended, and which occurs at doses 
normally used in humans for diagnosis, therapy of disease, or for the modification of 
physiological function.  These effects can range from minor irritants to severe reactions. Some 
examples of common ADRs include a rash or diarrhea caused by an antibiotic or a major 
hemorrhage from taking a blood-thinning agent (Lococo & Staplin, 2006).  
Advances in drug therapy have provided older adults with effective treatments that have 
made it possible to improve outcomes for conditions that were previously untreatable (Simonson 
& Feinberg, 2005).  However, if used inappropriately, pharmacological therapies can cause more 
harm than good.  If adverse drug effects were classified as a disease, they would rank as the fifth 
leading cause of death for among adults in the United States (ASA, 2001; Lazarou et al, 1998).   
In 2004 and 2005, over 700,000 individuals were treated for ADEs in U.S. emergency 
departments; one out of every six of these patients required hospital admission (Budnitz et al., 
2006).  Furthermore, older adults have a markedly greater risk for medication-related problems 
as a result of physiological changes associated with aging, the presence of multiple health 
problems, and the type and number of medications they consume (Chrischilles et al., 2007; 
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Simonson & Feinberg, 2005).  Therefore, medication safety among seniors is a major safety 
concern. 
The latest research indicated that rates of ADEs and ADRs among older adults are 
relatively high: among Medicare enrollees more than 1.9 million ADEs occur each year and 
approximately 200,000 of these events are life-threatening or fatal (Simonson & Feinberg, 2005; 
Gurwitz et al., 2003).  A recent study of injury-related visits to the emergency room among 
individuals aged 65 and older found that ADEs were the second most frequent mechanism of 
injury and were associated with a three-fold increase in hospitalization risk (Carter & Gupta, 
2007).  Factors related to the type and amounts of medications used, as well as individual 
characteristics, have been linked with an increased risk for experiencing an ADE (Evans et al., 
2005).  For example, a study of community-dwelling residents aged 72 and older found that total 
number of medications was associated with an increased risk of adverse drug outcomes (Agostini 
et al., 2004).  Other studies have shown that increased age, being female, and a greater number of 
comorbidities increase an individual’s great risk of suffering an ADE (Evans et al., 2005).  
Despite the high rates and severe costs associated with ADEs and ADRs, it is estimated that 
approximately half of the illnesses, disabilities and deaths caused by these events may have been 
preventable (Gurwitz et al., 2003).  
Many ADEs and ADRs result from medication adherence errors and are therefore 
preventable.  Common patient errors include: administering medications incorrectly; modifying 
the medication regime; and not following clinical advice regarding medication use, such as 
ignoring directives to avoid using certain foods, over-the-counter-medications, or alcohol with a 
particular drug (Field et al., 2007).  In a large sample of Medicare enrollees, Field and colleagues 
(2007) found that nearly 42% of ADEs resulted from a modification to the medication regimen; 
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31.8% occurred due to incorrect medication administration; and 21.7% happened because the 
patient did not follow clinical advice (Field et al., 2007).   
These findings are consistent with other studies on ADEs (Gurwitz et al., 2003).  
Investigations of adverse drug effects indicate that the most frequent types of preventable ADEs 
are related to electrolyte/renal, gastrointestinal, hemorrhagic and central nervous system issues 
(Chrischilles et al., 2007; Gurwitz et al., 2003).  Some of the most common medications 
associated with avoidable ADEs included: cardiovascular medications, diuretics, nonopioid 
analgesics, hypoglycemic and anticoagulants (Gurwitz et al., 2003).  Many of the medications 
associated with preventable adverse drug effects are alcohol-interactive.  Consequently, one of 
the major causes of preventable ADEs and ADRs is the concurrent use of alcohol and 
medications (Field et al., 2007; Onder et al., 2002).   
One of the major risk factors for experiencing an adverse drug event or reaction is 
medication nonadherence.  The concurrent use of alcohol and medication is a common and 
dangerous form of nonadherence that can have serious consequences for older adults.  Most 
people who consume alcohol also take medications; this is particularly true for older adults who 
consume more medications than any other age cohort (Perhats et al., 2008; Weathermon et al., 
1999).  As a result, many older adults ingest alcohol while a medication is in their body or vice 
versa.  A large number of prescription and over-the-counter medications can interact with 
alcohol, resulting in potentially serious medical consequences (Lococo & Staplin, 2006).  In fact, 
it is estimated that alcohol-drug interactions play a role in 25% of all emergency room 
admissions for all age groups (Holder, 1992).  Significant problems can result from the 
concurrent use of medications and alcohol, making alcohol-related adverse drug interactions an 
important health concern for older adults.  
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2.4 CONCURRENT ALCOHOL AND MEDICATION USE 
2.4.1 Prevalence of Concurrent Use among Older Adults 
While there is a large body of knowledge on the prevalence, usage patterns and epidemiology of 
alcohol use among older adults, few studies have focused on the concurrent use of alcohol and 
medications.  Consequently, estimates on the prevalence of concurrent use are limited.  
However, the research that does exist suggests that concomitant use is a common problem 
among older adults (Swift et al., 2007; Aira et al., 2005; Pringle et al., 2005; Fink et al., 2002; 
Onder et al., 2002; Adams, 1995).  Yet, most of these studies are cross-sectional in nature and 
were conducted in acute or primary care settings. 
A recent population-based study in Australia found that 35.4% of the individuals 
surveyed aged 65 years and older had recent (last 24 hours) concomitant use; 21.8% reported 
using both prescription and over-the-counter medications with alcohol in the last 24 hours (Swift 
et al., 2007).  Higher prevalence rates were also found in a study of community-dwelling elders 
75 years and older living in Finland:  nearly 87% of respondents who used alcohol also reported 
using medications on a regular basis (Aira et al., 2005).  In the same study, widespread rates of 
concurrent use of alcohol with alcohol-interactive drugs such as sedatives, pain killers and 
Warfarin were reported (Aira et al., 2005).  Although these studies are important and add to the 
knowledge base regarding the prevalence rates of concurrent use among older adults, cultural 
differences in alcohol and medication use as well as variations in prescribing practices between 
these countries make the results less generalizable to the United States.    
In the United States, estimates of concurrent use among community-dwelling older adults 
range from 19% to 38% (Pringle et al., 2005; Memmott, 2003; Fink et al., 2002; Adams, 1995). 
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Some of the first studies of concurrent use among older adults in the United States found fairly 
high rates of concomitant use.  One study reported that 25% of community-dwelling older adults 
were at risk for alcohol-drug interactions due to concurrent use (Forster et al., 1993).  In a study 
of older adults residing in retirement communities, Adams (1995) found that nearly 38% of the 
residents concurrently used alcohol with alcohol-interactive medications.  Adams’ work in 
retirement communities represents an important contribution to the literature regarding 
concurrent use among older adults yet, the sample is comprised of a unique subset of older adults 
who reside in retirement communities.  Therefore, it is possible that the concomitant use 
behaviors of individuals in this particular study may not be reflective of all community-dwelling 
older adults.   
More recent analyses of concomitant use among older adults have found lower 
prevalence rates than that in Adams’ (1995) study.  For example, an analysis of concurrent 
alcohol and prescription drug use among older adults living in the US and enrolled in the 
Pennsylvania Pharmaceutical Assistance Contract for the Elderly (PA-PACE) found that 77% of 
all prescription drug users were exposed to one or more alcohol-interactive medications.  
Moreover, nearly one-fifth (19%) of older adults who used alcohol-interactive drugs reported 
concurrent alcohol and medication use (Pringle et al., 2005).  However, this study utilized a 
cross-sectional design; therefore, we do not know if these prevalence rates hold true overtime 
and we are unable to ascertain various patterns of concurrent use.  Additionally, in the PA-PACE 
study, data on alcohol use was based on self-report data obtained from a mail survey; self-report 
data can be problematic with older adults for a number of reasons such as cognitive impairment 
or decline and underreported behavior.  Finally, the sample was comprised of PA-PACE 
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members who tend to be older, female, White and have more chronic conditions than the general 
population of older adults in the United States. 
Emerging research also suggests that concurrent use is associated with the number of 
drugs taken and the therapeutic class of those medications, as well as individual level 
characteristics.  For instance, in a study of current drinkers aged 65 and older, Fink and 
colleagues (2002) report that 88% of participants used alcohol-interactive medications; 46% used 
1 to 3 medications; 32% used 4 to 6 medications; and 9% used 7 or more medications.  The most 
common concurrent use pattern was one or more drinks per day with the following classes of 
medications: arthritis and pain medications, H2-receptor antagonist, antidepressants, 
anticoagulant (Warfarin), nitrates, antihistamines, or antiseizure drugs (Fink et al., 2002).  
Similar results were found in a large sample of older adults enrolled in the PA-PACE program; 
the most common medications concomitantly used with alcohol were NSAID pain relievers 
(20.2%), antihistamines (20.1%), antihypertensive (19.9%), and angiotensin-receptor blockers 
(19.6%) (Pringle et al., 2005).  Limited information exists on the influence of individual level 
characteristics on concurrent use; however, recent work suggests that such individuals are 
younger, White, better educated and in better health tend to have higher rates of concurrent use 
(Jalbert et al., 2008; Pringle et al., 2005). 
Although few studies have explored the concurrent use of alcohol and medications 
among older adults, the research that does exist suggests that concomitant use is common 
amongst this group.  Although rates of alcohol consumption typically decline with age, many 
older adults engage in patterns of use that exceed recommended guidelines.  This coupled with 
the high rate of alcohol-interactive medications taken by seniors places them at an increased risk 
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of experiencing ADRs or ADEs related to concurrent use.  The significant problems associated 
with concomitant use make it a salient public health concern for older adults.   
2.4.2 Consequences of Concurrent Use 
The use of alcohol not only has the potential to impact many of the health conditions for which 
medications are used, but it can also interact with the medicines themselves (Swift et al., 2007).  
Age-related physiological and metabolic changes can increase the likelihood of adverse 
interactions at lower alcohol and medication doses (Swift et al., 2007). As a result, there are a 
number of serious consequences associated with concurrent alcohol and medication use among 
older adults.  For example, concomitant use of medications like benzodiazepines, muscle 
relaxants, and opioids can cause ADEs such as increased sedation and decreased motor skills; 
these problems can lead to falls or other accidents (Tanaka, 2003; Weathermon & Crabb, 1999).  
Another common type of interaction that can result from concurrent alcohol and medication use 
occurs when alcohol adversely affects the illness for which the medication was prescribed.  
Many of the chronic conditions common among older adults such as hypertension, diabetes, 
gastrointestinal conditions, insomnia and depression are exacerbated by alcohol use (Moore et 
al., 2007).   
An extensive discussion of all the negative health outcomes resulting from concurrent 
alcohol and medication use is beyond the scope of this review; however, information on the two 
types of alcohol-drug interactions and some of the common reactions associated with 
concomitant use in older adults will be presented.  
 Alcohol-medication interactions fall into two primary categories: pharmacokinetic and 
pharmacodynamic.  When the presence of alcohol directly interferes with the normal metabolism 
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of a medication, the interaction is pharmacokinetic in nature (Weathermon & Crabb, 1999).  
Pharmacokinetic interactions either decrease the breakdown and excretion of the medication 
because the drug must compete with alcohol for metabolism or alcohol enhances the activity of 
medication-metabolizing enzymes, thereby accelerating the metabolism of the affected drug 
(Adams, 2002; ASA, 2001).  When alcohol alters the effects of a medication without changing 
the medication’s concentration in the blood, it is referred to as a pharmacodynamic reaction.  For 
example, the use of alcohol and antidepressants enhances the sedative effects of the medication 
(Adams, 2002; Weathermon & Crabb, 1999).  The type of ADE or ADR experienced is based on 
a number of factors, including the type of alcohol-drug interaction (pharmacokinetic or 
pharmacodynamic), the amount and type of alcohol consumed, physiological difference, and 
individual characteristics (Lococo & Staplin, 2006)   
There are a number of alcohol-interactive medications widely used by seniors that, when 
concurrently used with alcohol, can cause negative reactions.  Table 2 presents an overview of 
some of the alcohol-interactive medications commonly used by older adults and the potential 
reactions associated with concomitant use (A more extensive table is presented in Appendix A.).   
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Table 2  Examples of Common Alcohol-Interactive Medications Used by Older Adults 
 
Drug Class 
(Symptoms / Conditions) 
   Medication 
(Brand Name) 
 
Potential Reactions  
with Alcohol 
Antibiotics 
(infections) 
Acrodantin 
Flagyl 
Grisactin 
Nizoral 
 
Rapid heartbeat 
Sudden changes in blood pressure 
Stomach pain & upset; vomiting 
Headache 
Liver damage 
 
Anticoagulants 
(prevention of blood clots) 
 
Warfarin 
Coumadin 
Internal bleeding 
Blood clots, strokes, or heart attack 
 
Antihypertension 
(high blood pressure) 
Accupril 
Capozide 
Hytrin 
 
Drowsiness & Dizziness 
Fainting 
Heart problems such as arrhythmia 
Benzodiazepines 
(sedative agent) 
Ativan 
Valium 
Xanax 
Drowsiness 
Increased  sedation 
Decreased motor skills 
 
Histamine antagonists 
(ulcers, heartburn) 
 
Axid 
Zantac 
 
Increased alcohol effects 
Sudden changes in blood pressure 
NSAIDs 
(pain relief, inflammation) 
Naprosyn 
Orudis 
Voltaren 
 
Gastrointestinal bleeding 
Opioids 
(pain relief) 
Oxycodone 
Percocet 
Vicodin 
 
Drowsiness 
Increased  sedation 
Decreased motor skills 
Statins 
(high cholesterol) 
Advicor 
Crestor 
Lipitor 
Vytorin 
Zocor 
 
Liver damage 
Nausea & vomiting 
Rapid heartbeat 
Sudden change in blood pressure 
Risk stomach bleeding 
 
Tricyclic antidepressants 
(depression) 
Celexa 
Prozac 
Zoloft 
Dizziness 
Increased risk of sedation 
Increased risk overdose 
    Sources:  NIAAA, 2007; Lococo & Staplin, 2006; Weathermon & Crabb, 1999 
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Although reactions to concurrent use are specific to the medication involved, some of the 
most frequent consequences of interactions experienced by older adults fall into three broad 
categories: central nervous system depression, gastrointestinal issues, and liver toxicity (Adams, 
2002). 
2.4.2.1 Central Nervous System (CNS) Depression 
Older adults have substantial rates of CNS medication use, which places them at an increased 
risk for the negative reactions associated with concurrent use of alcohol and CNS depressants.  In 
addition, physiological changes make older adults more susceptible to the effects of medications 
that suppress central nervous system activity.  Table 3 gives an overview of therapeutic classes 
of drugs that are CNS depressants (Adams, 2002). 
 
 
Table 3  Classes of CNS Medications 
 
 
• Antihistamines 
• Antidepressants 
• Barbiturates 
• Benzodiazepines 
• Narcotic analgesic 
• Opioids 
 
 
These medications often cause sedation and decrease motor skills in older adults (NIAAA, 2007; 
Lococo & Staplin, 2006).  Alcohol, which is also a CNS depressant, has an added sedative effect 
when combined with these drugs (Weathermon & Crabb, 1999).  The concomitant use of alcohol 
and medications suppress central nervous system functioning, causing impaired balance and 
predisposing seniors to falls; slowing reaction times, which may lead to negative outcomes such 
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as automobile accidents; and excessive drowsiness (Lococo & Staplin, 2006; Adams, 2002).  The 
concomitant use of psychotropic drugs and alcohol is most likely to produce these impairments.  
Benzodiazepines, commonly used by older adults, have a strong potential for this type of 
alcohol-drug reaction (Lococo & Staplin, 2006; Adams, 2002).  Research has also shown that 
some tricyclic antidepressants also interact with alcohol, impairing alertness and motor 
functioning (Adams, 2002; Weathermon & Crabb, 1999).   
2.4.2.2 Gastrointestinal Issues 
Arthritis and other musculoskeletal problems are among the most common health problems faced 
by older adults (Adams, 2002).  Nonsteroidal anti-inflammatory drugs (NSAIDs) and over-the-
counter pain relievers (e.g., aspirin or ibuprofen) are often used to treat these disorders in seniors 
(Adams, 2002).  The use of NSAIDs has been associated with an increased risk for developing 
ulcers and gastrointestinal bleeding in older adults (Weathermon & Crabb, 1999).  The 
concurrent use of alcohol and NSAIDs or other anti-inflammatory drugs can have several 
detrimental effects.  Concomitant use may: 
1. increase risk for gastrointestinal bleeding; 
2. increase gastric inflammation; and 
3. cause longer bleeding times (Kaufman, 1999). 
In addition to pain relievers, some statins used to treat high cholesterol have been associated with 
gastrointestinal bleeding (NIAAA, 2007).  Further, the concurrent use of alcohol and aspirin has 
been shown to increase blood alcohol levels after small alcohol doses, possibly by inhibiting 
first-pass metabolism (Weathermon & Crabb, 1999).  All of these potential reactions are serious, 
especially in light of research that indicates that older adults are more likely to die from 
gastrointestinal bleeding than younger adults (Adams, 2002). 
 56 
 Concurrent use of alcohol and the anticoagulant Warfarin can also cause internal 
bleeding.  Warfarin is used to prevent blood clots in patients with irregular heartbeats or artificial 
hearts; it is also used to treat clots that form in the body’s extremities (Weathermon & Crabb, 
1999).  The anticoagulant effects of Warfarin are appreciably altered by even small amounts of 
alcohol (Weathermon & Crabb, 1999).  The interaction of alcohol and Warfarin results in the 
decreased metabolism of the drug; this increases the anticlotting effects of the medication, 
leading to an increased risk for bleeding (Adams, 2002).  On the other hand, the chronic use of 
alcohol results in increased enzyme activity in the liver, resulting in higher rates of drug 
metabolism (Weathermon & Crabb, 1999).  As a result, Warfarin breaks down faster than 
normal; therefore, higher doses of the drug are needed to achieve the desired effect (Adams, 
2002).  Anticoagulant medications are commonly used by older adults and Warfarin is one of the 
most common medications implicated in ADEs and ADRs.  The concurrent use of alcohol and 
Warfarin is, therefore, highly discouraged among older adults. 
2.4.2.3 Liver Toxicity 
Drugs can sometimes cause serious injury to the liver.  These injuries can cause loss of hepatic 
function leading to illness, disability, hospitalization, and even life threatening liver failure and 
death (Food & Drug Administration, 2009).  Medications can cause liver damage for a number 
of reasons, and many drugs are intrinsically toxic to the liver (Palmer, 2004).  Some drugs have 
the potential to cause liver injury when the medication is taken in a dosage that exceeds the 
recommended amount; drugs in this category are usually broken down by the cytochrome P450 
enzyme system (Palmer, 2004).  
 In situations of chemical-driven liver damage (hepatotoxicity), medications are broken 
down into toxic byproducts instead of benign ones; the byproducts cause liver damage as they 
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begin to accumulate (Palmer, 2004).  The drugs in this category may cause liver injury if taken in 
combined excess with another hepatotoxic substance, such as alcohol (Palmer, 2004; Adams, 
2002).  Some of the most notable examples of this effect are the hepatotoxicity of antibiotics 
such as isoniazid, acetaminophen, and the pain reliever phenylbutazone (Palmer, 2004; Adams, 
2002).   
It is worth noting that certain opioids commonly used by older adults to treat pain also 
contain acetaminophen (Weathermon & Crabb, 1999).  Using these pain medications with 
alcohol can be especially harmful because of these “hidden” doses of acetaminophen, a known 
hepatotoxic drug (Weathermon & Crabb, 1999).  Liver toxicity is a particularly salient issue for 
older adults since they commonly use many of the medications that, if taken incorrectly and 
combined with alcohol, can lead to liver damage.  
2.4.3 Summary 
As stated earlier, research indicates that approximately 50% of older adults consume some 
alcohol and the vast majority of older adults take one or more medications a day (Onder et al., 
2002; ASA, 2001).  However, little is known about the sociodemographic and health factors 
associated with concurrent use of alcohol and medications in older Americans.  The majority of 
research regarding alcohol-medication interactions has been conducted with young or middle-
aged populations and has focused primarily on chronic heavy drinkers; few studies have 
examined the adverse drug effects among low to moderate users in the general population of 
older adults (Onder et al., 2002).  Some studies have investigated the prevalence of concomitant 
use of alcohol and medication in retirement communities (Adams, 1995), emergency room 
departments (Adams, 1992), primary care settings (Blow et al., 2000; Adams et al., 1996), and 
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hospitals (Bristow & Clare, 1992).  Yet, community-level studies are scarce, and those focusing 
on the effects of moderate alcohol and medication use among older adults are even more 
uncommon.   
The limited research that does exist suggests that older adults are at risk for adverse 
health effects due to concomitant use of alcohol and medications.  As reported earlier, studies 
indicate that approximately 1 out of every 5 older adults concurrently use alcohol with alcohol-
interactive medications, placing themselves at risk for alcohol-related ADEs or ADRs (Pringle et 
al., 2005; Fink et al., 2002).  Even more alarming is the recent finding that 5.5% of all 
medication users were exposed to five or more alcohol-interactive drugs in combination with 
some amount of alcohol (Pringle et al., 2005).   
An additional concern is the fact that many concurrent users drink above the 
recommended guidelines.  The risk for interactions is greater at higher levels of use.  Research 
indicates that anywhere between 1% to 15% are considered problem drinkers and in one recent 
analysis 6% of concomitant users meet the criteria for heaving drinking (Pringle et al., 2005; 
NIAAA, 2004).  Despite the fairly common concurrent use of alcohol and medications and the 
severe negative consequences associated with the interaction of the two, most studies of adverse 
drug effects in older adults have focused on concomitant use of interactive prescription drugs 
(i.e., drug-drug interactions); little attention has been give to alcohol-drug interactions.   
2.5 CURRENT STUDY 
With the demographic projections and alcohol use trends indicating that newer cohorts of older 
adults are more likely to drink and have heavier drinking habits than previous generations, 
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alcohol use among older adults presents one of the most salient health problems facing this 
country.  Moreover, as the number of older individuals using prescription medications increases, 
so will the absolute number of older individuals using alcohol-interactive medications.  Despite 
these trends, little is known about the prevalence of concurrent alcohol and medication use 
among community-dwelling among older adults 
In recent years, significant advances have been made in the understanding of both the 
aging process (with its attendant health problems) and in the understanding and consequences of 
alcohol misuse.  However, our understanding of concomitant alcohol and medication use in older 
adults remains limited.  Traditionally, studies examining the concurrent use of alcohol and 
medication have focused on heavy or chronic drinkers.  Thus, we know very little about the 
prevalence rates and adverse effects of concurrent use among low or moderate drinkers. 
  Research paradigms that focus on persons who abuse or are dependent on alcohol are 
not as useful when applied to older drinkers whose alcohol use, regardless of consumption level, 
can be problematic due to age-related physiological changes, medication use, and functional 
mobility (Moore et al., 1999).  In addition to issues associated with the conceptualization of 
concurrent use in past studies, the small body of research that does examine concomitant alcohol 
and medication use in older adults has largely drawn from acute or primary care settings and 
tends to focus on prevalence rates rather than examining health outcomes (Aira et al., 2005).  In 
the majority of these studies, adverse drug reactions have been the primary outcome measure.  
Therefore, we have very limited knowledge about the broader adverse health consequences 
associated with concurrent alcohol and drug use in older adults.   
Gaining a better understanding of the prevalence, correlates   and consequences of 
concomitant alcohol and medication use is critical to developing prevention and intervention 
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strategies that effectively meet the needs of older adults.  The current study expands upon the 
existing knowledge base by examining concurrent alcohol and medication use outside of the 
acute and primary care settings.  Rates and correlates of concomitant use are reported for a large 
sample of community-dwelling older adults.  Examining concurrent use in community-dwelling 
older adults will aid in the development of a more thorough understanding of concomitant usage 
rates and patterns among seniors.  Past research has found that identifying problem alcohol 
and/or medication misuse is particularly difficult in elderly individuals; this analysis will assist in 
identifying specific subpopulations that may be at an increase risk for concomitant use.  Finally, 
given their heightened susceptibility to the effects of alcohol and medications due to various 
physiological factors, it is critical that we explore concurrent use in all older adults who consume 
alcohol, not just those who are considered problem drinkers.  Subsequently, the current study 
explores longitudinal patterns of concomitant use in older adults with various alcohol 
consumption patterns. 
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3.0  METHODOLOGY 
3.1 METHODS AND PROCEDURES 
3.1.1 Design, Sampling and Selection Criteria 
Funded by the National Heart, Lung, and Blood Institute (NHLBI), the Cardiovascular Health 
Study (CHS) is a population-based, longitudinal study of risk factors for the development and 
progression of coronary heart disease and stroke in adults 65 years or older.  Starting in 1989 and 
continuing through 1999, participants underwent annual clinical examinations and were 
contacted by phone at six-month intervals.  Since 1999, participants have been contacted every 
six months by phone, primarily to ascertain health status.  The CHS is one of the richest 
available data sets characterizing the health status of the elderly.  Only a few other longitudinal 
studies have followed cohorts of older individuals for as long as the CHS.  The CHS data set is 
extensive and includes information from interviews as well as from physical and laboratory 
examinations.  It has excellent measures of alcohol use, physical and mental health status, and—
one particularly unique aspect—a vast amount of longitudinal data available on medication use.  
Finally, unlike many other existing data sets, the CHS sample is comprised of a sufficient 
number of both women and African Americans.   
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The CHS cohort consists of men and women ages 65 and older drawn from four U.S. 
communities: Forsyth County, North Carolina; Sacramento County, California; Washington 
County, Maryland; and Allegheny County, Pennsylvania (Fried et al., 1991; Tell et al., 1993).  
Potential participants were identified using Medicare eligibility lists of the Health Care Finance 
Administration (HCFA) from these four counties.  To be eligible to participate in the study 
individuals needed to meet the following criteria: (a) they were 65 years or older at the time of 
examination, (b) were non-institutionalized, (c) were expected to remain in the area for the next 
three years, and (d) were able to give informed consent and did not require a proxy respondent at 
baseline (Fried et al., 1991; Tell et al., 1993).  Individuals were ineligible to participate in the 
study if they were wheelchair-bound in the home at baseline or were receiving hospice treatment, 
radiation therapy or chemotherapy for cancer (Fried et al., 1991 & Tell et al., 1993).   
Recruitment began in June of 1989 and ended one year later.  Stratified random samples 
were selected from the four site and were designed to produce a cohort with a 60:40 female to 
male ratio in each of four age groups with the following age strata: 65 – 69 (35%), 70 -74 (20%), 
75 – 79 (20%), and 80+ (20%) (Fried et al., 1991; Tell et al., 1993).  The population from the 
Allegheny County site was entirely urban; the remaining three sites recruited a mixture of urban 
and rural populations.  A total of 3,695 individuals were recruited from the HCFA sample; an 
additional 1,547 eligible persons who lived in households with sampled individuals were 
enrolled into the study (Tell et al., 1993).  The initial study sample was primarily Caucasian 
(95%); therefore, in an effort to achieve better representation of the African American 
community, three of the study sites were asked to recruit an additional 200 African American 
participants between 1992 and 1993 (Tell et al., 1993).   
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All of the recruitment procedures initially employed were also followed in the second 
recruitment period.  An additional 687 African Americans were recruited to participate in the 
study during this second recruitment phase (Tell et al., 1993).  Data collected during the baseline 
exam on the original 244 African American participants were compared to data collected during 
1992-93 on the additional 687 African American participants to look for differences related to 
protocol changes or technician drift (Tell et al., 1993).  All of the continuous variables were 
comparable for the two groups; therefore, baseline data for the new cohort of African Americans 
was combined with baseline data collected on the original sample.  The final sample consisted of 
5,888 individuals.  These individuals were examined yearly from 1989 through 1999 (Tell et al., 
1993).  
3.1.2 Procedures 
The baseline examinations consisted of two stages: a home interview and a clinic examination.  
First, interviewers went to the participants’ homes to collect a variety of personal and medical 
information.  If the person was eligible and agreed to participate in CHS, an appointment was 
made for a clinical evaluation.  The second phase of the baseline consisted of a clinical visit 
where a variety of procedures, including a physical exam, were completed.  In addition, 
participants completed several interviews assessing their cognitive functioning, nutrition habits, 
and neurological history. 
Prior to 1999, semi-annual contacts alternated between clinic examinations and telephone 
contacts, during which information about hospitalizations and health status was collected.  Major 
exam components were repeated during annual follow-up examinations through 1999.  
Participants have been contacted by telephone twice a year since 1999.  During these telephone 
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interviews, participants were asked to provide information about their general health, major 
illnesses, hospitalizations, and medication use.  Although primary data collection ended in 1999, 
follow-up information on key health outcomes has been continually collected through telephone 
interviews. 
3.1.3 Sample 
The basic demographic characteristics of study participants at baseline are presented in Table 4.  
The respondents mean age at baseline was 72.8 (5.61), with a range 65 to 100 years of age.  Of 
the 5,888 study participants, 57.6% were female and 42.4% were male.  The majority of study 
participants are White (83.6%), the remaining 16.7% of the sample are African American or 
classified as “other.” 
At baseline, most of the respondents reported being married (66.1%) and nearly 25% 
reported being widowed.  The remaining respondents were divorced (4.1%), separated (1.1%), or 
never married (4.0%).  The mean educational attainment was 13.7 years (SD=4.76).  The range 
of years of education spanned from no schooling to 21 years.  Nearly 30% of participants 
reported having 11 years of education or less. Just over 27% of respondents reported having a 
high school degree or GED, and 20.4% graduated from college or held a graduate or professional 
degree.  The majority of the sample reported an income of less than $25,000 a year (61.8%), with 
nearly 27% of respondents reporting an income of $12,000 or less. 
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Table 4. Overview of Study Participants at baseline 
 
             Variable Sample (n= 5,888) 
Gender 
     Female 
     Male 
 
57.6% 
42.4% 
            Race 
     White 
     African American 
 
             83.6% 
16.4% 
 
Education 
     Less than high school 
     High school diploma 
     Some college 
     1-3 Years Vocational Training 
     College Degree 
     Graduate or Professional Degree 
 
 
29.5% 
27.5% 
14.0% 
8.6% 
10.4% 
10.0% 
            Marital Status 
     Married 
     Widowed 
     Divorced 
     Separated 
     Never Married 
 
             66.2% 
24.6% 
4.1% 
1.1% 
4.0% 
 
Income 
     Under $12,000 
     $12,000 to $15,999 
     $16,000 to $24,999 
     $25,000 to $34,999 
     $35,000 to $49,999 
     Greater than $50,000 
 
 
25.0% 
14.5% 
18.3% 
14.4% 
  9.3% 
12.1% 
3.2 HUMAN SUBJECTS 
The Institutional Review Board at each participating study site approved the Cardiovascular 
Health Study and all participants gave informed consent.  Allegheny County was one of the four 
communities that participated in the CHS study, and the University Center for Social and Urban 
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Research (UCSUR) at the University of Pittsburgh has access to the CHS data.  The CHS data 
used in this study were provided by UCSUR; they have permission as one of the primary data 
collections sites to utilize these data and are in compliance with NHLBI requirements.  In 
addition, the Institutional Review Board at the University of Pittsburgh, which adheres to all 
federal regulations involving studies with human subjects, approved this study.  This secondary 
data analysis was conducted using a de-identified version of the CHS dataset; no additional 
human subject involvement was needed with respect to the present investigation.    
3.3 STUDY VARIABLES AND MEASUREMENT 
Below is an overview of the key variables used in the present study.  Many of the variables 
utilized in the analysis were transformed from their original state in the CHS datasets.   
3.3.1 Alcohol Use 
During the baseline and follow-up interviews, participants were asked to report their usual 
consumption of alcoholic beverages (daily, weekly, monthly, yearly, or rarely/never). 
Respondents were then asked to report the usual number of 12-ounce cans or bottles of beer, 6-
ounce glasses of wine, and liquor drinks or shots (approximately 1.5 oz)  that they drank on each 
occasion (Mukamal et al., 2001).  This information was used to calculate a continuous variable 
representing each individual’s weekly alcohol consumption (Mukamal et al., 2001; CHS, 1999) 
Calculated weekly alcohol use was then used to create a categorical variable representing 
various levels of alcohol consumption.  Participants were placed into one of five categories 
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according to weekly ethanol consumption: abstainers, below recommended guidelines (< 1 drink 
weekly), within recommended guidelines (1 to 7 drinks weekly), above recommended guidelines 
(8 to 14 drinks weekly), and problem users (15 or more drinks a week).  These categories were 
based on the recommended guidelines for alcohol consumption by older adults (NIAAA, 2004; 
Oslin & Holden, 2002; Barry et al., 2002; Blow, 1999).  Additionally, a dichotomous alcohol 
variable was computed for hazardous alcohol consumption (0= no problem use, 1= problem use) 
with individuals who drank 14 or more drinks a week (two times the amount of drinks 
recommended for weekly consumption by older adults) classified as hazardous users. 
3.3.2 Medication Use 
To assess the prevalence of prescription medication use, the medication inventory method of 
assessment was used.  Study participants were asked to bring the medications they had used in 
the past 14 days to their annual clinical visits.  Interviewers then transcribed information directly 
from the medication containers, including the name of the drug, the dose in milligrams, and the 
total number of doses prescribed daily, weekly, or monthly.  In addition, study participants were 
asked how often they had actually used each medication in the past 14 days (self-reported 
dosing).  Questions were also asked about the use of certain non-prescription medications 
including aspirin, sleeping pills and antihistamines.  This method of collecting prescription drug 
information from older adults has been shown to be more reliable than recall methods of 
medication ascertainment (Psaty et al., 1992).  A computer program developed by CHS was used 
to match the medication names collected by interviewers with the corresponding National Drug 
Code Directory numbers and then used to group medications into analytical categories (i.e., 
antidepressants or beta blockers).  
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In order to assess each medication’s risk for interaction with alcohol, a pharmaceutical 
consultant was employed to code the CHS medication data on a three point scale based on the 
severity of the drugs interaction with alcohol.  Thomson Micromedex, a comprehensive drug 
database, was used to look up the class and clinical teaching for each medication.  Medications 
were recoded into a three-point scale based on the severity of the drug’s interaction with alcohol, 
where 0= no interaction, 1= minor to moderate interaction and 2= severe interaction.  Interaction 
ratings were determined by the following criteria: 
a) Medication with an ethanol interaction rated contraindicated or major by Micromedex 
Interactions received a rating of two, severe interaction. 
b) Drugs classified as having a moderate or minor interaction in Thomson Micromedex 
were given a rating of one, minor to moderate interaction. 
c) If the drug summary document in Thomson Micromedex did not discuss any potential 
interactions with alcohol, the medication received a rating of zero, no interaction. 
d) In certain cases Thomson Micromedex did not specify an alcohol interaction or the 
drug received an unknown rating for ethanol interaction.  In these situations ratings 
were based on a combination of the pharmacist’s clinical knowledge and the 
information listed in the drug monograph of Thomson Micromedex.   
After each medication was coded for its level of interaction with alcohol, the information 
was used to create several new scale variables: the total number of alcohol-interactive 
medications, the total number of medications with a mild to moderate interaction, and the total 
number of medications with a severe interaction taken in the past 14 days.  Also, a dichotomous 
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variable was created with zero being no alcohol-interactive medication use and one representing 
any alcohol-interactive medication use in the past 14 days. 
3.3.3 Concurrent Use 
Information from the alcohol use and medication use measures was used to derive the variable 
“concurrent use.”  For the purposes of this analysis, concomitant use was defined as those 
individuals who consumed alcohol on a weekly basis and were taking one or more alcohol-
interactive medications.  A dichotomous variable was created where 0= no concomitant use and 
1= concomitant use.  A variable representing the level of concurrent use was derived by 
multiplying the total number of alcohol-interactive medications by weekly alcohol consumption; 
this scale was then recoded into a categorical variable representing low to high levels of 
concurrent use.  Individuals were placed into one of four categories: no concurrent use, low level 
of use (.02 – 10), moderate level of use (11 – 29.99), and high level of use (30 or more).  Finally, 
a continuous variable was created indicating the total number of years an individual concurrently 
used alcohol with alcohol-interactive medications over the course of the study (range 1 – 6).   
3.3.4 Health Status 
Past research indicates that a broad range of measures are necessary to accurately assess physical 
and mental health functioning (Newsom & Schulz, 1996).  The CHS questionnaire on physical 
health was designed to assess the spectrum of physical functioning in study participants.  The 
questionnaire was modified from the National Center for Health Statistic Supplement on Aging 
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and the NIA EPESE Study.  A combination of the array of measures collected by the CHS will 
be used to obtain the most comprehensive measure of health status possible.  
3.3.4.1 Physical Health 
The National Health Interview Survey Supplement on Aging questionnaire, which assesses 
activities of daily living (ADL) and instrumental ADL (IADL), was used to measure physical 
functioning (Fulton et al., 1989).  The ADL is designed to assess respondents’ difficulty with 
basic self-care activities.  It includes questions on essential activities, such as walking around the 
home, getting out of bed, bathing, dressing, and eating.  The IADL scale measures participants’ 
difficulty with activities considered essential for living in the community.  Respondents are 
asked about six tasks: heavy housework, light housework, shopping, preparing meals, managing 
money, and using the telephone.  For both the ADL and IADL scales, response alternatives are 
dichotomous: 0 = no difficulty and 1= difficulty.  The number of “yes” responses are summed to 
yield a total score; scores can range from 0 – 6 for each scale.  Higher scores reflect greater 
difficulties with ADL and IADL. The scale ADL and IADL variables were also converted into 
categorical variables; the categories were based on the frequency distributions of the raw number 
of ADL and IADLs.  The vast majority of respondents reported zero (91.8% and 75.1%) or one 
(4.8% and 18.1%) for total number of ADLs and IADLs, respectively.  The percentiles were so 
low in the other categories (less than 5%), that the scale variables were collapsed into categorical 
variables. The total number of ADL and IADL scale contained the following categories: 0=Zero, 
1=One, 2=Two and 3= Three or more. 
Perceived health was assessed using single-item measures of perception of one’s health.  
Participants were asked to rate their general health on a 5-point Likert scale from “excellent” to 
“poor.”  The second self-report health questionnaire asked respondents to compare their health to 
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that of others with three options: worse than, the same as, or better than others.  On these two 
measures, higher scores indicate better perceived health.   
3.3.4.2 Mental Health Status 
Depression status was measured using the 10-item Center for Epidemiological Studies 
Depression Scale (CES-D) (Radloff, 1977).  Participants were asked to describe how they had 
felt during the previous week.  Responses to statements such as “I am depressed” or “I felt 
lonely” – were rated on a 4-point scale ranging from 0 to 3 (“rarely to none of the time” to “most 
of the time”) and focuses on five areas: mood (5 items), level of irritability (1 item), energy level 
(2 items), concentration (1 item), and sleep (1 item). The 10-items were summed to create a 
depression score with a range from 0 to 30; higher scores indicated greater experience of 
depressive symptoms in the past week.   
The 10-item CES-D was derived from the 20-item CES-D, which is one of the most 
widely used self-report instruments for assessing depression status (Schroevers et al., 2009).  The 
psychometric properties of the CES-D scale have been tested in several populations of varying 
sociodemographic factors and health status.  In general these studies have supported the 
reliability and validity of the CES-D (Lee & Chokkanathan, 2008; Turvey et al., 1999; Pasacreta, 
1997; Andersen et al., 1994; Callahan & Wolinsky, 1994; Radloff, 1977).  Reliability statistics 
have found the 10-item CES-D to be comparable to those reported for the original CES-D (Irwin 
et al., 1999).   
The 10-item CES-D has been found to be a valid measure for use as a screening 
instrument for identification of depression in older adults (Irwin et al., 1999; Turvey et al., 1999).   
For example, Andersen and colleagues tested the reliability and validity of the CES-D 10 in a 
sample of healthy older adults (1994).  The CES-D showed good predictive accuracy when 
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compared to the full-length 20-item version of the CES-D (kappa = .97, P < .001) (Andersen et 
al., 1994). In addition, the CESD-10 showed a negative correlation with positive affect (r = -.63) 
and was also positively correlated with showed with poorer health status (r = .37) (Andersen et 
al., 1994).  Validation of the CESD-10 against the 20-item CES-D using a cut-offs points of 
eight, nine and ten 10 have been conducted.  A cut-off score of ten or more, which is used in the 
current study, has been shown to minimize false positives with little loss of sensitivity (Andersen 
et al., 1994). 
3.3.5 Demographic Information 
A number of demographic characteristics were measured during the baseline interviews and at 
each follow-up assessment.  The measures included gender, age, race, marital status, educational 
attainment, income, and employment status.   
3.4 DATA ANALYSIS PLAN 
3.4.1 Descriptive and Univariate Analyses 
The first part of the analysis consisted of cross-sectional analyses of baseline data using the 
statistical software SPSS 15.0.  As mentioned earlier, there were no statistically significant 
differences in baseline data between participants in the first wave of data collection and those in 
the additional recruitment period between 1992 and 1993.  Therefore, baseline data from the 
second wave of recruitment was combined and analyzed with that of the original cohort.     
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This preliminary analysis was employed to determine baseline rates of concurrent alcohol 
and medication use, as well as physical and mental health status among community-dwelling 
older adults.  The two goals of this descriptive data analysis were to derive a general description 
of the data and to establish baseline prevalence rates for crucial study variables.  These 
preliminary analyses were conducted on all key study variables at wave 1, time point 1 (face-to-
face interview), and serve as the primary source of comparison throughout the analysis.   
Analysis of sociodemographic variables (e.g., gender, race, age) related to alcohol, 
medication, and concurrent use was conducted.  Frequency counts and percentages were utilized 
to summarize the various categorical variables.  Additionally, descriptive statistics—including 
measures of central tendency (means, medians, modes) and dispersion (standard deviations and 
ranges)—were obtained for key study variables such as alcohol consumption, medication use, 
and health status.  Cross tabulations were run to examine bivariate relationships between 
sociodemographic variables and alcohol consumption, medication use, and concurrent use at 
baseline.  Finally, bivariate relationships between concurrent use and health status at baseline 
were also explored using cross tabulations.   
3.4.2 Multivariate Analysis 
The multivariate portion of the analysis focused on examining various patterns and consequences 
of concurrent alcohol and medication use over time.  The two primary goals of the multivariate 
analyses were to identify trajectories of concurrent use among older adults and to examine how 
various trajectories impacted health status over time.  The follow-up point, not the interview 
year, was essential to conducting the group-based trajectory modeling analyses, appropriately 
using both the original and the new cohort of study participants.  Because of the introduction of a 
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second cohort of individuals into the CHS study in year 5, the data needed to be reorganized so 
that each wave was representative of the equivalent follow-up time point for each of the two 
groups.  For example, year 3 is the second follow-up for the original cohort; however, the second 
follow-up time point for the new cohort actually took place in year 7.  These two datasets were 
combined to create wave 2 (follow-up 2).  Table 5 summarizes how the datasets used in this 
analysis were formulated. 
 
 
Table 5. Overview of CHS Data sets 
 
 Baseline Second 
Follow-up 
Third 
Follow-up 
Fourth 
Follow-up 
Fifth 
Follow-up 
Sixth 
Follow-up 
Original Year 1 & 2 Year 4 Year 5 Year 6 Year 7 Year 8 
New Year 5 Year 7 Year 8 Year 9 Year 10 Year 11 
 
Note:  Data from the first follow-up was not included in this analysis because several key study variables were not  
          collected for the original cohort at this measurement point (Year 3). 
 
 
3.4.2.1 Group-Based Trajectory Analysis 
Group-based trajectory modeling is a specialized application of finite mixture modeling that can 
be used to simplify longitudinal data by identifying clusters of individual developmental 
trajectories on a likelihood basis.  The technique creates groups by clustering individuals whose 
trajectories most closely resemble one another using a probability function.  The methodology 
assumes the existence of latent subpopulations.  Although these groups do not necessarily exist, 
their identification has applications in both the interpretation and further analysis of longitudinal 
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data (Broadbent et al., 2008).  Handling a small number of groups of trajectories is less 
complicated than analyzing hundreds of individual trajectories (Nagin, 2005).  Group-based 
trajectory analysis was used to: 1) identify the number of unique trajectories of concurrent use 
among older adults over the six-year study period; 2) examine the trends of concurrent use 
among this population, and; 3) assess whether group membership varied based on 
sociodemographic factors, including gender, race, and age.  To meet these objectives, trajectories 
based on concurrent use were generated using the SAS-based procedure known as Proc Traj.   
Group-based trajectory models are designed to identify clusters of individuals following 
similar progressions of behavior or outcomes over age or time.  Mixture models are useful for 
modeling unobserved heterogeneity in a population.  They also allow for the inclusion of time-
stable and time-dependent covariates (Jones & Nagin, 2007).  Time-stable covariates are 
incorporated into group-based trajectory models by assuming the influence the probability of 
belonging to a particular group.  On the other hand, time-dependent covariates can directly affect 
the observed behavior (Jones et al., 2001).  Proc Traj is a specialized application of finite mixture 
modeling intended to identify distinctive groups of individual trajectories within the study 
population and for profiling the characteristics of between-group differences (Nagin, 2005, 
1999).  The group-based logit modeling yields two results: the optimal number of groups and the 
proportion of the sample belonging in each of the trajectory groups.   
The group-based modeling is an elaboration of the conventional maximum likelihood 
model that forms the basis for many statistical methods, such as logit and Tobit regression (Xie 
et al., 2006).  The statistical method provides the basis for determining the number of groups that 
best fits the data.  Determining the optimal number of groups and the shape of the trajectory for 
each group is a dynamic modeling fitting process.  To determine the optimal number of 
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trajectory groups that best fit the data, models with various numbers of groups are estimated 
(Nagin, 2005).  After defining the models, the optimal number of groups and the appropriate 
degree of the polynomial (constant, linear, quadratic, or cubic), which is used to define the shape 
of the trajectory for each group, is determined (Xie, et al., 2006).    
Group-based trajectory modeling is a fairly new technique that is continuing to evolve.  
As a result, no true consensus on determining the best fitting model currently exists (Xie et al., 
2006).  However, the Bayesian Information Criterion (BIC) is widely recommended as the 
preferred goodness-of-fit statistic; the larger the BIC the better the fit of the model (Nagin, 
2005).  P-values for the specified order of each trajectory were also considered as a model-fit 
indicator.  Thus, the model with the highest BIC value and significant trajectories was considered 
the best fit for the data.   
Proc Traj not only allows for the determination of the optimal number of trajectories, it 
also determines the probability of belonging to each of the group trajectories.  The probability 
scores generated by Proc Traj show the percentage of individuals assigned to each group as well 
as the likelihood of correct group assignment.  It produces an explicit metric for every study 
participant (i.e., the probability of group membership to each trajectory) for evaluating the 
accuracy of group assignment (Nagin, 2005, 1999).  The term probability score refers to the 
probability of membership in each of the trajectory groups.  Proc Traj also assigns a categorical 
score based on each individual’s highest probability score, referred to as the categorical score.  
For example, if four groups were identified for a specified model, each participant would receive 
four probability scores based on that individual’s probability of being in each of the four groups.  
In addition to the probability score, each participant would be assigned a categorical score based 
on the respondent’s highest probability score (e.g., group 2).  Continuing on with the four group 
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solution, “Participant A” might have probability scores of .10, .05, .60 and .25 for groups 1, 2, 3 
and 4, respectively.  Because the probability score was highest for the third group, “Participant 
A” would be assigned to group 3.  Cote and colleagues (2002) assert that mean trajectory group 
assignment probabilities around or greater than .70 – .80 implies a good fit.  Group assignment 
probabilities were also considered when determining model fit. 
Group-based trajectory modeling assumes data is missing completely at random (MCR) 
or missing at random (MR).  Conceptually it was not appropriate to assume that data missing for 
concurrent use was MCR or MR because the majority of attrition in the CHS data is due to death.  
Therefore, in order to accurately classify an individual developmental trajectory and correctly 
assign them to a trajectory group it was necessary to be able to establish their concurrent use 
behavior at each of the study measurement points.  In order to accurately classify an individual 
into the correct trajectory group it was necessary to be able to establish their concurrent use 
behavior at each of the study measurement points.   Therefore, only individuals with data on 
concurrent use at all of the six data points were included in the longitudinal portion of the 
analysis.  Of the 5,888 study participants nearly 60% (58.9%) had no missing information on 
alcohol and medication use for all six waves of the study.  As a result, it was possible to 
determine whether or not these participants reported concomitant use at each measurement point 
making it possible to chart their longitudinal patterns of use and they were included in the 
trajectory analysis (N=3,470).  Of the 2,478 participants that were dropped from this section of 
the analysis, 15.5% were missing one wave of data, 8.2% were missing two waves of data and 
the remaining 17.3% were missing three or more waves of data.  As stated earlier, the entire 
sample was included in the cross-sectional analysis of baseline data.  In addition, post-hoc 
analyses were conducted to examine differences between participants who completed the study 
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and those who dropped out due to attrition or death.  As a result, it was possible to determine 
whether or not these participants reported concomitant use at each measurement point making it 
possible to chart their longitudinal patterns of use and they were included in the trajectory 
analysis (N=3,470).  Of the 2,418 participants that were dropped from this section of the 
analysis, 15% reported only one wave of data, 26.1% were had two or three waves of data and 
the remaining 57.9% four or five waves of data.  As stated earlier, the entire sample was included 
in the cross-sectional analysis of baseline data.  In addition, post-hoc analyses were conducted to 
examine differences between participants who completed the study and those who dropped out 
due to attrition or death. 
Post hoc analysis of sociodemographic factors and key study variables at baseline 
revealed that the participants who were excluded from the trajectory analysis were fairly 
comparable to those respondents who were included.  At baseline the majority of participants in 
each group were women and White.  The mean age at baseline for the excluded group was 74.5 
which is slightly higher than the mean age for individuals included in the multivariate analysis 
(71.7).  Just over 46% of those persons excluded from the analysis reported weekly alcohol 
consumption versus 52.6% of those individuals who were included.  Medication use was fairly 
comparable between the two groups although rates were slightly higher for individuals who were 
not included in the trajectory analysis.  The mean number of medications taken for the excluded 
group was 2.7 compared to 2.09 for the analysis group and the total number of alcohol-
interactive medications used by persons not included was 1.48 versus 1.09 for individuals 
included in the trajectory analysis.  Last, in both groups 28% of participants reported concurrent 
use at baseline.   
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Although the two groups have similar sociodemographic profiles, rates of medication 
use, and drinking behaviors, those participants who were excluded from the study reported 
poorer overall health.  Individuals in the excluded group were nearly two times more likely to 
report fair or poor (35.7%) than those participants who were included in the group-based 
trajectory analysis (18.3%).  In addition, analysis revealed that those persons excluded from the 
multivariate analyses had more difficulties with activities of daily living (ADL) as well as 
instrumental activities of daily living (IADL).  Only 5.8% of individuals who were included in 
the trajectory analysis reported difficulties with ADLs compared to 11.7% of those who were not 
included.  Also, 32.6% of individuals dropped from the analysis reported difficulties with IADLs 
where as only 21.1% of respondents who were included in the analysis reported problems with 
IADLs.  Finally, when compared to those participants who were included in the trajectory 
analysis, respondents in the excluded group reported higher rates of depression, 13.7% versus 
17.4%.  These differences in physical as well as mental health status at baseline are not 
unexpected given that the majority of attrition in the CHS data is due to mortality.  Therefore, it 
would be anticipated that individuals who did not complete the study due to death would report 
poorer over health status at baseline than those participants who completed the study.  
In the current study, it was hypothesized that there would be a minimum of two unique 
trajectories of concurrent use among older adults.  In addition, it was theorized that longitudinal 
patterns of concurrent use would vary by sociodemographic characteristics, including gender, 
race, and age.  In order to assess these hypotheses, group based trajectory analyses were run to 
determine the most appropriate number of groups.  For the current study the assessment points 
served as the independent variable and concurrent use (0=No, 1=Yes) served as the dependent 
variable.  To determine the optimal number of trajectory groups that fit the data, 1, 2, 3, 4, and 5 
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group models were estimated.  The model that best fit the data was determined by the use of the 
BIC P-values for the specified order of each trajectory and group assignment probabilities.  After 
determining the best fitting model, analysis was run on the model, including the time-dependent 
factors of gender and race.  
3.4.2.2 Multinomial Logistic Regression 
Multinomial logistic regression was used to examine how various trajectories of concurrent use 
affect the health status of older adult.  Respondent patterns of concurrent use along with 
demographic characteristics such as age, gender, and race were regressed on physical and mental 
health variables to examine which characteristics predicted health outcomes using SPSS 15.0. 
Multinomial logistic regression is designed to handle dependent variables that have more 
than two classes, although it is sometimes used for binary dependents (Garson, 2009).  Logistic 
regression can be used to predict the percentage of variance in the dependent variable explained 
by the independent variable, to rank the relative importance of independent, to assess the 
interaction effects, and to understand the impact of covariate control variables (Pampel, 2000).  
Logistic regression applies maximum likelihood estimates after transforming the dependent 
variable into a logit variable—the natural odds of the dependent variable occurring or not 
occurring (Pampel, 2000).  Thus, logistic regression estimates the odds of a certain event 
occurring.   
Logistic regression is popular because it lacks many of the restrictive assumptions of 
OLS regression.  Specifically, logistic regression does not assume a linear relationship between 
the dependent and the independent variable, does not require normally distributed variables, does 
not assume homoscedasticity, and has overall less stringent requirements (Garson, 2009).  
Multinomial logistic regression is the best regression procedure for this particular study because 
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it can handle dependent variables with multiple classes and allows for between-group 
comparisons.  Therefore, I am able to assess the results in relation to how members of a 
particular group compared to those classified in all the other trajectories.  For example, members 
of the no to low use trajectory may be significantly more likely than individuals in the increasing 
use group to report excellent health rather than good health.  Multinomial regression allows these 
types of comparisons to be made. 
In the current study, it was hypothesized that individuals with higher levels of concurrent 
use would report poorer overall health than those individuals who had no-to-low levels of 
concurrent use.  Main-effects multinomial logistic regression was used to test this hypothesis; 
models were run using data from the final follow-up point (Wave 6)4
                                                 
4 Multinomial logistic regressions were only run on the follow-up time point because the independent variable,  
group membership, was formulated based on the group-based logit modeling and includes the time component. 
.  Several logistic regression 
models were run. In all of the models, group membership (that is, belonging to the no to low use, 
decreasing use, increasing use or high use trajectory) served as the independent variable.  SPSS 
automatically generated three dummy variables for the group membership variable; no to low use 
served as the comparison group.  In order to assess the impact of concurrent use on physical 
health status, group membership was regressed on self-reported health status, the number of 
IADLs and the number of ADLs at wave six.  Assessing the impact of concurrent use on mental 
health status was determined by running a multinomial logistic regression with group 
membership predicting depression status at wave six.  The covariates of gender, race and age 
were included in all of the models.  Models were evaluated using the Person and Deviance 
goodness-of-fit statistics, the likelihood ratio tests and the parameter estimates. 
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3.4.2.3  Logistic Regression 
Four additional logistic regression models were run to investigate the extent to which 
participants physical and mental health status at baseline helped explain reported health status at 
Wave 6.  In each of the models, health status (self-reported health status, number of IADLs and 
ADLs and depression status) at baseline and group membership (belonging to either the low to 
no use, decreasing use, increasing use, or high use cohort) were included as independent 
variables.  The dependent variables from Wave 6 serving as proxies for physical health status 
included self-reported physical health status (1=Excellent, 2=Very Good, 3=Good, 
4=Fair,5=Poor), total number of IADLs (0=none,1= one to three, 2= four to six) and total 
number of ADLs (0= none, 1=one to two, 2= three to six).  The demographic covariates of 
gender (0=Female, 1=Male), race (0=African American, 1=White) and age (continuous) were 
included in all four of the logistic regression models.  Since no a priori hypotheses had been 
made to determine the order of entry of the predictor variables, a direct method was used for 
these multiple linear regression analyses. 
3.4.2.4  Cox Regression 
Cox regression analysis was employed to examine the relationship between concurrent use and 
mortality status; the entire sample was included in this regression analyses (N=5,888).  The time 
variable in this model, or duration to the event, was study wave and the binary variable of 
mortality was used as the status or outcome variable.  Two measures of concurrent use were used 
to predict the event (time until death): having ever concurrently used during the study (0=No and 
1=Yes) and the interaction of weekly alcohol consumption and total number of alcohol-
interactive medications (concurrent use) at baseline.  The additional covariates of gender 
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(0=Female, 1=Male), race (0=African American, 1= White) and age (continuous) were included 
in the model.   
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4.0  RESULTS 
4.1 OVERVIEW OF RESULTS 
The results are presented in three sections.  The first section includes baseline information on key 
study variables as well as information from cross-sectional analyses on concurrent use.  This 
preliminary analysis provides descriptive statistics about the prevalence of concurrent alcohol 
and medication use among community-dwelling older adults.  The second section focuses on 
longitudinal patterns and correlates of concurrent alcohol and medication use among older 
adults.  I tested the hypothesis that there would be several different trajectories of concurrent use 
among older adults.  Furthermore, I evaluate the relationship of various socio-demographic 
characteristics with different patterns of concurrent use.  To tests these hypotheses I use group-
based trajectory modeling.  The final section discusses the impact of concurrent use on physical 
and mental health status.  I hypothesized that individuals with higher levels of concurrent use 
would have poorer physical and mental health outcomes than those individuals who reported no 
or low levels of concomitant use.  I use Multinomial logistic regression to assess these 
hypotheses. 
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4.2 DESCRIPTIVE ANALYSIS 
The following analysis provides a general description of the data and establishes the baseline 
status of the sample (wave 1) for key study variables.  Further, I review the relationship between 
concurrent use and socio-demographic as well as other key factors such as health status.  
4.2.1 Alcohol Use 
Table 6 provides an overview of alcohol consumption at baseline.  Most respondents either 
abstained from alcohol use (50.1%) or drank below (36.3%) or within (3.7%) NIAAA guidelines 
for older adults (1 drink a day).  However, 6.7% of participants drank above recommended 
guidelines (more than 1 drink a day) and 3.3% of respondents reported drinking twenty or more 
drinks a week, nearly three times the recommended consumption for older adults.  Moreover, 
7.7% of respondents were classified as hazardous users, drinking 14 or more drinks a week 
which is double the recommended alcohol consumption for older adults.  These statistics are 
consistent with past research on alcohol consumption patterns among older adults that suggests 
that approximately 50% of seniors consume alcohol and 10% drink above recommended 
guidelines (Blow & Barry, 2002).  
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Table 6  Overview of Alcohol Consumption at Baseline 
 
 
 
 
Men (58.2%) were statistically more likely than women (43.8%) to report weekly alcohol 
consumption.  Men also reported higher rates of alcohol consumption; the mean number of 
drinks per week for men (3.7) was nearly two and a half times as much as the reported mean for 
females (1.5).  In addition, 11.2% of men reported hazardous alcohol use, consuming 14 or more 
drinks a week or twice the NIAAA recommended guidelines, compared to only 5.1% of women.  
There were statistically significant differences in rates of alcohol consumption between Whites 
and African Americans.  Only 5.5% of African Americans reported drinking above NIAAA 
guidelines compared to 10.8% of Whites; Whites were also more likely than African Americans 
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to be hazardous alcohol users.  Furthermore, rates of alcohol use differed by age with those 
individuals age 75 and older having higher rates of abstinence and lower rates of alcohol 
consumption than individuals under the age of 75.  Additionally, individuals over the age of 75 
were less likely than their younger counterparts to report hazardous use, 8.3% versus 6.5% 
respectively.  These findings are consistent with past research that indicates that although rates 
and levels of alcohol consumption decrease with age, nearly half of all older adults continue to 
drink alcoholic beverages; consumption of alcohol among older adults is most prevalent among 
men, Whites, and younger individuals (Hanson & Gutheil, 2004). 
In looking at rates of alcohol use among drinkers only, the average number of alcoholic 
beverages consumed weekly by drinkers only was 4.9; 15% of the drinkers were classified as 
hazardous users (consuming 14 or more drinks a week) (see Table 7.).  Men and Whites had 
higher rates of weekly alcohol consumption than women and African Americans.  Nearly 16% of 
male drinkers reported consuming levels of alcohol above the recommended guidelines and 9.4% 
drank 20 or more drinks a week whereas only 11.3% of women drinkers reported rates of 
consumption above the recommended guidelines and even fewer (3.6%) consumed 20 or more 
drinks a week.  
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Table 7  Overview of Alcohol Consumption at Baseline (Drinkers Only) 
 
 
 
4.2.2 Medication Use 
Table 8 describes the sample baseline of medication use.  Seventy-seven percent of participants 
took at least one medication in the past 14 days; on average participants took 2.34 medications a 
day.  Just over 52% of participants reported daily use of 1 to 3 medications, 19.6% were using 4 
to 6 medications and 5.1% took seven or more medications a day.  Sixty-two percent of the 
sample reported taking an alcohol-interactive medication at baseline; the mean number of 
alcohol-interactive medications used by respondents was 1.25.  
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Table 8  Medication Use at Baseline 
 
 
 
Women were statistically significantly more likely than men to be taking any 
medications, ( p < .001).  Analysis of the total number of alcohol-interactive medications being 
take by study participants revealed that usage rates for alcohol-interactive medication also varied 
by gender with women taking more alcohol-interactive medications than their male counterparts 
(p < .001).  The percentage of participants using medications differed by race.  African 
Americans were less likely than Whites to be taking no medications, 18.5% versus 24.0% (p < 
.001).  In addition to taking fewer medications than African Americans, Whites used alcohol-
interactive medications less than African Americans (p < .001).  Finally, age was found to be a 
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significant predictor of medication use.  At baseline individuals age 75 and older were more 
likely to be taking multiple medications, χ2(4, N = 5888) = 30.33, p < .001.  However, there were 
no statistically significant differences in rates of usage of alcohol-interactive medications 
between age categories. 
 
 
Figure 1  Alcohol-Interactive Medication Use by Age at Baseline 
 
 
4.2.3 Health Status 
One of the primary goals of this investigation was to examine the impact of various patterns of 
concurrent use on the physical as well as mental health status of older adults.  Prevalence rates of 
key health status indicators were analyzed at baseline in order to gain a general overview of the 
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health of the older adults in the sample.  The relationships between health status and gender, race 
and age were also examined. 
4.2.3.1 Physical Health Status 
The majority of participants, 61.1%, reported being in good or very good health at baseline (see 
Figure 2.).  Over 57% of respondents felt their health was better than others their age.  African 
Americans were significantly more likely than Whites to report fair or poor health, 42.4% versus 
22.2% respectively (p < .001).  However, no racial difference in how respondents viewed their 
health compared to others were found; the majority of both African Americans and Whites felt 
their health was better than others their age.  There was no statistically significant difference in 
self-report health status by gender, the majority of both women (60.7%) and men (61.7%) 
reported good to very good health.  However, men were significantly more likely than women to 
consider their health to be better than others their age, 60.1% versus 55.1% (p < .001).  
Individuals 80 and above were significantly more likely than other age groups to report fair or 
poor health (31.8%).  However, older individuals, eighty and above, were more likely to believe 
there health was better than others their age; for example, 61.3% of individual eighty and over 
compared to 52.8% of individuals age 65 to 69 (p < .001). 
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Figure 2  Self-Reported Health Status at Baseline 
 
 
 
 
Table 9 describes overall physical functioning for the study sample at baseline; 
percentages of total number of ADLs and IADLs are reported for the overall sample as well as 
by race and gender. 
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Table 9  Physical Functioning at Baseline 
 
 
94 
 
Women reported significantly more difficulties with Activities of Daily Living (ADL) 
and Instrumental Activities of Daily Living (IADL) than men (p < .001).  African Americans had 
significantly higher levels of reported ADL deficiencies than Whites (p < .001); they also had 
more difficulty with IADLs than Whites but the difference was not statistically significant.  Age 
was a significant predictor of both ADLs and IADLs with individuals in the older age categories 
reporting higher rates of ADLs and IADLs  (p < .001). 
4.2.3.2 Mental Health 
Using the recommended cut-point for the CES-D of 10, 13.8% of respondents were classified as 
depressed at baseline.  The mean CES-D score was 4.41 (SD=4.6) with a range from 0 to 29.  
Women and African Americans were significantly more likely to be depressed than men and 
Whites (p<.001).  Nearly 17% of women compared to only 9.8% of men were classified as 
depressed at baseline.  Twenty-one percent of African Americans had a positive screen for 
depression at baseline versus 12% of Whites.  Depression status was not significantly related to 
age category yet older individuals had higher rates of depression at baseline; for example 12.9% 
of individuals between the ages of 65 and 79 were classified as depressed at baseline compared 
to 15.7% of individuals in the age range of 80 to 84. 
4.2.4 Concurrent Use 
Twenty-eight percent of all study respondents reported concurrently using alcohol with one or 
more alcohol- interactive medications at baseline.  Of those individuals who reported weekly 
alcohol use, 56.7% were taking one or more alcohol-interactive medications.  The number of 
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alcohol-interactive medications used by individuals who reported concurrent use ranged from 1 
to 9 with a mean of 1.06 (SD=1.24).  Most participants were taking one alcohol-interactive 
medication (48%) however; 22.1% of respondents who reported concurrent use were taking three 
or more alcohol-interactive medications.   
At baseline, concurrent users had higher rates of overall medication use and were taking 
more alcohol-interactive medications than individuals who reported no concurrent use.  Over 
35% of concurrent users reported taking 4 or more medications compared to just 20.4% of non-
concurrent users, p < .001.   Study participants who reported concomitant use were also more 
likely than non-concurrent users to take multiple alcohol-interactive medications; 22.1% versus 
14.1% respectively (p < .001).   
Men had greater rates and reported more hazardous levels of concurrent use than women.  
At baseline, rates of concurrent use for women and men were 26% and 32% respectively. Men 
were statistically more likely to report concurrent alcohol and medication use than women, χ2= 
27.91, p < .001.  Men were also more likely than women to report high levels of concurrent use 
at baseline (see Figure 3.); level of concurrent use was determined by the amount of weekly 
alcohol consumption and total number of alcohol-interactive medications being taken.  Men 
(9.6%) were twice as likely as women (4.6%) to have high levels of concurrent use at baseline (p 
< .001). 
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Figure 3  Level of Concurrent Use by Gender at Baseline (Drinkers Only) 
 
 
 
Rates of concurrent use varied by race as well; 29% of Whites verses 23% of African 
Americans reported concurrent use at baseline.  Whites were significantly more likely than 
African Americans to report concurrent use, p < .001.  Additionally, Whites reported higher 
levels of concurrent use than their African American counterparts,  p < .04 (see Figure 4).  
Nearly 16.2% of Whites reported moderate levels of concurrent use compared to only 9.9% of 
African Americans.  No significant difference in rates of concurrent use were found for age (p = 
.66), concurrent usage rates remained fairly stable regardless of age category.  
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Figure 4  Level of Concurrent Use by Race at Baseline (Drinkers Only) 
 
 
 
Although the majority of individuals taking alcohol-interactive medications drink at or 
below the NIAAA recommended guidelines for older adults (81.2%), nearly 19% of respondents 
reported drinking above the recommended guidelines (>8 drinks a week).  Individuals who were 
classified as problem users, drinking nearly three times the weekly recommended guidelines for 
older adults (>20 drinks a week), were statistically more likely to concurrently use than non-
problem users; 54.4% versus 26.1% respectively (p < .001). 
Differences in health status between concurrent users and non concurrent users at 
baseline were also examined (these results were used as a comparison point for the later 
multivariate analysis that assessed whether or not longitudinal patterns of concurrent use impact 
health outcomes).  There were no statistically significant differences between concurrent users 
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and non concurrent users at baseline, Table 10 shows rates of self-reported health, physical 
functioning and depression status for concurrent users versus non concurrent users.  
 
 
Table 10  Health Status at Baseline: Concurrent User versus Non-Concurrent Users 
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4.3 GROUP-BASED TRAJECTORY MODELS 
As stated earlier, initial descriptive analyses were conducted as a precursor to more in-depth 
multivariate analysis examining concurrent alcohol and medication use among older adults.  It 
was hypothesized that there would be more than one pattern of concurrent use.  Preliminary 
explorations of the data revealed that, of the respondents with complete data on concurrent use 
for all measurement points (N=3,470) nearly half (48.9%) concurrently used alcohol with 
alcohol-interactive medications during at least one of the six waves of the study; 58.7% of 
concurrent users reported concomitant alcohol-medication use in 3 or more waves of the study 
(see Figure 5). 
 
 
Figure 5  Total Waves of Concurrent Use by Gender and Race 
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The preliminary findings indicated the possible existence of different trajectories of 
concurrent use.  Additionally, it appeared that longitudinal patterns of concomitant use varied by 
gender and race.  Group-based logit modeling was used to test these hypotheses.  The group-
based logit modeling yielded two results: the optimal number of trajectory groups as well as the 
proportion of the sample belonging in to each of the trajectory groups.  Determining the optimal 
number of groups and the shape of the trajectory for each group is a dynamic modeling fitting 
process.  In this analysis two, three, four, and five-group models were fitted.  The Bayesian 
Information Criterion (BIC) was used for model selection.  BIC scores for the various models are 
listed in Table 11; two BIC scores are presented, one based on the total number of participants 
and another based on the total number of observations.  Based on the BIC scores, the model with 
four groups has the best fit, as this model has the largest BICs (-8448.40 and -8465.43).  
After determining the model with four groups was the best-fitting model, the parameter 
estimates were refined to create a more parsimonious model.  In the initial analyses, all groups 
were set to calculate through the cubic order however, only the increasing use group was 
significant up to the cubic order.  Therefore, the model was refined to create a more 
parsimonious model.  In the refined four group model only the increasing use group was set to 
calculate up to the cubic order, the other three groups only calculated through the quadratic 
order.  All of the four groups maintained similar trajectory patterns, refining the model simply 
served to eliminate the unnecessary parameters to create the most parsimonious model that best 
reflects the four unique trajectory patterns.   
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Table 11  BIC Scores for Concurrent Use Models 
 
 
 
 
Parameter estimates for the four group model are displayed under Model One in Table 12 
and Figure 6.  This population includes a mixture of four distinctive groups that are defined by 
their trajectories with respect to concurrent use over the six years study period.  Group 1, which 
was classified as the no to low use trajectory constitutes the majority of the population (61.9%) 
and is defined by the intercept linear, and quadratic parameters.  The no to low use trajectory is 
characterized by a slight U-shaped pattern with concurrent use starting off slightly elevated in 
wave one, declining and maintain a fairly stable level in waves two through five and increasing 
slightly in the final wave of the study.   The trajectory for Group 2 or the decreasing use 
trajectory, accounts for 14.2% of the sample and is stable in the initial waves of the study but 
overtime it begins to steadily decline.  Group 3, the increasing use trajectory, is comprised of 
7.2% of the sample and is defined by all four of the parameters (intercept, linear, quadratic and 
cubic); this trajectory starts off low but, steadily increases overtime with a slightly decrease near 
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the end of the study.    Group 4 is defined by the intercept, linear, and quadratic parameters.  Just 
over 16.6% of study participants belonged to Group 4, entitled the high use trajectory, which is 
characterized by a curve shaped trajectory.  In the high use group there is an increase in 
concurrent use between waves one and two of the study; rates remain high and stable between 
waves two and four and then begin to decrease in wave five.  
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Table 12  Parameter Estimates for Group Trajectories and Group Membership5
 
 
Group (N=3470) Parameter Model 1   Model 2 
 
 
  Estimates SE  Estimates SE 
       
1   No to low Intercept 
Linear 
Quadratic 
-2.63 
-0.67 
 0.09 
0.11** 
0.10** 
0.02** 
 -2.69 
-0.67 
 0.09 
0.11** 
0.09** 
0.02** 
2   Decreasing Intercept 
Linear 
Cubic 
 0.41 
 0.08 
-0.06 
   0.17* 
   0.10 
0.02** 
  0.40 
 0.07 
-0.06 
    0.16* 
    0.09 
0.02** 
3   Increasing Intercept 
Linear 
Quadratic 
Cubic 
-1.19 
-1.60 
 0.87 
-0.09 
0.27** 
0.50** 
0.22** 
0.02** 
 -1.35 
-1.57 
 0.87 
-0.09 
0.28** 
0.51** 
0.22** 
0.02** 
4   High Intercept 
Linear 
Quadratic 
1.71 
 0.76 
-0.12 
0.15** 
0.13** 
0.02** 
  1.70 
 0.78 
-0.12 
 
0.15** 
0.13** 
0.02** 
 
Group Membership6
 
 
1   No to low Constant     0.00  
2   Decreasing Constant 
Sex (Male= 1) 
Race 
(White=1) 
   -1.22 
  0.08 
-0.28 
    0.16** 
0.16 
0.14 
3  Increasing  Constant 
Sex (Male= 1) 
Race 
(White=1) 
   -3.27 
  0.93 
  0.69 
    0.47** 
     0.20 ** 
 0.40 
4  High Constant 
Sex (Male= 1) 
Race 
(White=1) 
   -2.07 
  0.59 
  0.56 
     0.18** 
     0.10** 
     0.17** 
       *Significant at p<.05 
     **Significant at p<.001  
                                                 
5 Model 1 is an unconditional model that only identifies group membership.  Model 2 is a conditional  model that  
   links demographic variables to group membership. 
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Posterior probabilities were also determined and used as an indicator of good model fit 
(Cote et al., 2002).  Table 13 shows the number of individuals assigned to each group along with 
the average and range of posterior group assignment probabilities.  The percentage of the sample 
assigned to each of the four groups (64.4%, 12.2%, 6.1% and 17.4%) based on maximum 
posterior probabilities corresponds closely to the estimated group probabilities (61.9%, 14.2%, 
7.2% and 16.6%).  Table 13 also shows the average trajectory group assignment; these 
probabilities are 0.95, 0.80, 0.77 and 0.90 for the four groups, respectively.  Therefore, between 
77 to 95 percent of individuals were correctly assigned to different trajectory groups.  These 
probabilities are around or greater than the minimum acceptable threshold defined by Nagin 
(2005) as having all group posterior probabilities at or above 0.7.  The BIC scores and the 
posterior probabilities both indicate that the four trajectory model is the best fit. 
 
 
Table 13  Trajectory Group Assignment Probabilities 
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Each of the four cohorts identified by the best fitting model are characterized by their 
own distinct patterns of concurrent use.  The no to low use trajectory (Group 1), is comprised of 
individuals who did not concurrently use alcohol and medications or those individuals who had 
low levels of concomitant use.  The trajectory for the no to low use (Group 1) group is fairly flat 
and essentially these individuals maintained a stable pattern of no or low levels of use over the 
course of the study.  The decreasing use trajectory (Group 2) is characterized by a gradual and 
steady decrease in concurrent use over time.  Rates of concurrent use were moderately high 
among members of the decreasing use group (Group 2) in the initial waves of the study but 
substantially decreased with time so that by the final study wave concurrent use was fairly low 
among this population.  The trajectory for Group 3, increasing use, is best characterized as a 
group of individuals whose concurrent use fluctuates over time.  Initially levels of concurrent use 
in the increasing use cohort (Group 3) were fairly low.  However, concurrent use increases 
among this population over the course of the study; by wave 5 this group was characterized by 
moderate to high levels of concomitant use.  Finally, the trajectory for the high use cohort 
(Group 4) is indicative of high-stable rates of concurrent use over time.  Individuals in the high 
use cohort (Group 4) tended to concurrently use alcohol and medications throughout the course 
of the study. 
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Figure 6  Longitudinal Patterns of Concurrent Use among Older Adults 
 
 
 
In addition to identifying the best-fitting model in terms of the optimal number of groups 
and their trajectory shapes, analysis was also run to determine whether or not any of the 
individual-level covariates predict or distinguish group membership.  The model containing time 
constant demographic covariates is contained in Table 12; Model 1 identifies group membership 
only whereas Model 2 also assesses whether individual-level covariates are associated with 
group membership.  In Model 2, using the no to low use group as the comparison group, both 
gender and race were a significant predictors of group membership.  Males had a higher 
probability of group membership in the high use group and the increasing use.  There were no 
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significant differences by gender for membership in the decreasing use trajectory. Race also 
predicted cohort membership; being White increased the probability of group membership in the 
high use group with significant coefficients of 0.56.  However, race did not predict membership 
in the decreasing use (p=0.08) or increasing use (p=0.08) groups yet, African Americans had a 
higher percentage of membership in the decreasing use group and Whites had higher rates of 
membership in the increasing use trajectory.  Additional cross-tabular analyses displaying rates 
of group membership by gender, race, and age are displayed below in Table 14. 
Men were nearly twice as likely as women to be in the increasing use group and had 
higher rates of membership in the high use cohort, 21.6% of men compared to only 14.7% of 
women.  Just over 15% of African Americans were in either the increasing use or the high use 
trajectories whereas 24.8% of Whites were placed in one of these cohorts.   Age was 
significantly related to group membership (p=0.015).  The majority of individuals in each age 
category (65 – 69, 70 – 74, 75 – 79, 80 – 84, and 85+) were in the no to low use group.  
Membership in the decreasing use group was highest for individuals ages 80 to 84 (17.9%) and 
the 85 and over category (19.6%) which is nearly double the percentage of those ages 65 to 69 in 
this group (11%).  Membership in the high use trajectory was greatest among the younger age 
categories.  For example, 17.9% of individuals ages 65 to 69 were members of the high use 
trajectory compared to only 5.4% of individuals ages 85 and older. 
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Table 14  Demographic Characteristics by Group Membership 
 
 Men 
 
 
 
(n=1369) 
Women 
 
 
 
(n=2101) 
𝒙𝒙𝟐𝟐 African 
American / 
Other 
 
(n=489) 
White 
 
 
 
(n=2981) 
𝒙𝒙𝟐𝟐 
Group 
 
    No to low Use 
    Decreasing Use 
    Increasing Use 
    High Use 
 
 
58.3% 
11.8% 
 8.3% 
21.6% 
 
 
68.3% 
12.5% 
 4.6% 
14.7% 
 
 
.000** 
 
 
68.5% 
16.2% 
 4.5% 
10.8% 
 
 
63.7% 
11.5% 
 6.3% 
18.5% 
 
.000** 
 
 
 
4.4 MULTINOMIAL LOGISTIC REGRESSION 
After identifying the four major patterns of concurrent use (no to low use, increasing use, 
decreasing use, and high use) multinomial logistic regression was used to analyze the 
relationship between patterns of concurrent use and the physical as well as mental health status 
of community-dwelling older adults.  In the baseline analysis of the relationship between 
physical health status and concurrent use, no significant differences were found between 
concurrent users and non-concurrent users on measures of self-reported health and physical 
functioning (IADLs and ADLs) as well as depression status.  To examine how various 
trajectories of concurrent use impact upon the physical health of older adult’s four multinomial 
logistic models were run.  In each of the models, group membership served as the independent 
variable (belonging to either the low to no use, decreasing use, increasing use, or high use 
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cohort); dependent variables from Wave 6 serving as proxies for physical health status included 
self-reported physical health status, total number of IADLs, and total number of ADLs.  
Additionally, a model to assess the effects of patterns of concurrent use on mental health status 
was run with group membership as the predictor variable and depression status as the outcome 
variable.  The demographic covariates of gender (0=Female, 1=Male), race (0=African 
American, 1=White) and age (continuous) also included in the model were included in all four of 
the logistic regression models.   Frequency distributions were run to determine the appropriate 
reference category for each of the dependent variables.  For the independent variable of group 
membership, consisting of three dummy variable, the no to low use trajectory was used as the 
default comparison group in all analyses. 
4.4.1 Physical Health 
4.4.1.1 Self-Reported Health Status 
In the first model, group membership was regressed upon physical health status with the 
covariates of gender, race, and age also included in the model.  Model fitting information 
indicated the existence of a relationship between the independent variables and self-reported 
health status; the probability of the model chi-square (159.40) was significant at p<.001.  
Furthermore, the likelihood ratio test indicated a significant relationship between concurrent use 
and self-reported health status; ratio tests also confirmed a statistically significant relationship 
between health status and gender, race and age (see Table 15).   Finally, both the Persons 
(p=.637) and Deviance (p=.997) goodness-of-fit statistics were not statistically significant 
indicating adequate model fit.   
110 
 
Table 15  Likelihood Ratio Tests for Physical Health Regression Models (N=3470) 
 
 
 
 
111 
 
Using good health as the reference category, being male increased the odds of reporting 
excellent to very good health rather than good health by 1.7 and 1.2, respectively.  There were no 
significant differences between Whites and African Americans in reporting excellent rather than 
good health.  However, Whites were significantly more likely than African Americans to report 
very good health; African Americans had significantly higher rates of self-reported fair or poor 
(p<.001).  Being White was associated with a 46.5% decrease in fair and a 70.8% decrease in 
poor rather than good self-reported health status.  Additionally, compared to younger individuals, 
older respondents were significantly more likely to report fair or poor health than good health 
(p<.001).  Looking at trajectories of concurrent use, members of the high use trajectory are 
significantly less likely than those in the no to low use group members to report excellent health 
rather than good health; no other group membership contrasts were significant (see Table 16. for 
parameter estimates).  This finding is a departure from the initial baseline analysis which found 
no significant differences between non-concurrent users and concurrent users possibly indicating 
that it is the pattern of concurrent use, not necessarily concurrent use in itself that affects health 
status. 
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Table 16  Parameter Estimates for Self-Reported Health Status Regression Model (N=3,470) 
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4.4.1.2 Physical Functioning 
Two models were run to assess the relationship between patterns of concurrent use and physical 
functioning.  In the first model, group membership was regressed upon the categorical variable 
number of IADLs with the covariates of gender, race and age also included in the model.  In the 
second model, group membership was the independent variable and the categorical variable 
number of ADLs was the dependent variable.  In both models, the reference category for the 
independent variable of group membership was the low to no use trajectory and for the 
dependent variables the comparison group was having no IADLs or ADLs.  Model fitting 
information indicated the existence of a relationship between the independent variables and 
physical functioning; the probability of the model chi-square (295.59) was significant at p<.001 
for the IADLs model and the model chi-square for the ADLs model was also significant, χ2 = 
152.21, p<.001.  Goodness-of-fit statistics for both models were non-significant indicating 
satisfactory model fit for both physical functioning models (see Table 17).  The likelihood ratio 
tests indicated a significant relationship between concurrent use and physical functioning (see 
Table 13).  Additionally, statistically significant relationships between total number of IADLs as 
well as ADLs and gender, race and age were found (see Table 15).    
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Table 17  Goodness-of-Fit Statistics For Physical Functioning Regression Model 
 
 
 
Parameter estimates showing significant relationships between total number of IADLs 
and gender, race, and age can be found in Table 18.  An inverse relationship was found between 
total number of IADLs and gender and race. However, the likelihood ratio test did not show race 
to be significantly related to the independent variable, number of IADLs, therefore it is not 
appropriate to assess its role in distinguishing between pairs of groups.  Women were 
significantly more likely than men to report having any IADLs rather than no IADLs.  Being 
male was associated with a 34% decrease in reporting one IADL, a 62.2% decrease in reporting 
two IADLs and a 58.6% decrease in having four to nine IADLs.  Age was positively correlated 
with total number of IADLs with older individuals reporting higher rates of IADLs compared to 
no IADLs.  As with race, comparisons of group membership were not assessed because the 
likelihood ratio test found no significant relationship between cohort membership and number of 
IADLs. 
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Table 18  Parameter Estimates Physical Functioning (IADL) Regression Model (N=3,470) 
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Similar to the IADL model, gender, race and age were all significantly related to the total 
number of ADLs reported by an individual (See Table 15 for likelihood ratio tests and Table 19 
for parameter estimates).  Men were more likely than women to report having no ADLs versus 
having one or more ADLs.  Being female increases the odds of reporting one, two, and three or 
more ADLs rather than no ADLs by 0.61, 0.58 and 0.44, respectively.  Whites were more likely 
than African Americans to report having no ADLs versus one or more ADLs.   Being African 
American increases the odds of reporting one (0.65), two (0.56) or three or more (0.51) ADLs 
rather than no ADLs.  Increasing age was significantly related to the number of ADLs reported.  
Each one year increase in age corresponds to a 0.05 unit increase in reporting one ADL versus 
none, a 0.08 unit increase in reporting two ADLs rather than none and a 0.12 unit increase in 
reporting three or more ADLs rather than no ADLs.  Finally, among this set of predictors, group 
membership was helpful in distinguishing among the groups defined by total number of ADLs; 
this is a significant relationship that was not found when using a dichotomous comparison at 
baseline.  Respondents in the decreasing use group were more likely than individuals in the no to 
low use group to report having one ADL or two ADLs rather than no ADLs; there was no 
significant difference between reporting three or more ADLs for individuals in the decreasing 
use group compared to the no to low use group.   
 
117 
 
Table 19  Parameter Estimates for Physical Functioning (ADL) Regression Model (N=3,470) 
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4.4.2 Mental Health 
In order to assess the relationship between patterns of concurrent use and mental health status 
group membership was regressed on depression status; the covariates of gender, race, and age 
were also included in the model.  Goodness-of-fit statistics suggested an adequate model fit with 
both the Persons (p=.578) and Deviance (p=.1214) being non significant.  Model fitting 
information also indicated the existence of a relationship between the independent variables and 
depression status, χ2 = 49.26, p<.001.  Likelihood ratio test were significant indicating a 
relationship between group membership and depression status (See Table 20).  Finally, ratio tests 
confirmed statistically significant relationship between depression status and gender, race and 
age. 
 
 
Table 20  Likelihood Ratio Tests for Mental Health Regression Model 
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Table 21 shows the parameter estimates for the mental health regression model.  There 
was a significant inverse relationship between gender and depression status with females being 
more likely to have a diagnosis of depression than males.  The odds of being clinically depressed 
decreased by 0.64 for men compared to women.  There was also a significant relationship 
between race and depression status with African Americans having a higher rates of depression 
compared to Whites.  The odds of having a depression diagnosis rather than no depression 
diagnosis were 23% less for Whites versus African Americans.  Age is positively associated with 
depression status; older individuals have higher rates of depression than their younger 
counterparts. Considering patterns of concurrent use, a significant relationship between 
depression status and membership in the increasing use and the decreasing use trajectories was 
found; no other contrasts for group membership were significant.  The odds of being depressed 
rather than not depressed increased by a factor of 1.35 for individuals in the decreasing use 
group rather than those in the no to low use trajectory.  On the other hand, when compared to 
individuals in the no to low use group, being a member of the increasing use trajectory is 
associated with lower levels of depression; the odds of being depressed decrease by 0.64 for 
members of the increasing use group.  Given that rates of depression were comparable for non-
concurrent users and concurrent users, the results indicate that, as with physical functioning, it is 
the pattern of concurrent use that explains the relationship between concomitant use and 
depression status. 
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Table 21  Parameter Estimates for Mental Health Regression Model (N=3,470) 
 
 
 
4.4.3 Medication Use and Alcohol Consumption 
Follow-up analyses using multinomial logistic regression models were run to assess the 
relationship between medication and alcohol use and physical as well as mental health status in 
wave 6 of the study.  Alcohol use (number of drinks a week), total number of medications, the 
total number of alcohol-interactive and the interaction effect of alcohol with the medication 
variables was regressed on self-reported health status, total number of IADLs, and total number 
of ADLs; the covariates of gender, race, and age were also included in the model.  In the self-
reported health model, good health was used as the reference category in the analysis and in the 
physical functioning models reporting no IADLs or ADLs served as the reference point for the 
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models.  In the fourth model run alcohol use (number of drinks a week), total number of 
medications, the total number of alcohol-interactive, and the interaction of alcohol use with the 
medication variables was regressed on depression status. Sociodemographic characteristics were 
also included as covariates in the model and lack of a depression diagnosis was used as the 
reference category for this analyses. 
Men, African Americans, and older adults were significantly more likely to report poor 
health than good health.  Women, African Americans, and older individuals were more 
significantly more likely to report difficulties with IADLs and ADLs than men, Whites, and 
younger individuals.  Medication use was significantly related to self-reported health status.  
Individuals taking more medications were less likely to report excellent or very good health and 
significantly more likely to report poor or fair health rather than good health.  Additionally, 
medication use was significantly related to total number of ADLs and IADLs. There was a 
positive correlation between number of medications and difficulties with ADLs and IADLs; 
individuals with more ADLs and IADLs were more likely to be taking one or more medications 
rather than none.  Alcohol use was significantly related to self-reported health status yet there 
was no significant relationship between alcohol use and total number of ADLs or IADLs.  A 1 
unit increase in weekly alcohol consumption increased the odds of reporting very good rather 
than good health by 1.3%.  Conversely, a 1 unit increase in alcohol consumption decreased the 
odds of reporting poor rather than good health by 23.5%.  The interaction effect of alcohol and 
medications was not significantly related to self-reported health status or physical functioning 
models. 
Multinomial logistic regression models were also run to examine the effect of alcohol and 
medications use on depression status.  Females and older individuals were more likely to report 
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depression when compared to men and younger respondents.  Medication use was significantly 
related to depression status.  A one unit increase in the total number of medications being used 
increased the chance of being depressed rather than not depressed by 11.9%.  Alcohol use was 
not significantly related to depression status nor was the interaction between weekly alcohol use 
and total number of medications. 
4.4.4  The Relationship between Baseline Health Status and Overall Health in Wave 6 
Four additional logistic regression models were run to investigate the extent to which 
participants physical and mental health status at baseline helped explain reported health status at 
Wave 6.  In each of the models, health status (self-reported health status, number of IADLs and 
ADLs and depression status) at baseline and group membership (belonging to either the low to 
no use, decreasing use, increasing use, or high use cohort) were included as independent 
variables.  The dependent variables from Wave 6 serving as proxies for physical health status 
included self-reported physical health status (1=Excellent, 2=Very Good, 3=Good, 
4=Fair,5=Poor), total number of IADLs (0=none,1= one to three, 2= four to six) and total 
number of ADLs (0= none, 1=one to two, 2= three to six).  The demographic covariates of 
gender (0=Female, 1=Male), race (0=African American, 1=White) and age (continuous) were 
included in all four of the logistic regression models.  Since no a priori hypotheses had been 
made to determine the order of entry of the predictor variables, a direct method was used for 
these multiple linear regression analyses. 
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4.4.4.1  Physical Health Status 
In the first model, logistic regression was employed to help determine the influence of group 
membership and self-reported health status at baseline on reported health status in the final wave 
of the study.  Together group membership, health status at baseline, gender, race and age explain 
27.5% of the variance in self-reported health status in Wave 6 (F (5, 3453)= 262.98, p=.000).  
Regression coefficients are presented in Table 22.  The strongest predictor was self-reported 
health status at baseline (β=.43).  The independent variable of group membership also predicted 
health status (β=.26).  The covariates of race and age significantly predicted self-reported health 
status; gender was not a statistically significant.  African Americans and older respondents were 
more likely to report lower levels of self-reported health than Whites and younger study 
participants. 
 
 
Table 22  Regression Coefficients for Self-Reported Physical Health Regression Model (N=3,470) 
 
 Unstandardized 
Coefficients 
Standardized 
Coefficients 
  
 B SE Β t Significance 
Constant  1.09 .206   5.28  .000** 
Group Membership  .026 .010  .036  2.44 .015* 
Health Status (Wave 1)  .431 .013  .502 34.16  .000** 
Gender -.040 .026 -.022 -1.54      .124 
Race -.160 .036 -.064 -4.39  .000** 
Age .010 .003  .057  3.94  .000** 
  *Statistically Significant at p<.05 
**Statistically Significant at p<.001 
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4.4.4.2 Physical Functioning 
Two logistic regression models were run to determine the impact of physical functioning at 
baseline and cohort membership on reported functional status in Wave 6.  Group membership 
was not a significant predictor of number of reported difficulties with IADLs or ADLs in Wave 
6.  The covariates of gender, race and age significantly predicted physical functioning in both 
models.  The greatest predictor of total number of IADLs in the final wave of the study was total 
number of IADLs at baseline (β=.47). Number of IADLs at baseline, gender, race and age 
explain 19.9% of the variance in rates of IADLs in Wave 6 (F (5, 3434)= 172.07, p=.000).  
Approximately 12% of the variance in the number of ADLs in the final wave of the study was 
explained by the independent variable of ADLs at Wave 1 and the covariates of gender, race and 
age (F (5, 3406)= 92.48,  p=.000).  The predictor of total number of reported ADLs (β=.51) in 
the final wave of the study. Regression coefficients for both models are presented in Table 23.     
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Table 23  Regression Coefficients for Physical Functioning Regression Models (N=3,470) 
 
 Unstandardized 
Coefficients 
Standardized 
Coefficients 
  
 B SE Β t Significance 
IADLs      
  Constant -1.37 .134  -10.27 .000** 
  Group Membership  .005 .007  .012 .777      .437 
  Total IADLs (Wave 1)  .468 .020  .367 23.55 .000** 
  Gender -.068 .017 -.063 -4.02 .000** 
  Race -.047 .024 -.030 -1.97      .050* 
  Age  .022 .002  .198 12.88 .000** 
     
ADLs      
  Constant -.761 .129  -5.90 .000** 
  Group Membership  .009 .007  .023 1.43      .152 
  Total ADLs (Wave 1)  .514 .029  .284 17.52 .000** 
  Gender -.080 .016 -0.81 -4.96 .000** 
  Race -.077 .023 -.055 -3.38 .001** 
  Age  .013 .002  .132 8.20 .000** 
  *Statistically Significant at p<.05 
**Statistically Significant at p<.001 
  
 
4.4.4.3  Mental Health 
Multiple regression analyses was used to investigate the extent to which participants depression 
status at baseline and group membership explained reported depression status in the final wave 
of the study.  As was the case in the physical health models, the strongest predictor of depression 
status in Wave 6 was baseline depressive diagnosis (β=.26).  Depression status at baseline, 
gender and age explain 7.7% of the variance in mental health status in Wave 6 (F (5, 2596)= 
44.39, p=.000).  Regression coefficients are presented in Table 24.  Group membership and race 
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did not predict depression status. The covariates of gender and age significantly predicted mental 
health status; women and older individuals were more likely to report depression.   
 
 
Table 24  Regression Coefficients for Mental Health Regression Model (N=3,470) 
 
 Unstandardized 
Coefficients 
Standardized 
Coefficients 
  
 B SE Β t Significance 
Constant  1.09 .206   5.28   .000** 
Group Membership  .026 .010  .036  2.44 .015* 
Health Status (Wave 1)  .431 .013  .502 34.16   .000** 
Gender -.040 .026 -.022 -1.54       .124 
Race -.160 .036 -.064 -4.39   .000** 
Age .010 .003  .057   3.94   .000** 
  *Statistically Significant at p<.05 
**Statistically Significant at p<.001 
 
 
4.4.5 Concurrent Use and Mortality  
Cox regression analysis was employed to examine the relationship between concurrent use and 
mortality status; the entire sample was included in this regression analyses (N=5,888).  The time, 
variable in this model was study wave and the binary variable of mortality was used as the status 
or outcome variable.  Two measures of concurrent use were used to predict the event (time until 
death): having ever concurrently used (0=No and 1=Yes) and the interaction of weekly alcohol 
consumption and total number of alcohol-interactive medications (concurrent use) at baseline.  
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The additional covariates of gender (0=Female, 1=Male), race (0=African American, 1= White) 
and age (continuous) were included in the model.   
The likelihood ratio test for the model was significant indicating that one or more of the 
covariates contributes significantly to the explanation of duration to death.  The null model had a 
-2 Log Likelihood of 16,667.58 and the full model had a -2 Log Likelihood of 16188.07.  The 
model chi-square difference was 540.32 (p<.001).  The two measures of concurrent use and the 
covariates of gender, race and age were all significantly related to time until death (see Table 
25.) 
 
 
Table 25  Test Statistics for Cox Regression:  Concurrent Use and Mortality 
 
 B SE Wald df p β 
Ever Concurrent Use 
 
-.338 .069 23.98 1 .000** .713 
Concurrent Use (Wave 1) 
 
.007 .003 5.36 1 .021* 1.01 
Gender 
 
.699 .067 112.85 1 .000** 2.01 
Race 
 
-.187 .081 5.15 1 .023* .830 
Age 
 
.090 .005 347.22 1 .000** 1.09 
  *Significant at p<.05 
**Significant at p<.001 
 
 
For every one unit increase in concurrent use (the interaction of weekly alcohol use and total 
number of alcohol-interactive medications) the hazard ratio for mortality increased by a factor of 
128 
 
1.01.  The binary variable of having ever concurrently used over the course of the study was 
inversely related to mortality (β=.71).  Gender and age were both positively correlated with 
mortality with men and older individuals being more likely to experience an event than women 
and younger individuals.  Finally, being White was significantly associated with a lower risk of 
mortality. 
4.4.6 Summary of Results 
Concurrent use is fairly common among community-dwelling older adults; the majority of study 
participants (55.4%) concurrently used alcohol with alcohol-interactive medications during at 
least one of the six waves of the study; one-third of concurrent users reported concomitant 
alcohol-medication use in 3 or more waves of the study.  The majority of individuals who 
reported alcohol consumption also reported concurrent use; over the course of the study rates 
ranged between 57% to 64%.  The most common form of concurrent use was drinking below or 
within recommended guidelines and taking one alcohol-interactive medication.  Concomitant 
alcohol and medication use vary between the subgroups: men, Whites and problem drinkers were 
significantly more likely to concurrently use than women, African Americans and low to 
moderate alcohol users; there were no significant differences by age.   
Group-based logit analysis revealed four distinct patterns of concurrent use. Concurrent 
use among the first group of individuals increased over the course of the study. The second 
trajectory is fairly flat and is comprised of individuals who maintain a stable pattern of no to low 
use over the course of the study.  The third group, the decreasing use group, is characterized by 
moderately high levels of use in the initial waves of the study however there is a gradual steady 
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decrease in concurrent use over time.  The final group is indicative of high-stable rates of 
concurrent use over time.  Using the no to low use group as the comparison group, gender was a 
significant predictor of group membership.  Males had a higher probability of group membership 
in the increasing use and high use groups.  Race did not significantly predict membership in the 
increasing use group however the relationship was positive indicating a greater number of 
Whites in this cohort.  Yet, being White significantly increased the probability of group 
membership in the high use group.   
Regression analysis revealed that specific patterns of concurrent use are significantly 
related to both physical and mental health status among community-dwelling older adults. Using 
good health as the reference category, being male increased the odds of reporting excellent to 
very good health rather than good health.  There were no significant differences between Whites 
and African Americans in reporting excellent rather than good health.  However, Whites were 
significantly more likely than African Americans to report very good health; African Americans 
had significantly higher rates of self-reported fair or poor.  Additionally, compared to younger 
individuals, older respondents were significantly more likely to report fair or poor health than 
good health.  Looking at trajectories of concurrent use, members of the high use trajectory were 
significantly less likely than those in the no to low use group members to report excellent health 
rather than good health; no other group membership contrasts were significant.  Regression 
analysis also revealed a significant relationship between medication use and self-reported health 
status.  Individuals taking more medications were less likely to report excellent or very good 
health and significantly more likely to report poor or fair health rather than good health.  Alcohol 
use was significantly related to self-reported health status yet the interaction effect of alcohol use 
and medications was not significant. 
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In addition to assessing the relationship between self-reported health status and concurrent 
use, models were run to examine the relationship between concomitant use and physical 
functioning.  Women were significantly more likely than men to report having any IADLs or 
ADLs rather than no IADLs or ADLs.  Age was positively correlated with total number of 
IADLs and ADLs with older individuals reporting higher rates of IADLs and ADLs compared to 
no IADLs or ADLs.  Group membership was not found to be significantly related to total 
number of IADLs however, it was related to total number of ADLs.  Respondents in the 
decreasing use group were more likely than individuals in the no to low use group to report 
having one ADL or two ADLs rather than no ADLs; there was no significant difference between 
reporting three or more ADLs for individuals in the decreasing use group compared to the no to 
low use group.   A positive correlation between number of medications and difficulties with 
ADLs and IADLs was found; individuals with more ADLs and IADLs were more likely to be 
taking one or more medications rather than none.   
Depression status was found to be related to sociodemographic characteristics as well as 
group membership.  There was a significant inverse relationship between gender and depression 
status with females being more likely to have a diagnosis of depression than males.  The odds of 
being clinically depressed decreased for men compared to women.  There was also a significant 
relationship between race and depression status with African Americans having a higher rates of 
depression compared to Whites.  Age was found to be positively associated with depression 
status; older individuals have higher rates of depression than their younger. Significant 
relationships were also found between depression status and membership in the increasing use 
and the decreasing use trajectories.  The odds of being depressed rather than not depressed 
increased for individuals in the decreasing use group rather than those in the no to low use 
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trajectory.  Conversely being a member of the increasing use trajectory was found to be 
associated with lower levels of depression.  Multinomial logistic regression models were also run 
to examine the effect of alcohol and medications use on depression status.  Medication use was 
significantly related to depression status.  A one unit increase in the total number of medications 
being used increased the chance of being depressed rather than not depressed by 11.9%.  Alcohol 
use was not significantly related to depression status nor was the interaction between weekly 
alcohol use and total number of medications. 
Multiple logistic regression models were run to investigate the extent to which 
participants physical and mental health status at baseline helped explain reported health status at 
Wave 6. Logistic regression revealed that physical and mental health statuses at baseline were 
the best predictors of health status in the final wave of the study.  Group membership was a 
significant predictor of self-reported health status but it did not predict physical functioning or 
depression at Wave 6. 
A significant relationship was found between concurrent use and duration to death. For 
every one unit increase in concurrent use (the interaction of weekly alcohol use and total number 
of alcohol-interactive medications) the hazard ratio for mortality increased by a factor of 1.01.    
Gender and age were both positively correlated with mortality with men and older individuals 
being more likely to experience an event than women and younger individuals.  Finally, being 
White was significantly associated with a lower risk of mortality. 
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5.0  DISCUSSION AND IMPLICATION 
5.1 OVERVIEW 
The interaction of alcohol and prescription drugs is an important health concern for individuals 
of all ages, it is a particularly salient issue for older adults, who take more medication than any 
other age cohort and are more susceptible to the effects of alcohol and/or medications due to 
physiological changes associated with aging (Moore et al., 2007; Swift et al., 2007; Pringle et al., 
2005; SAMHSA, 2004).  Despite older adults’ increased risk of alcohol-medication interaction 
there has been limited research focused on the prevalence, patterns and correlates of 
simultaneous alcohol and medication use in community-dwelling older adults.  To date, the 
majority of research regarding concurrent alcohol and medication use has been conducted with 
young or middle-aged populations and has focused primarily on chronic heavy drinkers; few 
studies have examined the alcohol-medication interactions among low to moderate users in the 
general population of older adults (Onder, et al., 2002).  Additionally, the body of literature that 
has examined concurrent use among community-dwelling older adults has largely been 
conducted in primary and acute care settings and has focused on adverse drug reactions.   
The current study presents data on the prevalence, usage patterns and health outcomes 
associated with concurrent among community-dwelling older adults.  Many of the hypotheses 
examined in this investigation were at least partially substantiated by the results; however other 
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hypotheses were not supported by the data.  The following chapter discusses the results of this 
study and offers possible justifications for the study’s findings.  In addition, implications for 
social work practice and policy are presented.  Suggestions regarding future research are offered 
followed by a discussion of the study's strengths and limitations. 
5.1.1 The Prevalence of Concurrent Use among Older Adults 
Alcohol Consumption 
The first aim of this investigation was to examine rates and correlates of concurrent use among 
community-dwelling older adults.  In order to assess concurrent use it was first necessary to look 
at baseline rates of alcohol consumption and medication use in this sample.  Analysis revealed 
that half of the respondents reported weekly alcohol consumption; the majority of older adults 
who reported weekly alcohol usage drank below or within NIAAA recommended guidelines 
(39.8%).  However, 6.7% of respondents reported drinking above the recommended guidelines 
(8 – 19 drinks a week) and 3.3% consumed 20 or more drinks a week, nearly three times the 
recommended guidelines for weekly alcohol consumption for older adults.  These statistics are 
consistent with past research on alcohol consumption among older adults; research indicates that 
between 40% and 50% of seniors consume alcohol and 10% drank above recommended 
guidelines (Breslow, Faden & Smothers, 2003; Blow & Barry, 2002).  Therefore, rates of alcohol 
use in the study sample are comparable to past knowledge regarding drinking behavior among 
older adults.   
Reduced alcohol consumption in late life is associated with a number of factors including 
the onset of chronic condition, increased medication use, age, and gender.  However, recent 
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studies indicate that gender, not cohort effects, may be a better predictor of both rates and level 
of alcohol consumption.  Studies indicate that the rates of alcohol consumption among the newer 
cohort of aging baby bombers are decreasing slower than previous cohorts indicating that the 
“age effect” is not the only factor influencing level of alcohol consumption among older adults    
(Karlamangla et al., 2005; Moore et al., 2005) .  In addition, research indicates prevalence rates 
and the likelihood of heavy drinking declined more slowly with increasing age in men versus 
women (Karlamangla et al., 2005).  Given that women are more likely to abstain from alcohol 
use, have lower levels of consumption and tend to live longer than their male counterparts, it is 
likely that gender plays a large role in impacting the prevalence of alcohol use among older 
adults. 
Men were significantly more likely than women to report weekly alcohol consumption.  
Men also reported higher rates of alcohol consumption; the mean number of drinks per week for 
men was twice that for females.  In addition, males were more likely to be classified as 
hazardous alcohol users, consuming 14 or more drinks a week, twice the NIAAA recommended 
guidelines.  Whites reported higher rates of alcohol consumption than African Americans and 
were more likely than African Americans to report drinking above NIAAA guidelines.  
Furthermore, rates of alcohol use differed by age, with older individuals having higher rates of 
abstinence and lower rates of alcohol consumption.  Individuals over the age of 75 were less 
likely than their younger counterparts to report hazardous use.  The current study supports past 
findings regarding drinking behavior among older adults.  Although rates and levels of alcohol 
consumption decrease with age, nearly half of all older adults continue to drink alcoholic 
beverages; consumption of alcohol among older adults is most prevalent among men, Whites, 
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and younger individuals (Merrick et al., 2008; SAMHSA, 2005; Breslow et al., 2004; 
Schoenborn & Adams, 2002). 
By 2040 more than 20% of the US population will be over the age of 65, while alcohol 
use generally declines with age the results of this study indicate that at least half of seniors report 
weekly alcohol use (Kensella & He, 2009).  Moreover, this study further corroborates research 
findings that approximately 10% of people over 65 consume alcohol in excess of the NIAAA 
guideline for seniors of drinking no more than seven alcoholic beverages in a week (Kirchner et 
al., 2007; Blow & Barry, 2002).  Research has shown that birth cohorts that experience high rates 
of alcohol use in youth or young adulthood have subsequently shown higher rates of use as they 
age, relative to other cohorts (SAMHSA, 2000).  Significantly higher rates of alcohol and illicit 
drug use have been found in the birth cohorts of the “baby boom” generation (SAMHSA, 2001).  
The higher prevalence of alcohol and drug use among this generation coupled with the overall 
large population size of this cohort, suggests that the number of alcohol and illicit drug users 
among older adults will increase in the coming years as this group enters older adulthood. 
(SAMHSA, 2001).  Therefore, it is expected that the increasing number of aging baby boomers 
will probably have an enormous impact on the need and demand for health care among older 
adults (Blow, et al., 2002).  Of particular concern is the increasing rate of concurrent alcohol and 
medication use among older adults. 
Medication Use 
The hypothesis that concomitant use was fairly common among older adults was supported in the 
current study.  Seventy-seven percent of participants reported took at least one medication in the 
past 14 days; on average participants were taking 2.34 (SD=2.2) medications a day.  The rate of 
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medication use among the study sample was somewhat lower than national averages found in the 
past.  For example, in 2006 more than 93% of adults ages 65 and older reported taking at least 
one medication in the last week, over half (58%) reported taking five or more medications, and 
18% reported taking ten or more (Slone Epidemiology Center, 2006).  The lower percentage of 
medication use in the study sample is most likely due to the fact that a number of individuals 
such as those in institutional settings were excluded from participating in the study.   
Sixty-two percent of respondents were taking an alcohol-interactive medication at 
baseline; the mean number of alcohol-interactive medications used by respondents was 1.25 
(SD=1.35).  The majority of participants reported taking alcohol-interactive medications that had 
a low to moderate interaction with alcohol. Women were significantly more likely than men to 
be using one or more medications and were also significantly more likely to be taking more 
alcohol-interactive medications than their male counterparts.  As one might expect, age was 
found to be a significant predictor of medication use; older individuals were more likely to be 
taking multiple medications and had higher usage rates of alcohol-interactive medication than 
study participants younger study participants.  
The percentage of participants using medications differed by race as well.  African 
Americans were less likely than Whites to be taking no medications, 18.5% versus 24.0%.  
Interestingly African Americans had significantly higher rates of overall medication use and 
reported greater use of alcohol-interactive medications than Whites.  There are a number of 
possible explanations for this finding.  Racial and ethnic disparities in health care have been 
described across a wide spectrum of health services, research indicates that being a member of  
ethnic or racial minority group appears to be a risk factor for receiving less comprehensive care.  
There are three factors that most likely are responsible for racial differences in the rate of use of 
137 
 
alcohol-interactive medications.  First, older African Americans exhibit higher rates of many 
common chronic conditions, such as hypertension, diabetes, stroke, circulatory disease, arthritis 
and other musculoskeletal impairments, as well as mental health and nervous disorders 
(Fillenbaum et al., 2000; Martin & Soldo, 1997). Many of these chronic conditions are 
traditionally treated with medications that are alcohol-interactive such as antidiabetic agents, 
antihypertention drugs, and NSAIDs which contributes to differences in rates of use of alcohol-
interactive drug use between Whites and African Americans.  
In addition to differences in health conditions, recent research indicates disparities in 
prescribing practices (specifically regarding medication class) between Whites and African 
Americans (Hanlon et al., 2009; Blazer, et al., 2000).  Using the example of antidepressants, 
several recent studies have found that when African Americans are prescribed antidepressants 
they are more likely to receive tricyclic antidepressants than SSRIs despite the fact that there is a 
significant reduction in side effects with SSRIs than with tricyclic antidepressants (Blazer, et al., 
2000).  This is just one example of a difference in prescribing practices that is partially 
determined by the race of the patient that may partially explain differences in the use of alcohol-
interactive medications between Whites and African Americans.   
Finally, as stated earlier, there are differences in the quality of care received by African 
Americans.  White older adults are more likely than African Americans to receive regular 
ambulatory care from private physicians, whereas African Americans tend to use community 
health centers, hospital outpatient departments, or emergency rooms (Martin & Soldo, 1997). 
These practice settings are characterized by less satisfactory patient-physician relationships and 
less continuity of care than private physicians' offices (Martin & Soldo, 1997).  Whites may be 
less likely to be prescribed alcohol-interactive medications because of the higher quality of care 
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they receive; there physicians may be more likely to screen for and / or know about their alcohol 
consumption and write prescriptions accordingly. 
Concurrent Use 
At baseline, just over a quarter of study participants (28%) reported concurrently using alcohol 
with one or more alcohol-interactive medications.  Although national estimates of the combined 
prevalence of alcohol and medication use among individuals aged 65 and older are still 
unknown, the rates of concomitant use found in the current study are fairly consistent with the 
limited literature that does exist on concurrent use among older adults in the United States 
(Moore et al., 2007).  One investigation of 667 community-dwelling older adults in northeast 
New York estimated that 25% of study participants drank alcohol with alcohol-interactive 
medications (Foster et al., 1993).  In a more recent study using data from the Pennsylvania 
PACE program (a state-funded program providing prescription benefits to older person with low 
to moderate incomes), Pringle and colleagues (2005) found that 19% of those individuals who 
reported consuming alcohol (20.3% of the sample) took medications that could have negative 
interactions with alcohol.  The increased service needs of aging alcohol users will most likely 
place a financial strain on existing resources, particularly given the high rates of medication use 
among this group. Older adults are the heaviest users of prescription medicines and over-the-
counter drugs of all population sectors, and mixing these substances with alcohol can cause 
harmful interactions as well as exaggerate or reduce the effects of many medications. In addition, 
concomitant use increases the risks for falls and accidents, which can be very serious for people 
in this age group.  Finally, concurrent use can exacerbate many medical conditions common in 
older people, such as high blood pressure and ulcers.  
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Although medications are central to managing the health of older patients, medication 
nonadherence such as concurrent use can lead to a number of adverse outcomes. As the U.S. 
population ages, new drugs are developed, and new therapeutic and preventive uses for 
medications are discovered, medication use by older adults will most likely continue to grow 
(Budnitz & Layde, 2007).  Older patients, especially those who are chronically frail or acutely 
ill, may require special consideration when making prescribing decisions because of age-related 
changes in the metabolism and clearance of medications and enhanced pharmacodynamic 
sensitivities (Spinewine et al., 2007).  The growing population of older adults has made primary 
disease prevention and efforts to promote healthy lifestyles a top priority of those providing 
services to older adults.  Finding ways to prevent and reduce rates of concurrent use can play a 
key role in reducing the health care burden associated with alcohol use among older adults.   This 
study confirms previous findings that approximately one-quarter of community-dwelling older 
adults concurrently use alcohol and medications.  Given this statistic it is clear that concurrent 
use is a common public health issue among older adults that can lead to significant economic and 
social costs as the number of older adult’s increases in this country.   
5.1.1.1 Correlates of Concurrent Use among Older Adults 
Analyses at baseline reveled concurrent users had higher rates of overall medication use and 
were taking more alcohol-interactive medications than individuals who reported no concurrent 
use.  Study participants who reported concomitant use also were more likely than non-concurrent 
users to take multiple alcohol-interactive medications; 22.1% versus 14.1% respectively.  These 
findings are to be expected, one would hypothesize that individuals who consume more 
medications would have a higher likelihood of being prescribed an alcohol-interactive 
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medication placing them at an increased risk for concurrent use.  Thus, prevention efforts and 
education campaigns should target individuals who report taking multiple medications.  Men had 
greater rates and reported more hazardous levels of concurrent use than women.  At baseline, 
men had higher rates of concurrent use than women despite the fact the women were more likely 
than men to be taking one or more alcohol interactive medications.  Rates of concurrent use for 
women and men were 26% and 32% respectively. Men (8.4%) were twice as likely as women 
(4.8%) to have moderate to high levels of concurrent use at baseline.  Additionally, Whites 
reported higher levels of concurrent use than their African American counterparts.  Nearly 7% of 
Whites reported moderate to high levels of concurrent use compared to only 3.8% of African 
Americans.  Given that men and Whites have a higher frequency of alcohol use and consume 
greater quantities of alcohol when compared to women or African Americans it is not surprising 
that analysis revealed they were the group with the highest rates and levels of concurrent use.  
This finding points to the need for increased monitoring of alcohol consumption and medication 
adherence among White males.  Interestingly, there were no significant difference in rates of 
concurrent use found for age; concurrent usage rates remained fairly stable regardless of age 
category.  This pattern may be indicative of the fact that alcohol consumption is a behavior that 
is carried on throughout the course of life and although rates of consumption may decrease with 
age, individuals who have a history of alcohol use continue to drink regardless of the 
introduction of medications that can potentially interact with alcohol. 
Although many of the interactions between alcohol and medications occur primarily 
among individuals who drink heavily (> 3 drinks/occasion), interactions may also occur in 
individuals who consume light to moderate amounts of alcohol (1 – 2 drinks/occasion) (Moore et 
al., 2007).  Older adults are at increased risk for a variety of adverse consequences depending on 
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the amount of alcohol and the type of medications consumed.  In this investigation it was found 
that of those individuals who reported weekly alcohol use at baseline, 56.7% were concurrently 
using alcohol with alcohol-interactive medications.  Most participants were taking one alcohol-
interactive medication (48%) however; 22.1% of respondents who reported concurrent use were 
taking three or more alcohol-interactive medications.  Individuals who were classified as 
problem users, drinking nearly three times the weekly recommended guidelines for older adults 
(>20 drinks a week), were statistically more likely to concurrent use than non-problem users.  It 
is likely that these individuals have a history of misuse or abuse of alcohol that has continued on 
into late life. Therefore, they continue to consume alcohol irrespective of the fact that they are 
also using one or more alcohol-interactive medications.  
5.1.1.2 Prevalence and Correlates of Concurrent use among Older Adults:  Implications for 
Practice 
Social workers and geriatric social workers in particular, try to improve the quality of life for 
older adults by alleviating some of the negative aspects of aging.  As such, social workers play 
an integral role in improving the quality of life of older adults and their caregivers. Geriatric 
social workers are employed in a variety of settings and have a range of duties, making them 
uniquely situated to deal with issues associated with concurrent alcohol and medication use 
among older adults.  The results of this study offer data on the prevalence rates and correlates of 
concurrent use among community-dwelling older adults and can be used to inform both practice 
and policy. 
The two most important aspects of promoting medication adherence and preventing 
hazardous behavior such as concurrent alcohol and medication use are identifying problem 
142 
 
behaviors (screening and diagnosis) and providing a system of coordinated care.  Although the 
current investigation found that a quarter of seniors concomitantly use alcohol and medication 
rates more seniors could be at risk due to the increased number of older adults and higher rates of 
medication use.  Therefore, medication and alcohol use need to be part of the regular screenings 
received by older adults in both medical and Aging care network settings.  Because social 
workers frequently have contact with older adults and they are familiar with the types of 
information collected by various agencies in the Aging care network, social work professionals 
are in the position to assist in creating brief screening tools to assess medication adherence.  In 
addition, they can help in implementing screening tools for concurrent use among older adults.  
Social workers can also play a key role in creating linkages between primary care, other health 
care professionals and agencies in the Aging care network allowing for a continuum of care; 
linking these various providers can make it easier to ensure medication adherence.  If an 
individual not only concurrently uses alcohol and medications but also presents with an alcohol 
problem, social workers can assist in helping these individuals get the substance abuse treatment 
they need and in some cases actually provide the treatment itself.   
Educating older adults, their families, and caregivers about the dangers of concurrent use 
is a critical element in reducing concomitant use and improving the overall quality of life and 
health outcomes of older adults.  Social workers who have a rapport with clients and frequently 
meet with seniors, their families, and caregivers can make sure that these individuals are aware 
of the problems associated with concurrent use.  The findings from this study indicate a 
significant need for social work and health care professionals to educate older adults about the 
dangers of concurrent alcohol-medication use.  Additionally, it appears that there is a need for 
health campaigns that focus on the promotion of safer use of alcohol and medications and 
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increase public awareness about concurrent use among older adults.  Education initiatives should 
be senior-specific rather than targeting the larger adult population.  Because of their frequent and 
ongoing contacts with older adults, social workers are ideal candidates for designing and 
implementing educational initiatives aimed at educating the public about concurrent alcohol and 
medication use.  Social work professionals also have the skills necessary to assist in creating 
educational curriculums designed to prevent alcohol and medications by older adults as well as 
educational modules aimed at reducing or eliminating harmful medication practices such as 
concurrent use.  In addition to social workers, health care professionals and pharmacists can 
assist in identifying individuals at risk for concurrent use. 
The results of this study indicate that the use of medication in concert with alcohol is 
fairly common among Americans ages 65 and older it is imperative that health care professionals 
regularly ask seniors about their consumption of alcohol even if it is something as simple as 
asking “Do you drink any alcohol?” or “How do you use alcohol”.  Because even low to 
moderate alcohol consumption can lead to harmful adverse drug reaction, simply knowing that 
an older adult uses alcohol is useful in determining if they are at risk for or are currently 
concomitantly using alcohol and medications.  Health care professionals or caretakers who are 
with individuals in their homes and therefore are able to observe behaviors regarding alcohol and 
medication use are in a unique position to assess harmful behavior.  For example, home health 
care workers are ideally situated to engage in ongoing monitoring of medication adherence and 
to assess whether or not a particular client is at risk for or are engaging in concurrent alcohol and 
medication use. 
In addition, encouraging medication adherence and appropriate prescribing practices are 
critical components necessary to reduce concomitant use among older adults.  Health care 
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professionals can play a key role in reducing concurrent use by making certain older adults 
understand the medications they are taking and the possible side effects.  Health care 
professionals need to encourage older adults to keep an up to date list of all the medications they 
are taking and the dosing to provide at medical appointments; if an individual is seeing multiple 
doctors such a list will ensure safe prescribing practices.  The use of more than one pharmacy is 
a leading cause of adverse drug reactions because there is no running record of all the 
prescriptions an individual may be taking which makes it difficult for a pharmacist to assess any 
potential interactions.  Therefore, nurses and doctors should encourage patients to use only one 
pharmacy to fill prescriptions.   
Finally, nurses and doctors should encourage older adults to communicate with their 
pharmacist about any medications they are taking so that they understand any possible side 
effects or interactions.  Providers of services to seniors need to make sure that instructions for 
taking medications are explicit and understood.  Potential declines in hearing and vision may 
make it hard for seniors to understand how to properly use their medications; small fonts on 
labels and scientific terminology can often lead to the misuse of medications among older adults. 
Pharmacists are in a powerful position to assist in preventing concurrent use and can also 
aid in identifying problems with medication and alcohol interactions, misuse, or abuse (Sullivan 
et al., 2007).  Since they are uniquely situated to recognize and prevent concurrent use, 
pharmacists need to be aware of the various factors that place older adults at an increased risk for 
concurrent use. 
Communicating with older adults about their medication use is key; patience and 
persistence are crucial factors to effective communication with seniors.  Perceptions about 
medications used are a significant indicator of how well older adults will adhere to regimes; 
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older adults who see medications as necessary, useful, and less harmful are more likely to take as 
prescribed (Sullivan et al., 2007; Horne & Weinman, 1999).  Pharmacists can assist in 
medication adherence and reduce rates of concurrent use by properly explaining the reason for 
and the effects of any medications prescribed and dispersed; the dangers associated with 
concurrent use should also be reviewed with the patient and / or caregiver.  Pharmacists should 
get in the habit of asking older adults if they drink when they are filling a prescription for a 
medication that is considered alcohol-interactive.  Pharmacists should recommend than an 
individual not drink when they have been prescribed certain types of drugs such as 
benzodiazepines, sedatives and narcotic analgesics; medications commonly used by older adults.  
Lastly, when prescriptions for alcohol-interactive medications are refilled, pharmacists should 
remind the individual or the caretaker that alcohol should not be consumed when taking that 
medication. 
5.1.2 Patterns of Concurrent Use among Older Adults 
Preliminary explorations of the data revealed that nearly half of all study participants (46%) 
concurrently used alcohol with alcohol-interactive medications during at least one of the six 
waves of the study; one-third of concurrent users reported concomitant alcohol-medication use in 
4 or more waves of the study.  Based on these preliminary findings, it was hypothesized that 
there would be a minimum of two unique longitudinal trajectories of concurrent use.   Group-
based trajectory modeling was used to test the hypothesis that various trajectories of concurrent 
use exist among community-dwelling older adults.  Group-based modeling was particularly 
useful in helping to identify multiple trajectories of concurrent use among community-dwelling 
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older adults; often overall percentages obscure important trends and fail to take into account 
unique patterns of behavior.  The hypothesis regarding multiple patterns of concomitant use was 
substantiated by the data; four distinct trajectories of concurrent use were identified. 
Each of the four cohorts identified by the best fitting model were characterized by their 
own distinct patterns of concurrent use.  The majority of respondents were grouped into the no to 
low use trajectory which is comprised of individuals who did not concurrently use alcohol and 
medications or those respondents who had low levels of concomitant use.  The trajectory for the 
no to low use group is fairly flat and essentially these individuals maintained a stable pattern of 
no or low levels of use over the course of the study.  Given that half of seniors do not consume 
alcohol and drinking tends to decrease in age we would expect that the majority of older adults 
would fall into a developmental trajectory that includes no or low rates of concurrent use.  This 
cohort is most likely comprised of lifetime abstainers and occasional drinkers and individuals in 
this group are at low risk for concurrent use. 
The decreasing use trajectory is characterized by a gradual and steady decrease in 
concurrent use over time.  Rates of concurrent use were moderately high among members of the 
decreasing use group in the initial waves of the study but substantially decreased with time so 
that by the final study wave concurrent use was fairly low among this population.  It is possible 
that this group is characterized by individuals with declining health and / or the addition of new 
alcohol-interactive medications which lead them to make the decision to not drink alcohol.  An 
additional possibility is that members of this trajectory have declining rates of concurrent use 
because new or existing chronic conditions limit their ability to consume alcohol.  Social 
workers and other health care providers should encourage individuals in this cohort to continue 
to curtail their concurrent use and offer support in assisting them in altering their behavior. 
147 
 
The increasing use trajectory is best characterized as a group of individuals whose 
concurrent use fluctuates over time.  Initially levels of concurrent use in the increasing use 
cohort were fairly low. However, concurrent use increases among this population over the course 
of the study.  The most logical explanation for this pattern of concurrent use is this group is 
comprised of individuals who developed new chronic conditions over the course of time and 
these conditions are treated with alcohol-interactive medications.   Yet, despite the introduction 
of a new medication into their regime these individuals continue to consume alcohol; this may be 
due to the fact that patients are under informed about the potential for alcohol-drug interactions.  
Therefore, it is essential that geriatric social workers and health care providers monitor older 
adult’s medication regimes and counsel them about the potential interactions of a medication 
with alcohol each time the regime is altered.   
Finally, the trajectory for the high use cohort is indicative of high-stable rates of 
concurrent use over time.  Individuals in the high use group, approximately 15% of the sample, 
maintained a consistent pattern of concurrently using alcohol and alcohol-interactive medications 
throughout the course of the study.  As stated earlier it is most likely that this group is 
characterized by individuals who have a history of alcohol use and therefore, irrespective of their 
medication regime, they continue to drink.  This group which is disproportionately comprised of 
White males is at an elevated risk for the adverse consequences of concurrent use.  Thus, 
individuals in the aging care network should use consistently screen individuals who meet this 
profile for concurrent use behavior.  In addition, education and prevention strategies should 
target this at risk group. 
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5.1.2.1 Impact of Concurrent Use on the Health Status of Older Adults 
Regression analysis was used to examine the relationship between patterns of concurrent use and 
health status.  Specifically, it was hypothesized that individuals with developmental trajectories 
of ongoing concurrent use would have lower rates of self-reported health, lower levels of 
physical functioning as well as higher rates of depression.  The hypothesis that there was a 
relationship between longitudinal trajectories of concurrent use and health status was partially 
substantiated by the data.   The analysis revealed that specific patterns of concurrent use are 
significantly related to both physical and mental health status among community-dwelling older 
adults however, the directionality of some of the originally hypothesized relationships did not 
hold up.   
The hypothesis that self-reported health status would be lower among concurrent users 
was partially substantiated by the data.  Using good health as the reference category, being male 
increased the odds of reporting excellent to very good health.  Also, Whites were significantly 
more likely than African Americans to report very good health; African Americans had 
significantly higher rates of self-reported fair or poor.  This finding is consistent with research 
that suggests health disparities between Whites and African Americans.  Finally, compared to 
younger individuals, older respondents were significantly more likely to report fair or poor health 
rather than good health.  Members of the high use trajectory were significantly less likely than 
those in the no to low use group members to report excellent health rather than good health; no 
other group membership contrasts were significant.  This finding deviates from the results of the 
initial baseline analysis where no difference was found between concurrent users and non-
concurrent users.  Individuals in the high use may be less likely to report excellent health for a 
number of reasons which may be related to the side effects associated with concurrently using 
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alcohol with alcohol-interactive medications.  An equally valid explanation for this finding is 
that the onset or worsening of existing chronic conditions due to concomitant use has lowered 
the perceived health status for members of this group.  Interestingly, no differences were found 
between the no to low use group and the increasing or decreasing use cohorts.  Given the 
research on self-medication we might expect that individuals in the increasing use group would 
report lower levels of overall health when compared to those in the no to low use group.  An 
alternative explanation for this finding may be that the increasing use of alcohol and medications 
is due to pain management but the addition of additional medications to deal with chronic 
conditions. 
In addition to assessing the relationship between self-reported health status and concurrent 
use, models were run to examine the relationship between concomitant use and physical 
functioning.  Women and older individuals were significantly more likely than men and younger 
respondents to report having any IADLs or ADLs.  Group membership was found to be to total 
number of ADLs.  Respondents in the decreasing use group were more likely than individuals in 
the no to low use group to report having one ADL or two ADLs rather than no ADLs.   This 
finding is of particular interest because it partially substantiates the idea that individuals in the 
decreasing use trajectory are discontinuing concurrent use practices because of declining health 
and / or the addition of new alcohol-interactive medications. 
Depression status was also found to be related to socio-demographic characteristics as 
well as group membership.  There was a significant relationship between gender and depression 
status with females being more likely to have a diagnosis of depression than males.  There was 
also a significant relationship between race and depression status with African Americans having 
a higher rates of depression compared to Whites.  Age was found to be positively associated with 
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depression status; older individuals have higher rates of depression than their younger 
counterparts.  Finally, significant relationships were found between depression status and 
membership in the increasing use and the decreasing use trajectories.  The odds of being 
depressed rather than not depressed increased for individuals in the decreasing use group rather 
than those in the no to low use trajectory.  Increased rates of depression in the decreasing use 
group may be related to declining physical health or the introduction of a new chronic condition 
which has caused mental distress.  It is also possible that members of the decreasing use group 
have chosen to stop drinking because they are being treated for depression.  Conversely being a 
member of the increasing use trajectory was found to be associated with lower levels of 
depression.  Individuals in this group may be in better physical condition and more social 
therefore, they are less likely to be isolated which decreases rates of depression but can effect 
rates of alcohol consumption which can lead to concurrent use. 
Logistic regression revealed that, although group membership was related to specific 
health outcomes, physical and mental health statuses at baseline were the best predictors of 
health status in the final wave of the study.  Although it is not surprising that health status at 
baseline was found to be the greatest predictor of physical and mental health outcomes, it is 
interesting that trajectories of concurrent use were not related to health status in Wave 6.  Group 
membership was expected to predict health status and, although the relationships were in the 
predicted directions, with the exception of self-reported health, they were not significant.  It is 
possible that group membership was not a significant predictor of physical and mental health 
status because the majority of the people fall into the no to low use group.  Thus it is suggested 
that future research further investigate the relationship between overall health and concurrent use 
among older adults with a wide range of health outcomes. 
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Finally, survival analyses of the entire sample (No=5,888) showed a significant 
relationship between concurrent use and mortality.  The interaction of weekly alcohol 
consumption and the total number of alcohol-interactive medications taken at baseline was 
significantly related to duration until death; a one unit increase in time increased the risk of 
mortality by 1.  This finding points to the potentially hazardous consequences of concurrent use 
among older adults.  More research is needed to fully understand how concomitant use impacts 
upon mortality overtime.  Interestingly, having ever concurrently used was inversely related to 
mortality status.  This finding is most likely due to the fact that individuals who live longer are 
more likely to be exposed to alcohol-interactive medications and as a result have a higher 
likelihood of reporting concomitant use. 
5.1.2.2 The Patterns and Consequences of Concurrent Use among Older Adults:    
Implications for Practice 
The risk posed by concurrent alcohol and medication use among older adults is not minimal, 
therefore, from a prevention standpoint it is essential for clinicians to screen for concomitant use 
and to provide warnings to older adults to prevent adverse outcomes.  Although research has 
found that alcohol consumption declines with age, studies have shown that the average amount 
of alcohol consumed by older adults who continue to drink does not change overtime (Adams et 
al., 1990).  The current study reinforces past research, data show that for the majority of study 
participants patterns of concurrent use remained fairly stable over the course of the investigation 
with fluctuation in usage patterns reported by only 18% of concurrent users.  The identification 
of four major patterns of concurrent use has further delineated what we know about concomitant 
behavior among older adults.  This information is particularly useful given demographic 
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projections and alcohol use trends indicate that newer cohorts of older adults are more likely to 
drink and have heavier drinking habits (Patterson, 1999).   
The current investigation substantiates past work which has shown that alcohol use is a 
habitual behavior that tends to carry into late adulthood although consumption levels may be 
reduced.  Given what we know about trends in alcohol consumption it stands to reason that a 
subset of older adults are more likely to engage in concomitant use.  Individuals in the high use 
and increasing use cohorts are at an increased risk for poor health outcomes and lower quality of 
life; these individuals include males, Whites, problem users and individuals taking multiple 
alcohol-interactive medications.  Brief interventions such as harm reduction models can be 
useful in preventing and reducing concurrent use among these at risk groups.  Moreover, policies 
need to be put into place to aid in training of individuals in the Aging care network about 
concurrent use and to assist in establishing a more coordinated system of care. 
Harm reduction strategies may be useful in preventing and lowering concurrent use 
among older adults.  Brief interventions such as harm reduction approaches are useful in that 
they tolerate a continuum of behavior and do not just target individuals at the highest level of 
risk.  Such interventions are designed to increase motivation to change a behavior and are well 
suited for older adults.  In addition, harm reduction strategies are particularly useful for working 
with older adults because they can be carried out in numerous settings by a variety of 
professionals.  Harm reduction strategies are non-confrontational and non-judgmental; they are 
used to encourage learning and self awareness about risky behaviors (Royer et al., 2000).  
Although this type of intervention may not be useful in reducing concurrent use among 
individuals with severe alcohol problems, the current study found that the majority of individuals 
exhibited low to moderate patterns of concurrent use.  High risk concurrent users, typically 
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individuals with alcohol use disorders, will most likely need to be referred to geriatric specific 
substance abuse treatment programs to deal with both their medication use and problem drinking 
behaviors.  However, harm reduction models designed to address concurrent use in low to 
moderate users may be an effective strategy to reducing hazardous medication behavior among 
the majority of older adults who concurrently used.  Harm reduction strategies coupled with 
educational and prevention efforts implemented by social workers and other professionals in the 
Aging care network appears to be a cost effective strategy to addressing concurrent use among 
older adults.      
In addition to brief intervention strategies, policies need to be established to support 
educational initiatives to raise awareness among older adults, families, and caretakers about the 
risks associated with mixing alcohol and medications.  In addition, training programs need to be 
established for social workers, health care providers, and other individuals in the aging care 
network to assist them in understanding the issue of concurrent use among older adults and to 
provide them with the skills necessary to assess and intervene with older adults. 
          Collaboration and communication among professionals and agencies are critical 
components of delivering effective services to older adults.  Community partnerships can foster 
relationships that can increase the coordination of services and assist in the development of a 
continuum of care for seniors. Policies that enhance communication between clients, caregivers, 
social workers and health care professionals play a vital role in reducing potentially hazardous 
behaviors such as concurrent use among older adults. 
Older adults are most likely to come into contact with medical professionals in primary 
care settings, as well as professionals in the aging services network.  It is crucial that these 
individuals receive training in identifying potentially hazardous medication usage patterns in 
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geriatric populations.  In addition, screening tools that are specifically designed for older adults 
and are suited for primary care settings are needed to assist healthcare professionals in 
identifying individuals who are at risk for or are currently concomitantly using alcohol and 
medications.  With education, training, and improved tools professionals in primary care settings 
and the aging services network can play a vital role in preventing, identifying, and treating the 
misuse or abuse of alcohol and medications in older adults.  Unfortunately, programs and 
assessment tools do not exist to provide geriatric social workers and other health care 
professionals who work with older adults with the tools necessary to identify and address 
concurrent alcohol and medication use.   
In order for social workers and other professionals in the aging care network to 
effectively implement strategies aimed at preventing concurrent use as well as programs that deal 
with problems associated with the issue, they must first be educated about the issue themselves.  
Training programs are needed for service providers to help them gain a better understanding of 
alcohol or other drugs in late life and when the use of alcohol and medications may lead to 
negative outcomes for seniors (Spencer, 2008).  Policies need to be established to develop 
programs that provide training to these individuals on how to identify, diagnose, and treat older 
adult with hazardous medication use patterns or other substance abuse issues.  Medicare is one of 
the few federal programs with the ability to implement training initiatives with medical 
professionals and other professionals in the aging services network.   
Public programs, specifically Medicare and Medicaid, currently serve as the primary 
insurers for older adults. Investing in such an initiative would help save the program money in 
future healthcare costs associated with adverse drug reactions and health problems exacerbated 
or caused by concurrent use. If Medicare is committed to combating the abuse and / or misuse of 
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alcohol with medication among older adults, one key strategy would be to establish an outreach 
program designed to enhance education, prevention and screening for alcohol and medication 
abuse and / or misuse among the elderly.  The program would link Medicare to professionals in 
primary care settings and those working in the Aging care network who are uniquely situated to 
identify and address the needs of older adults who concurrently use alcohol and medications.   
Cross-training of healthcare professionals and aging service providers is critical to 
preventing, identifying and treating concurrent use among older Americans.  Healthcare 
professionals along with social workers and mental health service providers need training to 
understand how to effectively work with older adults to promote medication adherence and 
lower rates of concurrent use among this population (SAMHSA, 2002).  Likewise, aging service 
providers need to be trained to identify mental and behavioral health problems in older adults 
(SAMHSA, 2002).  In addition to training, the creation of linkages with community partners, 
healthcare professionals, and aging service providers can help identify substance related 
problems in an aging patient population by creating a system of coordinated care. 
Lastly, funding needs to be made available for research aimed at better understanding the 
barriers to prevention and interventions for older adults who concurrently use alcohol and 
medications.  Future research will be invaluable in assessing the current capacity to deal with 
concurrent use among older adults.  It will help in identifying gaps in service provision, and can 
provide projections regarding future needs of older adults who concomitantly use alcohol and 
medications.  Funding is of particular importance for the implementation and assessment of 
demonstration projects aimed at prevention and intervention with older adult concurrent users. 
Pilot projects are essential to identifying best practices for supporting positive decision making 
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among older adults, their families, and their caregivers concerning their alcohol and medication 
use behavior.  
As the number of older adults dramatically increases over the coming decade, service 
providers as well as the health care system as a whole will face a number of new challenges.  
Current Medicare policies around alcohol and medication use and / or abuse are not 
comprehensive, particularly in the areas of prevention, education, and diagnosis.  The healthcare 
system, especially Medicare, must prepare for the influx of older adults who will need services in 
the next twenty years by developing policies and programs designed to meet the unique needs of 
older adults; in order to do this the Medicare program and other agencies in the aging care 
network will need to being to place more emphasis on prevention.   
In summary, harm reduction models and education programs that raise awareness 
regarding the dangers of medication non-adherence among providers, patients, caregivers and the 
general public will play a key role in reducing adverse health outcomes associated with 
concurrent use thus assisting in lowering overall health care costs.  Additionally, as budgets 
tighten and health care costs increase, federal and state authorities will be increasingly 
challenged to emphasize prevention strategies and find new ways to promote healthy lifestyles 
among older adults.  Education and prevention strategies coupled with an infrastructure of 
coordinated care will go a long way in promoting positive health behaviors and preventing 
potentially harmful activities such as concurrent alcohol and medication use among older adults.   
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5.2 STRENGHTS AND LIMITATIONS OF THE STUDY 
5.2.1 Strengths of Current Study 
The current study attempted to address gaps in the literature regarding concurrent alcohol and 
medication use among community-dwelling older adults.  In addition, this investigation sought to 
address several important methodological issues present in the existing body of knowledge 
regarding concomitant use among older adults; specifically, the present study focused on 
measurement and research design.   
The Cardiovascular Health Study has the major advantage of including a large population 
based community sample of adults 65 years or older.  The CHS data set is a large sample 
comprised of nearly 6,000 individuals randomly selected from four communities located 
throughout the country representing a mix of both urban and rural areas.  The large sample size 
coupled with the random sampling strategy makes this sample applicable to community-dwelling 
older adults in the United States.  Unlike many other existing data sets, the CHS sample is 
comprised of a sufficient amount of both women and African Americans.  Therefore, this study 
is unique in that it allowed for the examination of differences in concurrent alcohol and 
medication use for various subpopulations within this population of community-dwelling older 
adults.  
The majority of research on concurrent alcohol and medication use among older adults 
comes out of acute or primary care settings and is cross-sectional in nature.  The CHS is one of 
the richest available data sets characterizing the health status of the elderly; only a few other 
longitudinal studies have followed cohorts of older individuals for as long as the CHS.  The CHS 
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data set is extensive and includes information from interviews as well as from physical and 
laboratory examinations.  Importantly, the CHS has excellent measures of alcohol use, physical 
and mental health status and, one particularly unique aspect, a vast amount of longitudinal data 
available on medication use.  Therefore, this data set was well suited for examining longitudinal 
patterns of concurrent use.   
The longitudinal nature of the data allowed for the examination of various trajectories of 
concurrent use over the course of the study.  Additionally, the use of longitudinal data made it 
possible to examine how various patterns of concomitant use affect general physical and mental 
health outcomes overtime, something not possible with cross-sectional data.  The extensive 
physical and mental health indicators available in the CHS data set made it feasible to assess 
general health via a number of proxies for physical and mental health status versus “incidents” of 
adverse reactions (ADRs) which is the outcome measure typically used in studies examining 
concurrent use.  The current study was able to move beyond the traditional means of assessing 
the effects of concurrent use on health through acute adverse reactions and examine the effect of 
concurrent use on health status and quality of life.  Finally, because the CHS sample is 
comprised only of community-dwelling older adults, information on alcohol use was obtained 
from a population of individuals representing the spectrum of drinking behavior among older 
adults.  Therefore, it was possible to focus the current study on all individuals in sample not just 
high risk or heavy alcohol users. 
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5.2.2 Limitations of the Current Study 
Despite the numerous strengths of the current study design, there are a number of limitations that 
should be addressed.  First, as with all observational studies, residual confounding factors cannot 
be ruled out. Thus, causal inferences about relationships between concurrent use and health 
status among community-dwelling older adults should be made with caution.   
Second there are several measurement issues that need to be acknowledged as limitation 
of the current study design.  The reliance on self-report measures for several of the central study 
variables including alcohol use and self-reported health status is a cause for concern.  The use of 
self-reported data can be problematic because of a number of issues including possible response 
distortions such as over or under reporting, recall error, and social desirability; this is a 
particularly salient measurement issue in research involving older adults.  Another measurement 
issue concerns the use of the CES-D to assess depression status.  There is the potential for 
misclassification of depression status, a key outcome measure, because the abbreviated version 
of the full CES-D questionnaire was used for this study. However, since several studies have 
found that reducing the screening scale to as little as the five-item CES-D scale resulted in a 
similar sensitivity and specificity compared with the full 20-item CES-D scale, misclassification 
should have been minimal (Irwin et al., 1999 & Turvey et al., 1999; Shrout & Yager, 1989).  One 
last shortfall associated with measurement concerns the variables used to assess physical and 
mental health; there are other indicators of health status that were not addressed in the current 
investigation.  The current study does not include more refined measures of health status that 
may be helpful in assessing the effects of concurrent use on physical and mental health. Future 
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studies should include additional measures of physical health status such as specific chronic 
health conditions and additional proxies for mental health (i.e. anxiety, quality of life indicators).   
Finally, missing data due to incomplete observations, drop-out, and mortality is an issue 
in all longitudinal studies.  Missing data can increase the potential for bias in study results.  In 
the subset of the CHS data used for this study, attrition due to drop out was fairly low, 4.7%; an 
additional 17.3% of the sample was lost to mortality by the final wave of the study.  In order to 
adequately model trajectories of concurrent use, all individuals who had incomplete data on 
concomitant use were dropped from the group-based trajectory analysis as well as the regression 
portion of the analysis.  Although nearly a quarter of the sample was lost to attrition by the final 
wave of the study, the large sample size negates any issues of inadequate power.  The decision to 
only include individuals with information on concurrent use for all six waves of the study 
ensures that information missing at various points is due to incomplete observations and is 
considered missing at random. 
5.3 SUGGESTIONS FOR FUTURE RESEARCH 
 
Although there is an emerging body of literature regarding concurrent use among older adults, 
there is still a dearth of knowledge on the subject particularly when it comes to assessing patterns 
of concurrent use.  The current study has a number of implications for further research in the 
field.  In order to address gaps in the literature, future research should focus on: 1) empirical 
research that continues to explore the prevalence, correlates, and patterns of concurrent use 
among older adults, 2) examination of the relationship between concurrent use and health status 
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and, 3) development and evaluation of educational campaigns and intervention strategies aimed 
at reducing concurrent use among older adults.   
          Future longitudinal studies are needed in order to gain a more complete picture regarding 
concurrent use and its associated covariates among community-dwelling older adults.  Rates of 
combined prevalence of alcohol and medication use among older adults in the United States are 
still unknown however, past studies estimate rates between 40% and 50% which is consistent 
with this study’s findings (Moore et al., 2006).  Variations in prevalence rates are largely due to 
variations in study methodology.  Future research should continue to examine rates of concurrent 
use among this population; efforts should be made to standardize methodological operations of 
concurrent use.   Additionally, empirical studies should continue investigating the covariates of 
concurrent use.  This study found that sociodemographic as well as behavioral variables, such as 
level of alcohol consumption, were related to concurrent use among older adults.  Future 
research should continue to explore the complex relationship between concurrent use and a wide 
variety of factors including factors like total number of alcohol-interactive medications or total 
number of chronic conditions. 
          The current study is one of the first investigations looking at various developmental 
trajectories of concurrent use.  Past research has focused on the relationship between concurrent 
use and ADRs.  The current investigation explored the relationship between concurrent use and 
health status in a new way by charting developmental trajectories of use and examining their 
impact on general health outcomes rather than ADRs.  In the current study, many of the 
hypotheses regarding the relationship between patterns of concurrent use and health status were 
not supported indicating that there is still much to be learned regarding the relationship between 
unique patterns of concurrent use and health outcomes.  Future work should continue to examine 
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the impact of various patterns of concurrent use on the overall health status of older adults.  
Research in this area should also use various health outcomes not included in this study such as 
chronic conditions or quality of life.  Furthermore, future research on concurrent use should look 
at how specific classes of medications and known alcohol-interactive drugs effect the physical 
and mental health status of older adults. 
Finally, future research should focus on the implementation and assessment of 
educational programs, prevention strategies, and intervention with older adult concurrent users. 
Research plays a critical role in defining best practices for social work practitioners and other 
professionals in the aging care network.  Research should begin to develop and test strategies 
aimed at fostering positive decision making among older adults, their families, and their 
caregivers concerning their alcohol and medication use behavior.  Evaluation of the effectiveness 
of public awareness and educational efforts aimed at reducing concurrent use among older adults 
is an important area of future research.  Moreover, future empirical work should also focus on 
assessing the effectiveness of various intervention strategies such as harm reduction models 
which can be adapted to use with older adults who concomitantly use alcohol and medications. 
5.4 CONCLUSION 
The current study examined the prevalence, correlates, patterns and consequences of concurrent 
alcohol and medication use among community-dwelling older adults.  Results suggest that 
concurrent use is fairly common among older adults with over half of the study participants 
reporting concomitant use in at least one of the six waves of the study.  The most common form 
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of concurrent use was drinking below or within recommended guidelines and taking one alcohol-
interactive medication.  Findings from this study provide a greater understanding of the rates of 
concurrent use as well as the socio-demographic characteristics associated with concurrent use 
among older adults.  Results revealed that men, Whites and problem drinkers were significantly 
more likely to concurrently use than women, African Americans and low to moderate alcohol 
users; there were no significant differences by age.  Furthermore, group-based logic analysis 
revealed four distinct patterns of concurrent use: a no to low use group, a decreasing use group, 
an increasing use group, and a high use group.  Males and Whites had the highest probability of 
being in the high use group.  Group membership was found to be related to physical as well as 
mental health.  Furthermore, concurrent use was found to be related to mortality.   
The growing number of older adults coupled with an increasing use of medications 
makes gaining a better understanding of the prevalence and consequences of concurrent use a 
particularly salient issue. Over 50% of older adults report regular alcohol use and the rate of take 
at least one medication for physical and/or mental health issues is rising among seniors.  Over 
the coming decades, the rising number of older adults will probably have an enormous impact on 
the need and demand for health care among this population.  The increased service needs of 
aging alcohol user’s comorbid conditions will most likely place a financial strain on existing 
resources.  The growing population of older adults has made primary disease prevention and 
efforts to promote healthy lifestyles a top priority.  Gaining a better understanding of the 
prevalence, correlates, and consequences of concomitant alcohol and medication use is critical to 
developing prevention and intervention strategies that effectively meet the needs of this unique 
population.   
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In conclusion, understanding the sociodemographic characteristics associated with 
concomitant use will aid social work practitioners and other health care providers who work with 
geriatric populations in identifying individuals at risk for medication non-adherence (i.e. 
concurrent use).  Moreover, understanding various development trajectories of concurrent use 
will be useful in helping to develop prevention and intervention strategies.  Finally, although 
further research is needed to fully understand the relationship, the results of this study suggest 
that there is a connection between various patterns of concurrent use and health status.  
Practitioners can use information on development trajectories of concomitant use to assess 
potential risks for adverse physical and mental health outcomes associated with concurrent use 
that may affect the quality of life among older adults. 
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APPENDIX A 
 
 
 
COMMON ALCOHOL-INTERACTIVE MEDICATIONS USED BY OLDER ADULTS 
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Drug Class 
(Symptoms / Conditions) 
Medication 
(Brand Name)* 
 
Potential Reactions with Alcohol 
 
Analgesics 
(pain relief) 
 
Aspirin 
Aleve 
Excedrin 
Motrin 
Tylenol 
 
 
Stomach upset, bleeding, ulcers 
Liver damage 
Rapid heartbeat 
Antibiotics 
(infections) 
Isoniazid 
Acrodantin 
Flagyl 
Grisactin 
Nizoral 
 
Rapid heartbeat 
Sudden changes in blood pressure 
Stomach pain & upset; vomiting 
Headache 
Liver damage 
 
Anticoagulants 
(prevention of blood clots) 
 
Warfarin 
Coumadin 
Occasional use:  internal bleeding 
Heavy use:  bleeding or can cause 
opposite effect resulting in blood 
clots, strokes, or heart attach 
 
Anticonvulsants 
(seizure disorders) 
 
Phenobarbital 
Dilantin 
Klonopin 
 
Drowsiness & Dizziness 
Increased seizure risk 
Antidiabetic Agents 
(blood sugar regulation) 
 
Glucophage 
Micronase 
Orinase 
 
Abnormally low blood sugar levels 
Nausea & vomiting 
Rapid heartbeat 
Sudden change in blood pressure 
 
Antihistamines 
(allergies, colds) 
 
Benadryl 
Allegra 
Claritin 
Sudafed 
Zyrtec 
 
Drowsiness & Dizziness 
Increased risk of overdose 
Decreased motor skills 
Antihypertension 
(high blood pressure) 
Accupril 
Capozide 
Hytrin 
Lotensin 
Minipress 
Vaseretic 
 
Drowsiness & Dizziness 
Fainting 
Heart problems such as arrhythmia 
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Drug Class 
(Symptoms / Conditions) 
Medication 
(Brand Name)* 
 
Potential Reactions with Alcohol 
 
Barbiturates 
(anesthesia, pain relief) 
 
 
Phenobarbital 
Butalbital 
Pentobarbital 
Secobarbital 
 
 
Increased sedative & hypnotic effects 
Benzodiazepines 
(sedative agent) 
Ativan 
Halcion 
Librium 
Restoril 
Valium 
Xanax 
Drowsiness 
Increased  sedation 
Decreased motor skills 
Histamine antagonists 
(ulcers, heartburn) 
 
Axid 
Reglan 
Tagamet 
Zantac 
 
Increased alcohol effects 
Rapid heartbeat 
Sudden changes in blood pressure 
Imidazopyridines 
(sleep disorders) 
 
Ambien 
Lunesta 
Prosom 
Unisom 
 
Drowsiness & dizziness 
Slowed or difficulty breathing 
Impaired motor skills 
Memory problems 
Increased risk overdose 
 
Muscle relaxants 
(muscle pain) 
 
Flexeril 
Soma 
Drowsiness & dizziness 
Slowed or difficulty breathing 
Increased seizure risk 
Impaired motor skills 
Memory problems 
Increased risk overdose 
 
Narcotic analgesic 
(pain relief) 
Darvocet 
Percocet 
Vicodin 
 
Drowsiness 
Increased  sedation 
Decreased motor skills 
NSAIDs 
(pain relief, inflammation) 
Ibuprofen 
Nalfon 
Naprosyn 
Orudis 
Voltaren 
 
 
 
Risk gastrointestinal bleeding 
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Drug Class 
(Symptoms / Conditions) 
Medication 
(Brand Name)* 
 
Potential Reactions with Alcohol 
Opioids 
(pain relief) 
Codeine 
Fentanyl 
Morphine 
Diaudid 
Darvon 
Demerol 
 
Drowsiness 
Increased  sedation 
Decreased motor skills 
Sedatives & Hypnotics 
 
Noctec 
Equanil 
 
Sleepiness 
Disorientation & incoherence  
Statins 
(high cholesterol) 
Advicor 
Crestor 
Lipitor 
Vytorin 
Zocor 
 
Liver damage 
Nausea & vomiting 
Rapid heartbeat 
Sudden change in blood pressure 
Risk stomach bleeding 
 
Tricyclic antidepressants 
(depression) 
Celexa 
Lexapro 
Paxil 
Prozac 
Zoloft 
Dizziness 
Increased risk of sedation 
Sudden drop in blood pressure 
Increased risk overdose 
 
    *  Generic names are italicized 
    Sources:  NIAAA, 2007; Lococo & Staplin, 2006; Weathermon & Crabb, 1999 
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